>Abagovomab|WholemAb|G1|Kappa|Phase-III|Discontinued|heavy
QVKLQESGAELARPGASVKLSCKASGYTFTNYWMQWVKQRPGQGLDWIGAIYPGDGNTRYTHKFKGKATL
TADKSSSTAYMQLSSLASEDSGVYYCARGEGNYAWFAYWGQGTTVTVSS
>Abagovomab|WholemAb|G1|Kappa|Phase-III|Discontinued|light
DIELTQSPASLSASVGETVTITCQASENIYSYLAWHQQKQGKSPQLLVYNAKTLAGGVSSRFSGSGSGTH
FSLKIKSLQPEDFGIYYCQHHYGILPTFGGGTKLEIK
>Abelacimab|WholemAb|G1|Lambda|Unknown|Unknown|heavy
QVQLLESGGGLVQPGGSLRLSCAASGFTFSTAAMSWVRQAPGKGLEWVSGISGSGSSTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRATAVYYCARELSYLYSGYYFDYWGQGTLVTVSS
>Abelacimab|WholemAb|G1|Lambda|Unknown|Unknown|light
QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNDVSWYQQLPGTAPKLLIYKNYNRPSGVPDRFSGSKSGT
SASLAISGLQSEDEADYYAWDQRQFDVVFGGGTKLTVL
>Abituzumab|WholemAb|G2|Kappa|Phase-II|Active|heavy
QVQLQQSGGELAKPGASVKVSCKASGYTFSSFWMHWVRQAPGQGLEWIGYINPRSGYTEYNEIFRDKATM
TTDTSTSTAYMELSSLRSEDTAVYYCASFLGRGAMDYWGQGTTVTVSS
>Abituzumab|WholemAb|G2|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQDISNYLAWYQQKPGKAPKLLIYYTSKIHSGVPSRFSGSGSGTD
YTFTISSLQPEDIATYYCQQGNTFPYTFGQGTKVEIK
>Abrezekimab|Fab|G1|Kappa|Phase-I|Discontinued|heavy
QVTLKESGPVLVKPTETLTLTCTVSGFSLTNYHVQWIRQPPGKALEWLGVMWSDGDTSFNSVLKSRLTIS
RDTSKSQVVLTMTNMDPVATYYCARDGTIAAMDYFDYWGQGTLVTVSS
>Abrezekimab|Fab|G1|Kappa|Phase-I|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCLASEDISNYLAWYQQKPGKAPKLLIYHTSRLQDGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCGYRFPLTFGGGTKVEIK
>Abrilumab|WholemAb|G2|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKVSGYTLSDLSIHWVRQAPGKGLEWMGGFDPQDGETIYAQKFQGRVTM
TEDTSTDTAYMELSSLKSEDTAVYYCATGSSSSWFDPWGQGTLVTVSS
>Abrilumab|WholemAb|G2|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASNLESGVPSRFSGSGSGTD
FTLTISSLQPEDFANYYCQQANSFPWTFGQGTKVEIK
>Acapatamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|heavy
QVQLVESGGGLVKPGESLRLSCAASGFTFSDYYMYWVRQAPGKCLEWVAIISDGGYYTYYSDIIKGRFTI
SRDNAKNSLYLQMNSLKAEDTAVYYCARGFPLLRHGAMDYWGQGTLVTVSS
>Acapatamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQNVDTNVAWYQQKPGQAPKSLIYSASYVYWDVPSRFSGSASGTD
FTLTISSVQSEDFATYYCQQYDQQLITFGCGTKLEIK
>Actoxumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFSFSNYGMHWVRQAPGKGLEWVALIWYDGSNEDYTDSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARWGMVRGVIDVFDIWGQGTVVTVSS
>Actoxumab|WholemAb|G1|Kappa|Phase-III|Active|light
DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQHKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQANSFPWTFGQGTKVEIK
>Adalimumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSS
>Adalimumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTD
FTLTISSLQPEDVATYYCQRYNRAPYTFGQGTKVEIK
>Adebrelimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWMGRIGPNSGFTSYNEKFKNRVTM
TRDTSTSTVYMELSSLRSEDTAVYYCARGGSSYDYFDYWGQGTTVTVSS
>Adebrelimab|WholemAb|G4|Kappa|Phase-II|Active|light
DIVLTQSPASLAVSPGQRATITCRASESVSIHGTHLMHWYQQKPGQPPKLLIYAASNLESGVPARFSGSG
SGTDFTLTINPVEAEDTANYYCQQSFEDPLTFGQGTKLEIK
>Aducanumab|WholemAb|G1|Kappa|Phase-III|Discontinued|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWFDGTKKYYTDSVKGRFTI
SRDNSKNTLYLQMNTLRAEDTAVYYCARDRGIGARRGPYYMDVWGKGTTVTVSS
>Aducanumab|WholemAb|G1|Kappa|Phase-III|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK
>Afasevikumab|WholemAb|G1|Kappa|Phase-I|Active|heavy
EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGINWSSGGIGYADSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTALYYCARDIGGFGEFYWNFGLWGRGTLVTVSS
>Afasevikumab|WholemAb|G1|Kappa|Phase-I|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSVRSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWPPATFGGGTKVEIK
>Afutuzumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYAFSYSWINWVRQAPGQGLEWMGRIFPGDGDTDYNGKFKGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARNVFDGYWLVYWGQGTLVTVSS
>Afutuzumab|WholemAb|G1|Kappa|Approved|Active|light
DIVMTQTPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGGGTKVEIK
>Alacizumab|di-Fab|na|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLEWVATITSGGSYTYYVDSVKGRFTI
SRDNAKNTLYLQMNSLRAEDTAVYYCVRIGEDALDYWGQGTLVTVSS
>Alacizumab|di-Fab|na|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQDIAGSLNWLQQKPGKAIKRLIYATSSLDSGVPKRFSGSRSGSD
YTLTISSLQPEDFATYYCLQYGSFPPTFGQGTKVEIK
>Alemtuzumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLEWIGFIRDKAKGYTTEYNPSVKGRV
TMLVDTSKNQFSLRLSSVTAADTAVYYCAREGHTAAPFDYWGQGSLVTVSS
>Alemtuzumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKLLIYNTNNLQTGVPSRFSGSGSGTD
FTFTISSLQPEDIATYYCLQHISRPRTFGQGTKVEIK
>Alirocumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLDWVSTISGSGGTTNYADSVKGRFII
SRDSSKHTLYLQMNSLRAEDTAVYYCAKDSNWGNFDLWGRGTLVTVSS
>Alirocumab|WholemAb|G1|Kappa|Approved|Active|light
DIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNRNFLGWYQQKPGQPPNLLIYWASTRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYYCQQYYTTPYTFGQGTKLEIK
>Alnuctamab|BispecificmAbwithDomainCrossover|G1;G1|Kappa;Lambda|TBC|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSDNAMGWVRQAPGKGLEWVSAISGPGSSTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKVLGWFDYWGQGTLVTVSS
>Alnuctamab|BispecificmAbwithDomainCrossover|G1;G1|Kappa;Lambda|TBC|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSDEYLSWYQQKPGQAPRLLIHSASTRATGIPDRFSGSGSGT
DFTLAISRLEPEDFAVYYCQQYGYPPDFTFGQGTKVEIK
>Alsevalimab|WholemAb|G1|Kappa|Phase-I|Active|heavy
QLQLQESGPGLVKPSETLSLTCTVSGGSIKSGSYYWGWIRQPPGKGLEWIGNIYYSGSTYYNPSLRSRVT
ISVDTSKNQFSLKLSSVTAADTAVYYCAREGSYPNQFDPWGQGTLVTVSS
>Alsevalimab|WholemAb|G1|Kappa|Phase-I|Active|light
EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTE
FTLTISSLQSEDFAVYYCQQYHSFPFTFGGGTKVEIK
>Amatuximab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLQQSGPELEKPGASVKISCKASGYSFTGYTMNWVKQSHGKSLEWIGLITPYNGASSYNQKFRGKATL
TVDKSSSTAYMDLLSLTSEDSAVYFCARGGYDGRGFDYWGSGTPVTVSS
>Amatuximab|WholemAb|G1|Kappa|Phase-II|Active|light
DIELTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPGRFSGSGSGNSY
SLTISSVEAEDDATYYCQQWSKHPLTFGSGTKVEIK
>Amivantamab|BispecificmAb|G1|Kappa;Kappa|Phase-I|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVIWDDGSYKYYGDSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARDGITMVRGVMKDYFDYWGQGTLVTVSS
>Amivantamab|BispecificmAb|G1|Kappa;Kappa|Phase-I|Active|light
AIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSESGTD
FTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK
>Andecaliximab|WholemAb|G4|Kappa|Phase-III|Active|heavy
QVQLQESGPGLVKPSETLSLTCTVSGFSLLSYGVHWVRQPPGKGLEWLGVIWTGGTTNYNSALMSRFTIS
KDDSKNTVYLKMNSLKTEDTAIYYCARYYYGMDYWGQGTLVTVSS
>Andecaliximab|WholemAb|G4|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQDVRNTVAWYQQKPGKAPKLLIYSSSYRNTGVPDRFSGSGSGTD
FTLTISSLQAEDVAVYYCQQHYITPYTFGGGTKVEIK
>Anetumab|WholemAbADC|G1|Lambda|Phase-II|Active|heavy
QVELVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQAPGKGLEWMGIIDPGDSRTRYSPSFQGQVTI
SADKSISTAYLQWSSLKASDTAMYYCARGQLYGGTYMDGWGQGTLVTVSS
>Anetumab|WholemAbADC|G1|Lambda|Phase-II|Active|light
DIALTQPASVSGSPGQSITISCTGTSSDIGGYNSVSWYQQHPGKAPKLMIYGVNNRPSGVSNRFSGSKSG
NTASLTISGLQAEDEADYYCSSYDIESATPVFGGGTKLTVL
>Anifrolumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
EVQLVQSGAEVKKPGESLKISCKGSGYIFTNYWIAWVRQMPGKGLESMGIIYPGDSDIRYSPSFQGQVTI
SADKSITTAYLQWSSLKASDTAMYYCARHDIEGFDYWGRGTLVTVSS
>Anifrolumab|WholemAb|G1|Kappa|Phase-III|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFFAWYQQKPGQAPRLLIYGASSRATGIPDRLSGSGSGT
DFTLTITRLEPEDFAVYYCQQYDSSAITFGQGTRLEIK
>Anrukinzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFISYAMSWVRQAPGKGLEWVASISSGGNTYYPDSVKGRFTIS
RDNAKNSLYLQMNSLRAEDTAVYYCARLDGYYFGFAYWGQGTLVTVSS
>Anrukinzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCKASESVDNYGKSLMHWYQQKPGKAPKLLIYRASNLESGVPSRFSGSG
SGTDFTLTISSLQPEDFATYYCQQSNEDPWTFGGGTKVEIK
>Apamistamab|WholemAbRadiolabelled|G1|Kappa|Phase-III|Active|heavy
EVKLLESGGGLVQPGGSLKLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPTSSTINFTPSLKDKVFI
SRDNAKNTLYLQMSKVRSEDTALYYCARGNYYRYGDAMDYWGQGTSVTVSS
>Apamistamab|WholemAbRadiolabelled|G1|Kappa|Phase-III|Active|light
DIALTQSPASLAVSLGQRATISCRASKSVSTSGYSYLHWYQQKPGQPPKLLIYLASNLESGVPARFSGSG
SGTDFTLNIHPVEEEDAATYYCQHSRELPFTFGSGTKLEIK
>Apitegromab|WholemAb|G4|Lambda|TBC|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARDLLVRFLEWSHYYGMDVWGQGTTVTVSS
>Apitegromab|WholemAb|G4|Lambda|TBC|Active|light
QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVHWYQQLPGTAPKLLIYSDNQRPSGVPDRFSGSKSGT
SASLAISGLQSEDEADYYCAAWDDSLNGVFGGGTKLTVL
>Aprutumab|WholemAbADC|G1|Lambda|Phase-I|Discontinued|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGTSTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARVRYNWNHGDWFDPWGQGTLVTVSS
>Aprutumab|WholemAbADC|G1|Lambda|Phase-I|Discontinued|light
QSVLTQPPSASGTPGQRVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYENYNRPAGVPDRFSGSKSGT
SASLAISGLRSEDEADYYCSSWDDSLNYWVFGGGTKLTVL
>Ascrinvacumab|WholemAb|G2|Kappa|Phase-II|Active|heavy
QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGEYYWNWIRQHPGKGLEWIGYIYYSGSTYYNPSLKSRVT
ISVDTSKNQFSLKLSSVTAADTAVYYCARESVAGFDYWGQGTLVTVSS
>Ascrinvacumab|WholemAb|G2|Kappa|Phase-II|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGTSSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSSPITFGQGTRLEIK
>Astegolimab|WholemAb|G2|Kappa|Phase-II|Active|heavy
EVQLVQSGAEVKKPGESLKISCKGSGYSFTNYWIGWVRQMPGKGLEWMGIIYPGNSDTRFSPSFQGQVTI
SADKSITTAYLQWSSLKASDTAMYYCARHGTSSDYYGLDVWGQGTTVTVSS
>Astegolimab|WholemAb|G2|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTD
FTFTISSLQPEDIATYYCQQDDNFPLTFGGGTKVEIK
>Atezolizumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDSWIHWVRQAPGKGLEWVAWISPYGGSTYYADSVKGRFTI
SADTSKNTAYLQMNSLRAEDTAVYYCARRHWPGGFDYWGQGTLVTVSS
>Atezolizumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYLYHPATFGQGTKVEIK
>Atidortoxumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLQESGPGLVRPSETLSLTCAVSGYSISSGMGWGWIRQPPGKGLEWIGSIDQRGSTYYNPSLKSRVTI
SVDTSKNQFSLKLSSVTAADTAVYYCARDAGHAVDMDVWGKGTTVTVSS
>Atidortoxumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSVSASVGDRVTITCRASQGISRWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQGYVFPLTFGGGTKVEIK
>Atinumab|WholemAb|G4|Kappa|Phase-I|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWMSWVRQAPGKGLEWVATIKQDGSQKNYVDSVKGRFTI
SRDNAKNSLYLRLNSLRAEDTAVYYCATELFDLWGRGSLVTVSS
>Atinumab|WholemAb|G4|Kappa|Phase-I|Discontinued|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWPITFGQGTKLEIK
>Atoltivimab|WholemAb|G1|Kappa|Preregistration|Discontinued|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFNNYGMHWVRQAPGMGLEWVAVIWHDGSDKYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARNWNLFDYWGQGTLVTVSS
>Atoltivimab|WholemAb|G1|Kappa|Preregistration|Discontinued|light
DIQMTQSPSSLSASVGDRITITCRASQSISTYLHWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQSFSTPPINFGQGTKLEIK
>Avdoralimab|WholemAb|G1|Kappa|Phase-I|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYVMHWVRQATGKGLEWVSAIDTGGGTYYADSVKGRFTIS
RENAKNSLYLQMNSLRAGDTAVYYCARDYYYYASGSYYKAFDIWGQGTMVTVSS
>Avdoralimab|WholemAb|G1|Kappa|Phase-I|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSRYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSPLTFGQGTKLEIK
>Avelumab|WholemAb|G1|Lambda|Approved|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYIMMWVRQAPGKGLEWVSSIYPSGGITFYADTVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARIKLGTVTTVDYWGQGTLVTVSS
>Avelumab|WholemAb|G1|Lambda|Approved|Active|light
QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSG
NTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL
>Avizakimab|WholemAb|G1|Kappa|Phase-I/II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYWMHWVRQAPGQGLEWMGTIDPSDQYTIYSQNFKGRVTM
TRDTSTSTVYMELSSLRSEDTAVYYCARYGFAMDYWGQGTLVTVSS
>Avizakimab|WholemAb|G1|Kappa|Phase-I/II|Active|light
DIQLTQSPSSLSASVGDRVTITCRASQDISNFLNWYQQKPGKAVKLLIYYTSRLHSGVPSRFSGSGSGTD
YTLTISSLQPEDFATYYCQQGHTLPRTFGGGTKVEIK
>Axatalimab|WholemAb|G4|Kappa|Unknown|Active|heavy
EVTLKESGPALVKPTQTLTLTCTFSGFSLTTYGMGVGWIRQPPGKALEWLANIWWDDDKYYNPSLKNRLT
ISKDTSKNQVVLTMTNMDPVDTATYYCARIGPIKYPTAPYRYFDFWGQGTMVTVSS
>Axatalimab|WholemAb|G4|Kappa|Unknown|Active|light
DIQMTQSPSSLSASVGDRVTITCLASEDIYDNLAWYQQKPGKAPKLLIYYASSLQDGVPSRFSGSGSGTD
YTLTISSLQPEDFATYYCLQDSEYPWTFGGGTKVEIK
>Azintuxizumab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYYMAWVRQAPGKGLEWVASINYDGSSTYYVDSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARDRGYYFDYWGQGTTVTVSS
>Azintuxizumab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|light
DVVMTQTPLSLSVTPGQPASISCRSSQSLVHSNGNTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYFCSQSTHVPPFTFGGGTKVEIK
>Balstilimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCASNGDHWGQGTLVTVSS
>Balstilimab|WholemAb|G4|Kappa|Phase-II|Active|light
EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTE
FTLTISSLQSEDFAVYYCQQYNNWPRTFGQGTKVEIK
>Bapineuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYGMSWVRQAPGKGLEWVASIRSGGGRTYYSDNVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCVRYDHYSGSSDYWGQGTLVTVSS
>Bapineuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DVVMTQSPLSLPVTPGEPASISCKSSQSLLDSDGKTYLNWLLQKPGQSPQRLIYLVSKLDSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCWQGTHFPRTFGQGTKVEIK
>Bapotulimab|WholemAb|G2|Kappa|TBC|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPILGIANYAQKFQGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARGRLPYGDFWDSWGQGTLVTVSS
>Bapotulimab|WholemAb|G2|Kappa|TBC|Active|light
DIVMTQSPLSLPVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCMQALQTPLTFGGGTKLEIR
>Barecetamab|WholemAb|G1|Lambda|TBC|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSDYDMSWVRQAPGKGLEWVSTIDLDSGSIYYADSVQGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKDLHMGPEGPFDYWGQGTLVTVSS
>Barecetamab|WholemAb|G1|Lambda|TBC|Active|light
QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNSVSWYQQLPGTAPKLLIYSDNHRPSGVPDRFSGSKSGT
SASLAISGLRSEDEADYYCQGWDTSLSGHVFGGGTKLTVL
>Basiliximab|WholemAb|G1|Kappa|Approved|NFD|heavy
QVQLQQSGTVLARPGASVKMSCKASGYSFTRYWMHWIKQRPGQGLEWIGAIYPGNSDTSYNQKFEGKAKL
TAVTSASTAYMELSSLTHEDSAVYYCSRDYGYYFDFWGQGTTLTVSS
>Basiliximab|WholemAb|G1|Kappa|Approved|NFD|light
QIVSTQSPAIMSASPGEKVTMTCSASSSRSYMQWYQQKPGTSPKRWIYDTSKLASGVPARFSGSGSGTSY
SLTISSMEAEDAATYYCHQRSSYTFGGGTKLEIK
>Batoclimab|WholemAb|G1|Lambda|Phase-II|Active|heavy
QLLLQESGPGLVKPSETLSLTCTVSGGSLSSSFSYWVWIRQPPGKGLEWIGTIYYSGNTYYNPSLKSRLT
ISVDTSKNHFSLKLSSVTAADTAVYYCARRAGILTGYLDSWGQGTLVTVSS
>Batoclimab|WholemAb|G1|Lambda|Phase-II|Active|light
SYVLTQSPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSASNSGNTA
TLTISRVEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL
>Bavituximab|WholemAb|G1|Kappa|Phase-III|Active|heavy
EVQLQQSGPELEKPGASVKLSCKASGYSFTGYNMNWVKQSHGKSLEWIGHIDPYYGDTSYNQKFRGKATL
TVDKSSSTAYMQLKSLTSEDSAVYYCVKGGYYGHWYFDVWGAGTTVTVSS
>Bavituximab|WholemAb|G1|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASLGERVSLTCRASQDIGSSLNWLQQGPDGTIKRLIYATSSLDSGVPKRFSGSRSGSD
YSLTISSLESEDFVDYYCLQYVSSPPTFGAGTKLELK
>Bedinvetmab|CanineWholemAb|G2|Lambda|Unknown|Active|heavy
EVQLVESGGDLVKPGGSLRLSCVASGFTFSSHGMHWVRQSPGKGLQWVAVINSGGSSTYYTDAVKGRFTI
SRDNAKNTVYLQMNSLRAEDTAMYYCAKESVGGWEQLVGPHFDYWGQGTLVIVSS
>Bedinvetmab|CanineWholemAb|G2|Lambda|Unknown|Active|light
QSVLTQPTSVSGSLGWRVTISCSGSTNNIGILGASWYQLFPGKAPKLLVYGNGNRPSGVPDRFSGADSGD
SVTLTITGLQAEDEADYYCQSFDTTLGAHVFGGGTHLTVL
>Befovacimab|WholemAb|G2|Lambda|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMDWVRQAPGKGLEWVSSIRGSRGSTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARLYRYWFDYWGQGTLVTVSS
>Befovacimab|WholemAb|G2|Lambda|Phase-II|Active|light
SYELTQPPSVSVSPGQTARITCSGDNLPKYYAHWYQQKPGQAPVVVIFYDVNRPSGIPERFSGSNSGNTA
TLTISGTQAMDEADYYCQAWWSSTPVFGGGTKLTVL
>Begelomab|WholemAb|G2b|Kappa|Phase-II/III|Active|heavy
QVQLQQSGAELVKPGASVKLSCKASGYTFRSYDINWVRQRPEQGLEWIGWIFPGDGSTKYNEKFKGKATL
TTDKSSSTAYMQLSRLTSEDSAVYFCARWTVVGPGYFDVWGAGTTVTVSS
>Begelomab|WholemAb|G2b|Kappa|Phase-II/III|Active|light
QIVLTQSPAIMSASPGEKVTITCSASSSVSYMNWFQQKPGTSPKLWIYSTSNLASGVPARFSGSGSGTSY
SLTISRMEAEDAATYYCQQRSSYPNTFGGGTKLEIK
>Belantamab|WholemAbADC|G1|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYWMHWVRQAPGQGLEWMGATYRGHSDTYYNQKFKGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARGAIYDGYDVLDNWGQGTLVTVSS
>Belantamab|WholemAbADC|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKLLIYYTSNLHSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYRKLPWTFGQGTKLEIK
>Belimumab|WholemAb|G1|Lambda|Approved|Active|heavy
QVQLQQSGAEVKKPGSSVRVSCKASGGTFNNNAINWVRQAPGQGLEWMGGIIPMFGTAKYSQNFQGRVAI
TADESTGTASMELSSLRSEDTAVYYCARSRDLLLFPHHALSPWGRGTMVTVSS
>Belimumab|WholemAb|G1|Lambda|Approved|Active|light
SSELTQDPAVSVALGQTVRVTCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTA
SLTITGAQAEDEADYYCSSRDSSGNHWVFGGGTELTVL
>Bemarituzumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYIFTTYNVHWVRQAPGQGLEWIGSIYPDNGDTSYNQNFKGRATI
TADKSTSTAYMELSSLRSEDTAVYYCARGDFAYWGQGTLVTVSS
>Bemarituzumab|WholemAb|G1|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQGVSNDVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTD
FTFTISSLQPEDIATYYCQQHSTTPYTFGQGTKLEIK
>Benralizumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVQSGAEVKKPGASVKVSCKASGYTFTSYVIHWVRQRPGQGLAWMGYINPYNDGTKYNERFKGKVTI
TSDRSTSTVYMELSSLRSEDTAVYLCGREGIRYYGLLGDYWGQGTLVTVSS
>Benralizumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCGTSEDIINYLNWYQQKPGKAPKLLIYHTSRLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQGYTLPYTFGQGTKVEIK
>Bentracimab|WholemAb|G1|Lambda|TBC|Active|heavy
QVQLQESGAEVKKPGSSVRVSCKASGGTFDSYSIHWVRQAPGQGLEWMGGIIPAFGTLSSAQDFQARVTI
SADKSTSTAYMELSGLRSEDTAVYYCARGSFDYYFWSASHPPNDALAIWGQGTLVTVSS
>Bentracimab|WholemAb|G1|Lambda|TBC|Active|light
QSVVTQPPSVSAAPGQKVTISCSGSNSDIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGT
SATLAITGLQAGDEADYYCGTWLYDRAVGLFGGGTKVTVL
>Benufutamab|WholemAb|G1|Kappa|Phase-I/II|Active|heavy
EVQLQQSGAEVVKPGASVKLSCKASGFNIKDTFIHWVKQAPGQGLEWIGRIDPANTNTKYDPKFQGKATI
TTDTSSNTAYMELSSLRSEDTAVYYCVRGLYTYYFDYWGQGTLVTVSS
>Benufutamab|WholemAb|G1|Kappa|Phase-I/II|Active|light
EIVMTQSPATLSVSPGERATLSCRASQSISNNLHWYQQKPGQAPRLLIKFASQSITGIPARFSGSGSGTE
FTLTISSLQSEDFAVYYCQQGNSWPYTFGQGTKLEIK
>Bepranemab|WholemAb|G4|Kappa|Phase-I|Active|heavy
EVQLQESGPGLVKPSETLSLTCTVSGFSLTSNDIAWIRQPPGKGLEWMGTIWTDGSTNYNTAVQSRVTIS
VDTSKNQFSLKLSSVTAADTAVYYCARHRLYYGAFDYWGQGTMVTVSS
>Bepranemab|WholemAb|G4|Kappa|Phase-I|Active|light
DIVMTQTPLSLSVTPGQPASISCRSSQSLEYSDGYTYLEWYLQKPGQSPQLLIYEVSNRFSGVPDRFSGS
GSGTDDFTLKISRVEAEDVGVYYCFQATHNPYTFGQGTKLEIK
>Berlimatoxumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
ELQLQESGPGLVKPSETLSLTCTVSGGSISSGSYYWDWIRQPPGKGLEWIGNIYKSGSTYYNPSLKSRVT
ISVDTSKNQFSLKLSSVTAADTAVYYCARERGMHYMDVWGKGTTVTVSS
>Berlimatoxumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQSINSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQQFDPPFTFGGGTKVEIK
>Bermekimab|WholemAb|G1|Kappa|Preregistration|Active|heavy
QVQLVESGGGVVQPGRSLRLSCTASGFTFSMFGVHWVRQAPGKGLEWVAAVSYDGSNKYYAESVKGRFTI
SRDNSKNILFLQMDSLRLEDTAVYYCARGRPKVVIPAPLAHWGQGTLVTFSS
>Bermekimab|WholemAb|G1|Kappa|Preregistration|Active|light
DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYEASNLETGVPSRFSGSGSGSD
FTLTISSLQPEDFATYYCQQTSSFLLSFGGGTKVEHK
>Bersanlimab|WholemAb|G1|Lambda|Phase-II|Discontinued|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVAFIWYDGSNKYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARYSGWYFDYWGQGTLVTVSS
>Bersanlimab|WholemAb|G1|Lambda|Phase-II|Discontinued|light
QSVLTQPPSASGTPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYDNNNRPSGVPDRFSGSKSG
TSASLAISGLRSEDEADYYCQSYDSSLSAWLFGGGTKLTVL
>Bevacizumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYTFTNYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTF
SLDTSKSTAYLQMNSLRAEDTAVYYCAKYPHYYGSSHWYFDVWGQGTLVTVSS
>Bevacizumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK
>Bexmarilimab|WholemAb|G4|Kappa|Phase-I/II|Active|heavy
QVTLKESGPTLVKPTQTLTLTCSFSGFSLSTSGMGIGWIRQPPGKALEWLAHIWWDDDKRYNPALKSRLT
ISKDTSKNQVVLTMTNMDPVDTATYYCARHYGYDPYYAMDYWGQGTLVTVSS
>Bexmarilimab|WholemAb|G4|Kappa|Phase-I/II|Active|light
EIVLTQSPGTLSLSPGERATLSCTASSSVSSSYLHWYQQKPGKAPKLLIYRTSNLASGVPSRFSGSGSGT
DYTLTISSLQPEDFATYYCHQYHRSPPTFGQGTKLEIK
>Bezlotoxumab|WholemAb|G1|Kappa|Approved|NFD|heavy
EVQLVQSGAEVKKSGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIFYPGDSSTRYSPSFQGQVTI
SADKSVNTAYLQWSSLKASDTAMYYCARRRNWGNAFDIWGQGTMVTVSS
>Bezlotoxumab|WholemAb|G1|Kappa|Approved|NFD|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSSTWTFGQGTKVEIK
>Bifikafusp|WholemAbFusion|E|Kappa|Phase-III|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSFSMSWVRQAPGKGLEWVSSISGSSGTTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKPFPYFDYWGQGTLVTVSS
>Bifikafusp|WholemAbFusion|E|Kappa|Phase-III|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFLAWYQQKPGQAPRLLIYYASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQTGRIPPTFGQGTKVEIK
>Bimagrumab|WholemAb|G1|Lambda|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSSYINWVRQAPGQGLEWMGTINPVSGSTSYAQKFQGRVTM
TRDTSISTAYMELSRLRSDDTAVYYCARGGWFDYWGQGTLVTVSS
>Bimagrumab|WholemAb|G1|Lambda|Phase-II|Active|light
QSALTQPASVSGSPGQSITISCTGTSSDVGSYNYVNWYQQHPGKAPKLMIYGVSKRPSGVSNRFSGSKSG
NTASLTISGLQAEDEADYYCGTFAGGSYYGVFGGGTKLTVL
>Bimekizumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYNMAWVRQAPGKGLEWVATITYEGRNTYYRDSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCASPPQYYEGSIYRLWFAHWGQGTLVTVSS
>Bimekizumab|WholemAb|G1|Kappa|Phase-III|Active|light
AIQLTQSPSSLSASVGDRVTITCRADESVRTLMHWYQQKPGKAPKLLIYLVSNSEIGVPDRFSGSGSGTD
FRLTISSLQPEDFATYYCQQTWSDPWTFGQGTKVEIK
>Bintrafusp|WholemAbFusion|G1|Lambda|Approved|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYIMMWVRQAPGKGLEWVSSIYPSGGITFYADTVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARIKLGTVTTVDYWGQGTLVTVSS
>Bintrafusp|WholemAbFusion|G1|Lambda|Approved|Active|light
QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSG
NTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL
>Birtamimab|WholemAb|G1|Kappa|Phase-III|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFNTYAMYWIRQAPGKGLEWVARIRSKSNNYAIYYADSVKDRF
TISRDDSKNSLYLQMNSLKTEDTAVYYCARPYSDSFAYWGQGTLVTVSS
>Birtamimab|WholemAb|G1|Kappa|Phase-III|Discontinued|light
DVVMTQSPLSLPVTPGEPASISCRSSQSLVHSTGNTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCSQSTHVPFTFGGGTKVEIK
>Bleselumab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QLQLQESGPGLLKPSETLSLTCTVSGGSISSPGYYGGWIRQPPGKGLEWIGSIYKSGSTYHNPSLKSRVT
ISVDTSKNQFSLKLSSVTAADTAVYYCTRPVVRYFGWFDPWGQGTLVTVSS
>Bleselumab|WholemAb|G4|Kappa|Phase-II|Active|light
AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASNLESGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQFNSYPTFGQGTKVEIK
>Blinatumomab|BispecificT-CellEngager|na|Kappa;Kappa|Approved|Active|heavy
QVQLQQSGAELVRPGSSVKISCKASGYAFSSYWMNWVKQRPGQGLEWIGQIWPGDGDTNYNGKFKGKATL
TADESSSTAYMQLSSLASEDSAVYFCARRETTTVGRYYYAMDYWGQGTTVTVSS
>Blinatumomab|BispecificT-CellEngager|na|Kappa;Kappa|Approved|Active|light
DIQLTQSPASLAVSLGQRATISCKASQSVDYDGDSYLNWYQQIPGQPPKLLIYDASNLVSGIPPRFSGSG
SGTDFTLNIHPVEKVDAATYHCQQSTEDPWTFGGGTKLEIK
>Blontuvetmab|CanineWholemAb|G2|Kappa|Unknown|Active|heavy
QVQLQQSRAELVRPGASVTLSCKPSGYTFTDYEVHWVKQTPVHGLEWIGAIDPETGGTADNQKFKGKAIL
TADKSSSTAYMELRSLTSEDSAVYYCTNFVDVWGTGTTVTVSS
>Blontuvetmab|CanineWholemAb|G2|Kappa|Unknown|Active|light
DVVMSQSPSSLAVSVGEKVTMSCKSSQSLLYSGNQKNYLAWYQQKPGQSPRLLIYWASTRESGVPDRFTG
SGSGTDFTLTISSVKAEDLAVFYCQQYYNYPLTFGGGTHL
>Blosozumab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKVSGFPIKDTFQHWVRQAPGKGLEWMGWSDPEIGDTEYASKFQGRVTM
TEDTSTDTAYMELSSLRSEDTAVYYCATGDTTYKFDFWGQGTTVTVSS
>Blosozumab|WholemAb|G4|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQDVHTAVAWYQQKPGKAPKLLIYWASTRWTGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYSDYPWTFGGGTKVEIK
>Bococizumab|WholemAb|G2|Kappa|Phase-III|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGEISPFGGRTNYNEKFKSRVTM
TRDTSTSTVYMELSSLRSEDTAVYYCARERPLYASDLWGQGTTVTVSS
>Bococizumab|WholemAb|G2|Kappa|Phase-III|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTD
FTFTISSLQPEDIATYYCQQRYSLWRTFGQGTKLEIK
>Brazikumab|WholemAb|G2|Lambda|Phase-II/III|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNEYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARDRGYTSSWYPDAFDIWGQGTMVTVSS
>Brazikumab|WholemAb|G2|Lambda|Phase-II/III|Active|light
QSVLTQPPSVSGAPGQRVTISCTGSSSNTGAGYDVHWYQQVPGTAPKLLIYGSGNRPSGVPDRFSGSKSG
TSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTRLTVL
>Brentuximab|WholemAbADC|G1|Kappa|Approved|Active|heavy
QIQLQQSGPEVVKPGASVKISCKASGYTFTDYYITWVKQKPGQGLEWIGWIYPGSGNTKYNEKFKGKATL
TVDTSSSTAFMQLSSLTSEDTAVYFCANYGNYWFAYWGQGTQVTVSA
>Brentuximab|WholemAbADC|G1|Kappa|Approved|Active|light
DIVLTQSPASLAVSLGQRATISCKASQSVDFDGDSYMNWYQQKPGQPPKVLIYAASNLESGIPARFSGSG
SGTDFTLNIHPVEEEDAATYYCQQSNEDPWTFGGGTKLEIK
>Briakinumab|WholemAb|G1|Lambda|Preregistration(w)|Discontinued|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAFIRYDGSNKYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCKTHGSHDNWGQGTMVTVSS
>Briakinumab|WholemAb|G1|Lambda|Preregistration(w)|Discontinued|light
QSVLTQPPSVSGAPGQRVTISCSGSRSNIGSNTVKWYQQLPGTAPKLLIYYNDQRPSGVPDRFSGSKSGT
SASLAITGLQAEDEADYYCQSYDRYTHPALLFGTGTKVTVL
>Brodalumab|WholemAb|G2|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTRYGISWVRQAPGQGLEWMGWISTYSGNTNYAQKLQGRVTM
TTDTSTSTAYMELRSLRSDDTAVYYCARRQLYFDYWGQGTLVTVSS
>Brodalumab|WholemAb|G2|Kappa|Approved|Active|light
EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWFQQKPGQAPRPLIYDASTRATGVPARFSGSGSGTD
FTLTISSLQSEDFAVYYCQQYDNWPLTFGGGTKVEIK
>Brolucizumab|scFv|na|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCTASGFSLTDYYYMTWVRQAPGKGLEWVGFIDPDDDPYYATWAKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAGGDHNSGWGLDIWGQGTLVTVSS
>Brolucizumab|scFv|na|Kappa|Approved|Active|light
EIVMTQSPSTLSASVGDRVIITCQASEIIHSWLAWYQQKPGKAPKLLIYLASTLASGVPSRFSGSGSGAE
FTLTISSLQPDDFATYYCQNVYLASTNGANFGQGTKLTVL
>Brontictuzumab|WholemAb|G2|Lambda|Phase-I|Active|heavy
QVQLVQSGAEVKKPGASVKISCKVSGYTLRGYWIEWVRQAPGKGLEWIGQILPGTGRTNYNEKFKGRVTM
TADTSTDTAYMELSSLRSEDTAVYYCARFDGNYGYYAMDYWGQGTTVTVSS
>Brontictuzumab|WholemAb|G2|Lambda|Phase-I|Active|light
QAVVTQEPSLTVSPGGTVTLTCRSSTGAVTTSNYANWFQQKPGQAPRTLIGGTNNRAPGVPARFSGSLLG
GKAALTLSGAQPEDEAEYYCALWYSNHWVFGGGTKLTVL
>Budigalimab|WholemAb|G1|Kappa|Phase-I|Active|heavy
EIQLVQSGAEVKKPGSSVKVSCKASGYTFTHYGMNWVRQAPGQGLEWVGWVNTYTGEPTYADDFKGRLTF
TLDTSTSTAYMELSSLRSEDTAVYYCTREGEGLGFGDWGQGTTVTVSS
>Budigalimab|WholemAb|G1|Kappa|Phase-I|Active|light
DVVMTQSPLSLPVTPGEPASISCRSSQSIVHSHGDTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCFQGSHIPVTFGQGTKLEIK
>Burosumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTNHYMHWVRQAPGQGLEWMGIINPISGSTSNAQKFQGRVTM
TRDTSTSTVYMELSSLRSEDTAVYYCARDIVDAFDFWGQGTMVTVSS
>Burosumab|WholemAb|G1|Kappa|Approved|Active|light
AIQLTQSPSSLSASVGDRVTITCRASQGISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQFNDYFTFGPGTKVDIK
>Cabiralizumab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDNYMIWVRQAPGQGLEWMGDINPYNGGTTFNQKFKGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARESPYFSNLYVMDYWGQGTLVTVSS
>Cabiralizumab|WholemAb|G4|Kappa|Phase-II|Active|light
EIVLTQSPATLSLSPGERATLSCKASQSVDYDGDNYMNWYQQKPGQAPRLLIYAASNLESGIPARFSGSG
SGTDFTLTISSLEPEDFAVYYCHLSNEDLSTFGGGTKVEIK
>Camidanlumab|WholemAbADC|G1|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSRYIINWVRQAPGQGLEWMGRIIPILGVENYAQKFQGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARKDWFDYWGQGTLVTVSS
>Camidanlumab|WholemAbADC|G1|Kappa|Phase-II|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTD
FTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK
>Camrelizumab|WholemAb|G4|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYMMSWVRQAPGKGLEWVATISGGGANTYYPDSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARQLYYFDYWGQGTTVTVSS
>Camrelizumab|WholemAb|G4|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCLASQTIGTWLTWYQQKPGKAPKLLIYTATSLADGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQVYSIPWTFGGGTKVEIK
>Canakinumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSVYGMNWVRQAPGKGLEWVAIIWYDGDNQYYADSVKGRFTI
SRDNSKNTLYLQMNGLRAEDTAVYYCARDLRTGPFDYWGQGTLVTVSS
>Canakinumab|WholemAb|G1|Kappa|Approved|Active|light
EIVLTQSPDFQSVTPKEKVTITCRASQSIGSSLHWYQQKPDQSPKLLIKYASQSFSGVPSRFSGSGSGTD
FTLTINSLEAEDAAAYYCHQSSSLPFTFGPGTKVDIK
>Cantuzumab|WholemAbADC|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGETVKISCKASDYTFTYYGMNWVKQAPGQGLKWMGWIDTTTGEPTYAQKFQGRIAF
SLETSASTAYLQIKSLKSEDTATYFCARRGPYNWYFDVWGQGTTVTVSS
>Cantuzumab|WholemAbADC|G1|Kappa|Phase-II|Discontinued|light
DIVMTQSPLSVPVTPGEPVSISCRSSKSLLHSNGNTYLYWFLQRPGQSPQLLIYRMSNLVSGVPDRFSGS
GSGTAFTLRISRVEAEDVGVYYCLQHLEYPFTFGPGTKLELK
>Caplacizumab|Nanobody|na|na|Approved|NFD|heavy
EVQLVESGGGLVQPGGSLRLSCAASGRTFSYNPMGWFRQAPGKGRELVAAISRTGGSTYYPDSVEGRFTI
SRDNAKRMVYLQMNSLRAEDTAVYYCAAAGVRAEDGRVRTLPSEYTFWGQGTQVTVSS
>Carlumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYGISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTI
TADESTSTAYMELSSLRSEDTAVYYCARYDGIYGELDFWGQGTLVTVSS
>Carlumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
EIVLTQSPATLSLSPGERATLSCRASQSVSDAYLAWYQQKPGQAPRLLIYDASSRATGVPARFSGSGSGT
DFTLTISSLEPEDFAVYYCHQYIQLHSFTFGQGTKVEIK
>Carotuximab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVKLEESGGGLVQPGGSMKLSCAASGFTFSDAWMDWVRQSPEKGLEWVAEIRSKASNHATYYAESVKGRF
TISRDDSKSSVYLQMNSLRAEDTGIYYCTRWRRFFDSWGQGTTLTVSS
>Carotuximab|WholemAb|G1|Kappa|Phase-II|Active|light
QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSY
SLTISRVEAEDAATYYCQQWSSNPLTFGAGTKLELK
>Cemiplimab|WholemAb|G4|Kappa|Approved|Active|heavy
EVQLLESGGVLVQPGGSLRLSCAASGFTFSNFGMTWVRQAPGKGLEWVSGISGGGRDTYFADSVKGRFTI
SRDNSKNTLYLQMNSLKGEDTAVYYCVKWGNIYFDYWGQGTLVTVSS
>Cemiplimab|WholemAb|G4|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDSITITCRASLSINTFLNWYQQKPGKAPNLLIYAASSLHGGVPSRFSGSGSGTD
FTLTIRTLQPEDFATYYCQQSSNTPFTFGPGTVVDFR
>Cendakimab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVTLRESGPGLVKPTQTLTLTCTLYGFSLSTSDMGVDWIRQPPGKGLEWLAHIWWDDVKRYNPALKSRLT
ISKDTSKNQVVLKLTSVDPVDTATYYCARTVSSGYIYYAMDYWGQGTLVTVSS
>Cendakimab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTISCRASQDIRNYLNWYQQKPGKAPKLLIFYTSKLHSGVPSRFSGSGSGTD
YTLTISSLQPEDIATYYCQQGNTLPLTFGGGTKVEIK
>Cergutuzumab|WholemAbFusion|G1|Kappa|Phase-I|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTEFGMNWVRQAPGQGLEWMGWINTKTGEATYVEEFKGRVTF
TTDTSTSTAYMELRSLRSDDTAVYYCARWDFAYYVEAMDYWGQGTTVTVSS
>Cergutuzumab|WholemAbFusion|G1|Kappa|Phase-I|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCKASAAVGTYVAWYQQKPGKAPKLLIYSASYRKRGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCHQYYTYPLFTFGQGTKLEIK
>Certolizumab|Fab|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYVFTDYGMNWVRQAPGKGLEWMGWINTYIGEPIYADSVKGRFTF
SLDTSKSTAYLQMNSLRAEDTAVYYCARGYRSYAMDYWGQGTLVTVSS
>Certolizumab|Fab|G1|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQNVGTNVAWYQQKPGKAPKALIYSASFLYSGVPYRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYNIYPLTFGQGTKVEIK
>Cetrelimab|WholemAb|G4|Kappa|Phase-II/III|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFDTANYAQKFQGRVTI
TADESTSTAYMELSSLRSEDTAVYYCARPGLAAAYDTGSLDYWGQGTLVTVSS
>Cetrelimab|WholemAb|G4|Kappa|Phase-II/III|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSVRSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRNYWPLTFGQGTKVEIK
>Cetuximab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSIN
KDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSA
>Cetuximab|WholemAb|G1|Kappa|Approved|Active|light
DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTD
FTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELK
>Cevostamab|BispecificmAb|G1|Kappa;Kappa|Phase-I|Active|heavy
EVQLVESGPGLVKPSETLSLTCTVSGFSLTRFGVHWVRQPPGKGLEWLGVIWRGGSTDYNAAFVSRLTIS
KDNSKNQVSLKLSSVTAADTAVYYCSNHYYGSSDYALDNWGQGTLVTVSS
>Cevostamab|BispecificmAb|G1|Kappa;Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQDVRNLVVWFQQKPGKAPKLLIYSGSYRYSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQHYSPPYTFGQGTKVEIK
>Cibisatamab|BispecificmAbwithDomainCrossover|G1|Kappa;Lambda|Phase-I/II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTEFGMNWVRQAPGQGLEWMGWINTKTGEATYVEEFKGRVTF
TTDTSTSTAYMELRSLRSDDTAVYYCARWDFAYYVEAMDYWGQGTTVTVSS
>Cibisatamab|BispecificmAbwithDomainCrossover|G1|Kappa;Lambda|Phase-I/II|Active|light
DIQMTQSPSSLSASVGDRVTITCKASAAVGTYVAWYQQKPGKAPKLLIYSASYRKRGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCHQYYTYPLFTFGQGTKLEIK
>Cinpanemab|WholemAb|G1|Lambda|Phase-II|Active|heavy
EVQLVESGGGLVEPGGSLRLSCAVSGFDFEKAWMSWVRQAPGQGLQWVARIKSTADGGTTSYAAPVEGRF
IISRDDSRNMLYLQMNSLKTEDTAVYYCTSAHWGQGTLVTVSS
>Cinpanemab|WholemAb|G1|Lambda|Phase-II|Active|light
SYELTQPPSVSVSPGQTARITCSGEALPMQFAHWYQQRPGKAPVIVVYKDSERPSGVPERFSGSSSGTTA
TLTITGVQAEDEADYYCQSPDSTNTYEVFGGGTKLTVL
>Citatuzumab|FabFusion|G1|Kappa|Phase-I|Active|heavy
EVQLVQSGPGLVQPGGSVRISCAASGYTFTNYGMNWVKQAPGKGLEWMGWINTYTGESTYADSFKGRFTF
SLDTSASAAYLQINSLRAEDTAVYYCARFAIKGDYWGQGTLLTVSS
>Citatuzumab|FabFusion|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCRSTKSLLHSNGITYLYWYQQKPGKAPKLLIYQMSNLASGVPSRFSSS
GSGTDFTLTISSLQPEDFATYYCAQNLEIPRTFGQGTKVELK
>Cixutumumab|WholemAb|G1|Lambda|Phase-II|Discontinued|heavy
EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARAPLRFLEWSTQDHYYYYYMDVWGKGTTVTVSS
>Cixutumumab|WholemAb|G1|Lambda|Phase-II|Discontinued|light
SSELTQDPAVSVALGQTVRITCQGDSLRSYYATWYQQKPGQAPILVIYGENKRPSGIPDRFSGSSSGNTA
SLTITGAQAEDEADYYCKSRDGSGQHLVFGGGTKLTVL
>Claudiximab|WholemAb|G1|Kappa|Phase-III|Active|heavy
QVQLQQPGAELVRPGASVKLSCKASGYTFTSYWINWVKQRPGQGLEWIGNIYPSDSYTNYNQKFKDKATL
TVDKSSSTAYMQLSSPTSEDSAVYYCTRSWRGNSFDYWGQGTTLTVSS
>Claudiximab|WholemAb|G1|Kappa|Phase-III|Active|light
DIVMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTG
SGSGTDFTLTISSVQAEDLAVYYCQNDYSYPFTFGSGTKLEIK
>Clazakizumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFSLSNYYVTWVRQAPGKGLEWVGIIYGSDETAYATSAIGRFTIS
RDNSKNTLYLQMNSLRAEDTAVYYCARDDSSDWDAKFNLWGQGTLVTVSS
>Clazakizumab|WholemAb|G1|Kappa|Phase-III|Active|light
AIQMTQSPSSLSASVGDRVTITCQASQSINNELSWYQQKPGKAPKLLIYRASTLASGVPSRFSGSGSGTD
FTLTISSLQPDDFATYYCQQGYSLRNIDNAFGGGTKVEIK
>Clervonafusp|di-FabFusion|G1|Kappa|Phase-I/II|Active|heavy
EVQLQESGGGVVQPGGSLRLSCAASGFTFSNYGMHWIRQAPGKGLEWVSYISSGSSTIYYADSVKGRFTI
SRDNSKNTLYLQMNSLRSEDTAVYYCARRGLLLDYWGQGTLVTVSS
>Clervonafusp|di-FabFusion|G1|Kappa|Phase-I/II|Active|light
DIQMTQSPSSLSASVGDRVTISCRASKSVSTSSYSYMHWYQQKPEKALIKYASYLQSGVPSRFSGSGSGT
DFTLTISSLQPEDVATYYCQHSRETFGAGTKLELK
>Clivatuzumab|WholemAbRadiolabelled|G1|Kappa|Phase-III|Discontinued|heavy
QVQLQQSGAEVKKPGASVKVSCEASGYTFPSYVLHWVKQAPGQGLEWIGYINPYNDGTQYNEKFKGKATL
TRDTSINTAYMELSRLRSDDTAVYYCARGFGGSYGFAYWGQGTLVTVSS
>Clivatuzumab|WholemAbRadiolabelled|G1|Kappa|Phase-III|Discontinued|light
DIQLTQSPSSLSASVGDRVTMTCSASSSVSSSYLYWYQQKPGKAPKLWIYSTSNLASGVPARFSGSGSGT
DFTLTISSLQPEDSASYFCHQWNRYPYTFGGGTRLEIK
>Cobolimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAAASGFTFSSYDMSWVRQAPGKGLDWVSTISGGGTYTYYQDSVKGRFT
ISRDNSKNTLYLQMNSLRAEDTAVYYCASMDYWGQGTTVTVSS
>Cobolimab|WholemAb|G4|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQSIRRYLNWYHQKPGKAPKLLIYGASTLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFAVYYCQQSHSAPLTFGGGTKVEIK
>Codrituzumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYEMHWVRQAPGQGLEWMGALDPKTGDTAYSQKFKGRVTL
TADKSTSTAYMELSSLTSEDTAVYYCTRFYSYTYWGQGTLVTVSS
>Codrituzumab|WholemAb|G1|Kappa|Phase-II|Active|light
DVVMTQSPLSLPVTPGEPASISCRSSQSLVHSNRNTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCSQNTHVPPTFGQGTKLEIK
>Cofetuzumab|WholemAbADC|G1|Kappa|Phase-I|Active|heavy
QVQLVQSGPEVKKPGASVKVSCKASGYTFTDYAVHWVRQAPGKRLEWIGVISTYNDYTYNNQDFKGRVTM
TRDTSASTAYMELSRLRSEDTAVYYCARGNSYFYALDYWGQGTSVTVSS
>Cofetuzumab|WholemAbADC|G1|Kappa|Phase-I|Active|light
EIVLTQSPATLSLSPGERATLSCRASESVDSYGKSFMHWYQQKPGQAPRLLIYRASNLESGIPARFSGSG
SGTDFTLTISSLEPEDFAVYYCQQSNEDPWTFGGGTKLEIK
>Coltuximab|WholemAbADC|G1|Kappa|Phase-II|Active|heavy
QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKL
TVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSS
>Coltuximab|WholemAbADC|G1|Kappa|Phase-II|Active|light
EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTDY
SLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK
>Conatumumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYFWSWIRQLPGKGLEWIGHIHNSGTTYYNPSLKSRVT
ISVDTSKKQFSLRLSSVTAADTAVYYCARDRGGDYYYGMDVWGQGTTVTVSS
>Conatumumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
EIVLTQSPGTLSLSPGERATLSCRASQGISRSYLAWYQQKPGQAPSLLIYGASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQFGSSPWTFGQGTKVEIK
>Concizumab|WholemAb|G4|Kappa|Phase-III|Active|heavy
EVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQTPEKRLEWVATISRSGSYSYFPDSVQGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARLGGYDEGDAMDSWGQGTTVTVSS
>Concizumab|WholemAb|G4|Kappa|Phase-III|Active|light
DIVMTQTPLSLSVTPGQPASISCKSSQSLLESDGKTYLNWYLQKPGQSPQLLIYLVSILDSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCLQATHFPQTFGGGTKVEIK
>Coprelotamab|WholemAb|G1|Kappa|TBC|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTI
SADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS
>Coprelotamab|WholemAb|G1|Kappa|TBC|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTD
FTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK
>Cosfroviximab|WholemAb|G1|Kappa|Phase-II|Active|heavy
DVKLLESGGGLVQPGGSLKLSCAASGFSLSTSGVGVGWFRQPSGKGLEWLALIWWDDDKYYNPSLKSQLS
ISKDFSRNQVFLKISNVDIADTATYYCARRDPFGYDNAMGYWGQGTSVTVSS
>Cosfroviximab|WholemAb|G1|Kappa|Phase-II|Active|light
DIVMTQSPLSLSTSVGDRVSLTCKASQNVGTAVAWYQQKPGQSPKLLIYSASNRYTGVPDRFTGSGSGTD
FTLTISNMQSEDLADYFCQQYSSYPLTFGAGTKLELR
>Cosibelimab|WholemAb|G1|Lambda|Phase-I|Active|heavy
EVQLVQSGAEVKKPGSSVKVSCKASGGTFSRSAISWVRQAPGQGLEWMGVIIPAFGEANYAQKFQGRVTI
TADESTSTAYMELSSLRSEDTAVYYCARGRQMFGAGIDFWGQGTLVTVSS
>Cosibelimab|WholemAb|G1|Lambda|Phase-I|Active|light
NFMLTQPHSVSESPGKTVTISCTRSSGSIDSNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSS
SNSASLTISGLKTEDEADYYCQSYDSNNRHVIFGGGTKLTVL
>Crenezumab|WholemAb|G4|Kappa|Phase-III|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLELVASINSNGGSTYYPDSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCASGDYWGQGTTVTVSS
>Crenezumab|WholemAb|G4|Kappa|Phase-III|Active|light
DIVMTQSPLSLPVTPGEPASISCRSSQSLVYSNGDTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK
>Crizanlizumab|WholemAb|G2|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKVSGYTFTSYDINWVRQAPGKGLEWMGWIYPGDGSIKYNEKFKGRVTM
TVDKSTDTAYMELSSLRSEDTAVYYCARRGEYGNYEGAMDYWGQGTLVTVSS
>Crizanlizumab|WholemAb|G2|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQSVDYDGHSYMNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSG
SGTDFTLTISSLQPEDFATYYCQQSDENPLTFGGGTKVEIK
>Crotedumab|WholemAb|G4|Kappa|Phase-I|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYLMNWVRQAPGKGLEWLANIQEDGIEKYYVDSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCAREPSHYDILTGYDYYYGMDVWGQGTTVTVSS
>Crotedumab|WholemAb|G4|Kappa|Phase-I|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTE
FILTVSSLQPEDFATYYCLQYNSNPFTFGPGTKVDIK
>Crovalimab|WholemAb|G1|Kappa|Phase-I/II|Active|heavy
QVQLVESGGGLVQPGRSLRLSCAASGFTVHSSYYMAWVRQAPGKGLEWVGAIFTGSGAEYKAEWAKGRVT
ISKDTSKNQVVLTMTNMDPVDTATYYCASDAGYDYPTHAMHYWGQGTLVTVSS
>Crovalimab|WholemAb|G1|Kappa|Phase-I/II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQGISSSLAWYQQKPGKAPKLLIYGASETESGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQNTKVGSSYGNTFGGGTKVEIK
>Cudarolimab|WholemAb|G1|Kappa|Phase-I|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARGRPWYSETGTSAFDIWGQGTMVTVSS
>Cudarolimab|WholemAb|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTD
FTFTISSLQPEDIATYYCQQSDHYPTFGGGTKVEIK
>Cusatuzumab|WholemAb|G1|Lambda|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSVYYMNWVRQAPGKGLEWVSDINNEGGTTYYADSVKGRFTI
SRDNSKNSLYLQMNSLRAEDTAVYYCARDAGYSNHVPIFDSWGQGTLVTVSS
>Cusatuzumab|WholemAb|G1|Lambda|Phase-II|Active|light
QAVVTQEPSLTVSPGGTVTLTCGLKSGSVTSDNFPTWYQQTPGQAPRLLIYNTNTRHSGVPDRFSGSILG
NKAALTITGAQADDEAEYFCALFISNPSVEFGGGTQLTVL
>Dacetuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYSFTGYYIHWVRQAPGKGLEWVARVIPNAGGTSYNQKFKGRFTL
SVDNSKNTAYLQMNSLRAEDTAVYYCAREGIYWWGQGTLVTVSS
>Dacetuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRSSQSLVHSNGNTFLHWYQQKPGKAPKLLIYTVSNRFSGVPSRFSGS
GSGTDFTLTISSLQPEDFATYFCSQTTHVPWTFGQGTKVEIK
>Daclizumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYRMHWVRQAPGQGLEWIGYINPSTGYTEYNQKFKDKATI
TADESTNTAYMELSSLRSEDTAVYYCARGGGVFDYWGQGTLVTVSS
>Daclizumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSTLSASVGDRVTITCSASSSISYMHWYQQKPGKAPKLLIYTTSNLASGVPARFSGSGSGTEF
TLTISSLQPDDFATYYCHQRSTYPLTFGQGTKVEVK
>Dafsolimab|WholemAb|G2b|Kappa|TBC|Active|heavy
QVQLQQSGAELARPGASVKMSCKASGYTFTSYTMHWVKQRPGQGLEWIGYINPSSGYTNYIQRFKDKATL
TADKSSSTAYMQVSSLTSEDSAVYYCARGSRYDYYGMDYWGQGTSVTVSS
>Dafsolimab|WholemAb|G2b|Kappa|TBC|Active|light
QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPARFSGSGSGTSY
SLTISSMEAEDAATYYCQQWSSNPLTFGAGTKLELK
>Dalotuzumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLQESGPGLVKPSETLSLTCTVSGYSITGGYLWNWIRQPPGKGLEWIGYISYDGTNNYKPSLKDRVTI
SRDTSKNQFSLKLSSVTAADTAVYYCARYGRVFFDYWGQGTLVTVSS
>Dalotuzumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIVMTQSPLSLPVTPGEPASISCRSSQSIVHSNGNTYLQWYLQKPGQSPQLLIYKVSNRLYGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCFQGSHVPWTFGQGTKVEIK
>Dapirolizumab|Fab|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAVSGFSSTNYHVHWVRQAPGKGLEWMGVIWGDGDTSYNSVLKSRFTIS
RDTSKNTVYLQMNSLRAEDTAVYYCARQLTHYYVLAAWGQGTLVTVSS
>Dapirolizumab|Fab|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASEDLYYNLAWYQRKPGKAPKLLIYDTYRLADGVPSRFSGSGSGTD
YTLTISSLQPEDFASYYCQQYYKFPFTFGQGTKVEIK
>Daratumumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAVSGFTFNSFAMSWVRQAPGKGLEWVSAISGSGGGTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYFCAKDKILWFGEPVFDYWGQGTLVTVSS
>Daratumumab|WholemAb|G1|Kappa|Approved|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWPPTFGQGTKVEIK
>Datopotamab|WholemAb|G1|Kappa|Phase-I|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTTAGMQWVRQAPGQGLEWMGWINTHSGVPKYAEDFKGRVTI
SADTSTSTAYLQLSSLKSEDTAVYYCARSGFGSSYWYFDVWGQGTLVTVSS
>Datopotamab|WholemAb|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQDVSTAVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTD
FTLTISSLQPEDFAVYYCQQHYITPLTFGQGTKLEIK
>Daxdilimab|WholemAb|G1|Lambda|Phase-I|Active|heavy
QVQLQQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTM
TIDTSTSTAYMELRSLRSDDTAVYYCARNGLWGWDSDAFDIWGRGTLVTVSS
>Daxdilimab|WholemAb|G1|Lambda|Phase-I|Active|light
QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSG
NTASLTISGLQAEDEADYYCSSYTSSSTVVFGGGTKVTVL
>Dectrekumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAIIWYDGSNKYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARLWFGDLDAFDIWGQGTMVTVSS
>Dectrekumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
EIVLTQSPATLSLSPGERAILSCRAGQSVSSYLVWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSSWPPVYTFGQGTKLEIK
>Demcizumab|WholemAb|G2|Kappa|Phase-I|Discontinued|heavy
QVQLVQSGAEVKKPGASVKISCKASGYSFTAYYIHWVKQAPGQGLEWIGYISSYNGATNYNQKFKGRVTF
TTDTSTSTAYMELRSLRSDDTAVYYCARDYDYDVGMDYWGQGTLVTVSS
>Demcizumab|WholemAb|G2|Kappa|Phase-I|Discontinued|light
DIVMTQSPDSLAVSLGERATISCRASESVDNYGISFMKWFQQKPGQPPKLLIYAASNQGSGVPDRFSGSG
SGTDFTLTISSLQAEDVAVYYCQQSKEVPWTFGGGTKVEIK
>Demupitamab|WholemAb|G1|Kappa|Phase-I|Active|heavy
QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGDYYWTWIRQSPGKGLEWIGHIYYSGNTNYNPSLKSRLT
ISIDTSKTQFSLKLSSVTAADTAIYYCVRDRVTGAFDIWGQGTMVTVSS
>Demupitamab|WholemAb|G1|Kappa|Phase-I|Active|light
DIQMTQSPSTLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTD
FTFTISSLQPEDIATYFCQHFDHLPLAFGGGTKVEIK
>Denintuzumab|WholemAbADC|G1|Kappa|Phase-II|Discontinued|heavy
QVQLQESGPGLVKPSQTLSLTCTVSGGSISTSGMGVGWIRQHPGKGLEWIGHIWWDDDKRYNPALKSRVT
ISVDTSKNQFSLKLSSVTAADTAVYYCARMELWSYYFDYWGQGTLVTVSS
>Denintuzumab|WholemAbADC|G1|Kappa|Phase-II|Discontinued|light
EIVLTQSPATLSLSPGERATLSCSASSSVSYMHWYQQKPGQAPRLLIYDTSKLASGIPARFSGSGSGTDF
TLTISSLEPEDVAVYYCFQGSVYPFTFGQGTKLEIK
>Denosumab|WholemAb|G2|Kappa|Approved|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGITGSGGSTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKDPGTTVIMSWFDPWGQGTLVTVSS
>Denosumab|WholemAb|G2|Kappa|Approved|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVRGRYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVFYCQQYGSSPRTFGQGTKVEIK
>Depatuxizumab|WholemAbADC|G1|Kappa|Phase-III|Discontinued|heavy
QVQLQESGPGLVKPSQTLSLTCTVSGYSISSDFAWNWIRQPPGKGLEWMGYISYSGNTRYQPSLKSRITI
SRDTSKNQFFLKLNSVTAADTATYYCVTAGRGFPYWGQGTLVTVSS
>Depatuxizumab|WholemAbADC|G1|Kappa|Phase-III|Discontinued|light
DIQMTQSPSSMSVSVGDRVTITCHSSQDINSNIGWLQQKPGKSFKGLIYHGTNLDDGVPSRFSGSGSGTD
YTLTISSLQPEDFATYYCVQYAQFPWTFGGGTKLEIK
>Depemokimab|WholemAb|G1|Kappa|TBC|Active|heavy
QVTLRESGPALVKPTQTLTLTCTVSGFSLTGSSVHWVRQPPGKGLEWLGVIWASGGTDYNSALMSRLSIS
KDTSRNQVVLTMTNMDPVDTATYYCARDPPSGLLRLDYWGRGTLVTVSS
>Depemokimab|WholemAb|G1|Kappa|TBC|Active|light
DIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYYCQNVHSFPFTFGGGTKLEIK
>Derlotuximab|WholemAbRadiolabelled|G1|Kappa|Approved|Active|heavy
QVQLKESGPGLVAPSQSLSITCTVSGFSLTDYGVRWIRQPPGKGLEWLGVIWGGGSTYYNSALKSRLSIS
KDNSKSQVFLKMNSLQTDDTAMYYCAKEKRRGYYYAMDYWGQGTSVTVSS
>Derlotuximab|WholemAbRadiolabelled|G1|Kappa|Approved|Active|light
ENVLTQSPAIMSASPGEKVTMTCRASSSVSSSYLHWYQQKSGASPKLWIYSTSNLASGVPARFSGSGSGT
SYSLTISSVEAEDAATYYCQQYSGYPLTFGGGTKLEIK
>Dezamizumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGFTFATYNMHWVRQAPGQGLEWMGYIYPGDGNANYNQQFKGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARGDFDYDGGYYFDSWGQGTLVTVSS
>Dezamizumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASENIYSYLAWYQQKPGKAPKLLIHNAKTLAEGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQHHYGAPLTFGQGTKLEIK
>Dilpacimab|BispecificmAb|G1|Kappa;Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSNFPMAWVRQAPGKGLEWVATISSSDGTTYYRDSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARGYYNSPFAYWGQGTLVTVSS
>Dilpacimab|BispecificmAb|G1|Kappa;Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASEDIYSNLAWYQQKPGKAPKLLIYDTNNLADGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYNNYPPTFGQGTKLEIK
>Dinutuximab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLLQSGPELEKPGASVMISCKASGSSFTGYNMNWVRQNIGKSLEWIGAIDPYYGGTSYNQKFKGRATL
TVDKSSSTAYMHLKSLTSEDSAVYYCVSGMEYWGQGTSVTVSS
>Dinutuximab|WholemAb|G1|Kappa|Approved|Active|light
EIVMTQSPATLSVSPGERATLSCRSSQSLVHRNGNTYLHWYLQKPGQSPKLLIHKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDLGVYFCSQSTHVPPLTFGAGTKLELK
>Diridavumab|WholemAb|G1|Lambda|Phase-II|Active|heavy
EVQLVESGAEVKKPGSSVKVSCKASGGPFRSYAISWVRQAPGQGPEWMGGIIPIFGTTKYAPKFQGRVTI
TADDFAGTVYMELSSLRSEDTAMYYCAKHMGYQVRETMDVWGKGTTVTVSS
>Diridavumab|WholemAb|G1|Lambda|Phase-II|Active|light
QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNDYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGT
SATLGITGLQTGDEANYYCATWDRRPTAYVVFGGGTKLTVL
>Disitamab|WholemAbADC|G1|Kappa|Phase-II|Active|heavy
EVQLVQSGAEVKKPGATVKISCKVSGYTFTDYYIHWVQQAPGKGLEWMGRVNPDHGDSYYNQKFKDKATI
TADKSTDTAYMELSSLRSEDTAVYFCARNYLFDHWGQGTLVTVSS
>Disitamab|WholemAbADC|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSVSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASIRHTGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCHQFATYTFGGGTKVEIK
>Divozilimab|WholemAb|G1|Kappa|TBC|Active|heavy
EVQLVQPGAEVVKPGASVKVSCKASGYTFTSYNMHWVRQAPGRGLEWMGAIYPGNGDTSYNQKFKGRVTM
TRDKSTSTVYMELSSLRSEDTAVYYCARSTYYGGDWYFNVWGQGTLVTVSS
>Divozilimab|WholemAb|G1|Kappa|TBC|Active|light
QIVLSQSPAILSASPGERVTLTCRASSSVSYIHWFQQKPGKAPKPLIYATSNLASGVPSRFSGSGSGTDF
SLTISRVEPEDFAVYYCQQWTSNPPTFGGGTKVEIK
>Docaravimab|WholemAb(Mouse)|G2b|Kappa|Phase-I|Active|heavy
QVQLKESGPGLLAPSQSLSITCTVSGFSLTGHGVNWVRQPPGKGLEWLGIIWADGTTNYNSALKSRLSIS
KDNSKSQVFLKMNSLQTDDTASYYCAREGDISGYYFDYWGQGTTLTVSS
>Docaravimab|WholemAb(Mouse)|G2b|Kappa|Phase-I|Active|light
DVQMTQTTSSLSASLGDRVTITCRPSQDINNYLSWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTD
YSLTISNLEQEDFATYFCQQGNTLPPTFGGGTKLEIK
>Domagrozumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTISSGGSYTSYPDSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKQDYAMNYWGQGTLVTVSS
>Domagrozumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQDVSTAVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQHYSTPWTFGGGTKVEIK
>Donanemab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYDFTRYYINWVRQAPGQGLEWMGWINPGSGNTKYNEKFKGRVTI
TADESTSTAYMELSSLRSEDTAVYYCAREGITVYWGQGTTVTVSS
>Donanemab|WholemAb|G1|Kappa|Phase-II|Active|light
DIVMTQTPLSLSVTPGQPASISCKSSQSLLYSRGKTYLNWLLQKPGQSPQLLIYAVSKLDSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCVQGTHYPFTFGQGTKLEIK
>Dostarlimab|WholemAb|G4|Kappa|Phase-III|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVSTISGGGSYTYYQDSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCASPYYAMDYWGQGTTVTVSS
>Dostarlimab|WholemAb|G4|Kappa|Phase-III|Active|light
DIQLTQSPSFLSAYVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTLHTGVPSRFSGSGSGTE
FTLTISSLQPEDFATYYCQHYSSYPWTFGQGTKLEIK
>Dovanvetmab|FelineWholemAb|G1|Kappa|Unknown|Active|heavy
QVLLVQSGAEVRTPGASVKIFCKASGYSFTSYTIHWLRQAPAQGLEWMGNINPTSGYTENNQRFKDRLTL
TADTSTNTAYMELSSLRSADTAMYYCARWGFKYDGEWSFDVWGAGTTVTVSS
>Dovanvetmab|FelineWholemAb|G1|Kappa|Unknown|Active|light
EIQMTQSPSSLSASPGDRVTITCRASQGISIWLSWYQQKPGNIPKVLINKASNLHIGVPSRFSGSGSGTD
FTLTISSLEPEDAATYYCLQSQTYPLTFGGGTKLEIK
>Drozitumab|WholemAb|G1|Lambda|Phase-II|Discontinued|heavy
EVQLVQSGGGVERPGGSLRLSCAASGFTFDDYAMSWVRQAPGKGLEWVSGINWQGGSTGYADSVKGRVTI
SRDNAKNSLYLQMNSLRAEDTAVYYCAKILGAGRGWYFDYWGKGTTVTVSS
>Drozitumab|WholemAb|G1|Lambda|Phase-II|Discontinued|light
SELTQDPAVSVALGQTVRITCSGDSLRSYYASWYQQKPGQAPVLVIYGANNRPSGIPDRFSGSSSGNTAS
LTITGAQAEDEADYYCNSADSSGNHVVFGGGTKLTVL
>Duligotuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTLSGDWIHWVRQAPGKGLEWVGEISAAGGYTDYADSVKGRFTI
SADTSKNTAYLQMNSLRAEDTAVYYCARESRVSFEAAMDYWGQGTLVTVSS
>Duligotuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQNIATDVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQSEPEPYTFGQGTKVEIK
>Dupilumab|WholemAb|G4|Kappa|Approved|Active|heavy
EVQLVESGGGLEQPGGSLRLSCAGSGFTFRDYAMTWVRQAPGKGLEWVSSISGSGGNTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKDRLSITIRPRYYGLDVWGQGTTVTVSS
>Dupilumab|WholemAb|G4|Kappa|Approved|Active|light
DIVMTQSPLSLPVTPGEPASISCRSSQSLLYSIGYNYLDWYLQKSGQSPQLLIYLGSNRASGVPDRFSGS
GSGTDFTLKISRVEAEDVGFYYCMQALQTPYTFGQGTKLEIK
>Durvalumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCAREGGWFGELAFDYWGQGTLVTVSS
>Durvalumab|WholemAb|G1|Kappa|Approved|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQRVSSSYLAWYQQKPGQAPRLLIYDASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSLPWTFGQGTKVEIK
>Dusigitumab|WholemAb|G2|Lambda|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPNSGNTGYAQKFQGRVTM
TRNTSISTAYMELSSLRSEDTAVYYCARDPYYYYYGMDVWGQGTTVTVSS
>Dusigitumab|WholemAb|G2|Lambda|Phase-II|Discontinued|light
QSVLTQPPSVSAAPGQKVTISCSGSSSNIENNHVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGT
SATLGITGLQTGDEADYYCETWDTSLSAGRVFGGGTKLTVL
>Duvortuxizumab|BispecificscFvwithCrossover|na|Kappa;Lambda|Phase-I|Discontinued|heavy
QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMGVGWIRQPPGKALEWLAHIWWDDDKRYNPALKSRLT
ISKDTSKNQVFLTMTNMDPVDTATYYCARMELWSYYFDYWGQGTTVTVSS
>Duvortuxizumab|BispecificscFvwithCrossover|na|Kappa;Lambda|Phase-I|Discontinued|light
ENVLTQSPATLSVTPGEKATITCRASQSVSYMHWYQQKPGQAPRLLIYDASNRASGVPSRFSGSGSGTDH
TLTISSLEAEDAATYYCFQGSVYPFTFGQGTKLEIK
>Ebronucimab|WholemAb|G1|Lambda|TBC|Active|heavy
EVQLVESGGGLVQPGRSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSGISSSSSYISYADSVQGRFTI
SRDNGKNSLYLQMNSLRAEDTALYFCAREYDFWSAYYDAFDVWGQGTMVTVSS
>Ebronucimab|WholemAb|G1|Lambda|TBC|Active|light
QSELTQPRSVSGSPGQSVTISCTGTSRNIGGGNDVHWYQQHPGKAPKLLISGVIERSSGVPDRFSGSKSG
NTASLTISGLQAEDEADYYCQSFDGSLSGSVFGTGTDVTVL
>Eculizumab|WholemAb|G2|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTM
TRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSSPNWYFDVWGQGTLVTVSS
>Eculizumab|WholemAb|G2|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK
>Edrecolomab|WholemAb|G2a|Kappa|Approved(w)|Discontinued|heavy
QVQLQQSGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKGKATL
TADKSSSTAYMQLSSLTSDDSAVYFCARDGPWFAYWGQGTLVTVSA
>Edrecolomab|WholemAb|G2a|Kappa|Approved(w)|Discontinued|light
NIVMTQSPKSMSMSVGERVTLTCKASENVVTYVSWYQQKPEQSPKLLIYGASNRYTGVPDRFTGSGSATD
FTLTISSVQAEDLADYHCGQGYSYPYTFGGGTKLEIK
>Efalizumab|WholemAb|G1|Kappa|Approved|NFD|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYSFTGHWMNWVRQAPGKGLEWVGMIHPSDSETRYNQKFKDRFTI
SVDKSKNTLYLQMNSLRAEDTAVYYCARGIYFYGTTYFDYWGQGTLVTVSS
>Efalizumab|WholemAb|G1|Kappa|Approved|NFD|light
DIQMTQSPSSLSASVGDRVTITCRASKTISKYLAWYQQKPGKAPKLLIYSGSTLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQHNEYPLTFGQGTKVEIK
>Efungumab|scFv|na|Kappa|Phase-III|Discontinued|heavy
EVQLVESGAEVKKPGESLRISCKGSGCIISSYWISWVRQMPGKGLEWMGKIDPGDSYINYSPSFQGHVTI
SADKSINTAYLQWNSLKASDTAMYYCARGGRDFGDSFDYWGQGTLVTVSS
>Efungumab|scFv|na|Kappa|Phase-III|Discontinued|light
DVVMTQSPSFLSAFVGDRITITCRASSGISRYLAWYQQAPGKAPKLLIYAASTLQTGVPSRFSGSGSGTE
FTLTINSLQPEDFATYYCQHLNSYPLTFGGGTKVDIK
>Eldelumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QMQLVESGGGVVQPGRSLRLSCTASGFTFSNNGMHWVRQAPGKGLEWVAVIWFDGMNKFYVDSVKGRFTI
SRDNSKNTLYLEMNSLRAEDTAIYYCAREGDGSGIYYYYGMDVWGQGTTVTVSS
>Eldelumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSSPIFTFGPGTKVDIK
>Elezanumab|WholemAb|G1|Lambda|Phase-II|Active|heavy
EVQLVQSGAEVKKPGASVKVSCKASGYTFTSHGISWVRQAPGQGLDWMGWISPYSGNTNYAQKLQGRVTM
TTDTSTSTAYMELSSLRSEDTAVYYCARVGSGPYYYMDVWGQGTLVTVSS
>Elezanumab|WholemAb|G1|Lambda|Phase-II|Active|light
QSALTQPRSVSGSPGQSVTISCTGTSSSVGDSIYVSWYQQHPGKAPKLMLYDVTKRPSGVPDRFSGSKSG
NTASLTISGLQAEDEADYYCYSYAGTDTLFGGGTKVTVL
>Elgemtumab|WholemAb|G1|Kappa|Phase-I/II|Discontinued|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAINSQGKSTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARWGDEGFDIWGQGTLVTVSS
>Elgemtumab|WholemAb|G1|Kappa|Phase-I/II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQGISNWLAWYQQKPGKAPKLLIYGASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYSSFPTTFGQGTKVEIK
>Elipovimab|WholemAb|G1|Lambda|Phase-I|Active|heavy
QMQLQESGPGLVKPSETLSLTCSVSGASISDSYWSWIRRSPGKGLEWIGYVHKSGDTNYNPSLKSRVHLS
LDTSKNQVSLSLTGVTAADSGKYYCARTLHGRRIYGIVAFNEWFTYFYMDVWGTGTQVTVSS
>Elipovimab|WholemAb|G1|Lambda|Phase-I|Active|light
SDISVAPGETARISCGEKSLGSRAVQWYQHRAGQAPSLIIYNNQDRPSGIPERFSGSPDSRPGTTATLTI
TSVEAGDEADYYCHIWDSRVPTKWVFGGGTTLTVL
>Elotuzumab|WholemAb|G1|Kappa|Approved|NFD|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYAPSLKDKFII
SRDNAKNSLYLQMNSLRAEDTAVYYCARPDGNYWYFDVWGQGTLVTVSS
>Elotuzumab|WholemAb|G1|Kappa|Approved|NFD|light
DIQMTQSPSSLSASVGDRVTITCKASQDVGIAVAWYQQKPGKVPKLLIYWASTRHTGVPDRFSGSGSGTD
FTLTISSLQPEDVATYYCQQYSSYPYTFGQGTKVEIK
>Eluvixtamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|heavy
QVQLVQSGAEVKKPGESVKVSCKASGYTFTNYGMNWVKQAPGQGLEWMGWINTYTGEPTYADKFQGRVTM
TTDTSTSTAYMEIRNLGGDDTAVYYCARWSWSDGYYVYFDYWGQGTSVTVSS
>Eluvixtamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|light
DIVMTQSPDSLTVSLGERTTINCKSSQSVLDSSTNKNSLAWYQQKPGQPPKLLLSWASTRESGIPDRFSG
SGSGTDFTLTIDSPQPEDSATYYCQQSAHFPITFGQGTRLEIK
>Emactuzumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDISWVRQAPGQGLEWMGVIWTDGGTNYAQKLQGRVTMT
TDTSTSTAYMELRSLRSDDTAVYYCARDQRLYFDVWGQGTTVTVSS
>Emactuzumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASEDVNTYVSWYQQKPGKAPKLLIYAASNRYTGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQSFSYPTFGQGTKLEIK
>Emapalumab|WholemAb|G1|Lambda|Approved|NFD|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKDGSSGWYVPHWFDPWGQGTLVTVSS
>Emapalumab|WholemAb|G1|Lambda|Approved|NFD|light
NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSS
SNSASLTISGLKTEDEADYYCQSYDGSNRWMFGGGTKLTVL
>Emerfetamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|heavy
QVQLVQSGAEVKKPGESVKVSCKASGYTFTNYGMNWVKQAPGQCLEWMGWINTYTGEPTYADKFQGRVTM
TTDTSTSTAYMEIRNLGGDDTAVYYCARWSWSDGYYVYFDYWGQGTSVTVSS
>Emerfetamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|light
DIVMTQSPDSLTVSLGERTTINCKSSQSVLDSSTNKNSLAWYQQKPGQPPKLLLSWASTRESGIPDRFSG
SGSGTDFTLTIDSPQPEDSATYYCQQSAHFPITFGCGTRLEIK
>Emicizumab|BispecificmAb|G4;G4|Kappa;Kappa|Approved|NFD|heavy
QVQLVQSGSELKKPGASVKVSCKASGYTFTDNNMDWVRQAPGQGLEWMGDINTRSGGSIYNEEFQDRVIM
TVDKSTDTAYMELSSLRSEDTATYHCARRKSYGYYLDEWGEGTLVTVSS
>Emicizumab|BispecificmAb|G4;G4|Kappa;Kappa|Approved|NFD|light
DIQMTQSPSSLSASVGDRVTITCKASRNIERQLAWYQQKPGQAPELLIYQASRKESGVPDRFSGSRYGTD
FTLTISSLQPEDIATYYCQQYSDPPLTFGGGTKVEIK
>Emibetuzumab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGRVNPNRRGTTYNQKFEGRVTM
TTDTSTSTAYMELRSLRSDDTAVYYCARANWLDYWGQGTTVTVSS
>Emibetuzumab|WholemAb|G4|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCSVSSSVSSIYLHWYQQKPGKAPKLLIYSTSNLASGVPSRFSGSGSGT
DFTLTISSLQPEDFATYYCQVYSGYPLTFGGGTKVEIK
>Enapotamab|WholemAbADC|G1|Kappa|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMNWVRQAPGKGLEWVSTTSGSGASTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKIWIAFDIWGQGTMVTVSS
>Enapotamab|WholemAbADC|G1|Kappa|Phase-II|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSSPYTFGQGTKLEIK
>Enavatuzumab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAEIRLKSDNYATHYAESVKGRF
TISRDDSKNSLYLQMNSLRAEDTAVYYCTGYYADAMDYWGQGTLVTVSS
>Enavatuzumab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQSVSTSSYSYMHWYQQKPGKAPKLLIKYASNLESGVPSRFSGSG
SGTDFTLTISSLQPEDFATYYCQHSWEIPYTFGGGTKVEIK
>Encelimab|WholemAb|G4|Kappa|Phase-I|Active|heavy
EVQLVQSGAEVKKPGATVKISCKASGFSIKDDYIHWVQQAPGKGLEWMGWIDAMNDDSQYSSKFQGRVTI
TVDTSTNTAYMKLSSLRSEDTAVYYCTYAFGGYWGQGTTVTVSS
>Encelimab|WholemAb|G4|Kappa|Phase-I|Active|light
DIVMTQTPLSLSVTPGQPASISCRSSQSLVHSDSNTYLHWYLQKPGQSPQLLIYLVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYFCGQSTHVPYAFGGGTKVEIK
>Enfortumab|WholemAbADC|G1|Kappa|Approved|NFD|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYNMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTI
SRDNAKNSLSLQMNSLRDEDTAVYYCARAYYYGMDVWGQGTTVTVSS
>Enfortumab|WholemAbADC|G1|Kappa|Approved|NFD|light
DIQMTQSPSSVSASVGDRVTITCRASQGISGWLAWYQQKPGKAPKFLIYAASTLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQANSFPPTFGGGTKVEIK
>Enibarcimab|WholemAb|G1|Kappa|TBC|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYTFSRYWIEWVRQAPGQGLEWIGEILPGSGSTNYNQKFQGRVTI
TADTSTSTAYMELSSLRSEDTAVYYCTEGYEYDGFDYWGQGTTVTVSS
>Enibarcimab|WholemAb|G1|Kappa|TBC|Active|light
DVVLTQSPLSLPVTLGQPASISCRSSQSIVYSNGNTYLEWYLQRPGQSPRLLIYRVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCFQGSHIPYTFGGGTKLEIK
>Enoblituzumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAYISSDSSAIYYADTVKGRFTI
SRDNAKNSLYLQMNSLRDEDTAVYYCGRGRENIYYGSRLDYWGQGTTVTVSS
>Enoblituzumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQLTQSPSFLSASVGDRVTITCKASQNVDTNVAWYQQKPGKAPKALIYSASYRYSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYNNYPFTFGQGTKLEIK
>Enokizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSYYWIEWVRQAPGQGLEWMGEILPGSGTTNPNEKFKGRVTI
TADESTSTAYMELSSLRSEDTAVYYCARADYYGSDYVKFDYWGQGTLVTVSS
>Enokizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCKASQHVITHVTWYQQKPGKAPKLLIYGTSYSYSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQFYEYPLTFGGGTKVEIK
>Enoticumab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVSFLWYDGTNKNYVESVKGRFTI
SRDNSKNMLYLEMNSLRAEDTAVYYCARDHDFRSGYEGWFDPWGQGTLVTVSS
>Enoticumab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQHRSNWPPTFGGGTKVEIK
>Ensituximab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLKESGPDLVAPSQSLSITCTVSGFSLSKFGVNWVRQPPGKGLEWLGVIWGDGSTSYNSGLISRLSIS
KENSKSQVFLKLNSLQADDTATYYCVKPGGDYWGHGTSVTVSS
>Ensituximab|WholemAb|G1|Kappa|Phase-II|Active|light
QVVLTQSPVIMSASPGEKVTMTCSASSSISYMYWYQQKPGTSPKRWIYDTSKLASGVPARFSGSGSGTSY
SLTISNMEAGDAATYYCHQRDSYPWTFGGGTNLEIK
>Envafolimab|SingleDomainVariableFragment;H|G1|na|Phase-III|Active|heavy
QVQLVESGGGLVQPGGSLRLSCAASGKMSSRRCMAWFRQAPGKERERVAKLLTTSGSTYLADSVKGRFTI
SRDNSKNTVYLQMNSLRAEDTAVYYCAADSFEDPTCTLVTSS
>Epcoritamab|BispecificmAb|G1|Lambda;Kappa|Phase-I/II|Active|heavy
EVKLVESGGGLVQPGGSLRLSCAASGFTFNTYAMNWVRQAPGKGLEWVARIRSKYNNYATYYADSVKDRF
TISRDDSKSSLYLQMNNLKTEDTAMYYCVRHGNFGNSYVSWFAYWGQGTLVTVSS
>Epcoritamab|BispecificmAb|G1|Lambda;Kappa|Phase-I/II|Active|light
QAVVTQEPSFSVSPGGTVTLTCRSSTGAVTTSNYANWVQQTPGQAFRGLIGGTNKRAPGVPARFSGSLIG
DKAALTITGAQADDESIYFCALWYSNLWVFGGGTKLTVL
>Epratuzumab|WholemAb|G1|Kappa|Phase-III|Discontinued|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYWLHWVRQAPGQGLEWIGYINPRNDYTEYNQNFKDKATI
TADESTNTAYMELSSLRSEDTAFYFCARRDITTFYWGQGTTVTVSS
>Epratuzumab|WholemAb|G1|Kappa|Phase-III|Discontinued|light
DIQLTQSPSSLSASVGDRVTMSCKSSQSVLYSANHKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSG
SGSGTDFTFTISSLQPEDIATYYCHQYLSSWTFGGGTKLEIK
>Eptinezumab|WholemAb|G1|Kappa|Preregistration|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAVSGIDLSGYYMNWVRQAPGKGLEWVGVIGINGATYYASWAKGRFTIS
RDNSKTTVYLQMNSLRAEDTAVYFCARGDIWGQGTLVTVSS
>Eptinezumab|WholemAb|G1|Kappa|Preregistration|Active|light
QVLTQSPSSLSASVGDRVTINCQASQSVYHNTYLAWYQQKPGKVPKQLIYDASTLASGVPSRFSGSGSGT
DFTLTISSLQPEDVATYYCLGSYDCTNGDCFVFGGGTKVEIK
>Erenumab|WholemAb|G2|Lambda|Approved|NFD|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAVISFDGSIKYSVDSVKGRFTI
SRDNSKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHYKYYGMAVWGQGTTVTVSS
>Erenumab|WholemAb|G2|Lambda|Approved|NFD|light
QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGT
STTLGITGLQTGDEADYYCGTWDSRLSAVVFGGGTKLTVL
>Etaracizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVAKVSSGGGSTYYLDTVQGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARHLHGSFASWGQGTTVTVSS
>Etaracizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
EIVLTQSPATLSLSPGERATLSCQASQSISNFLHWYQQRPGQAPRLLIRYRSQSISGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQSGSWPLTFGGGTKVEIK
>Etevritamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|heavy
QVQLVESGGGVVQSGRSLRLSCAASGFTFRNYGMHWVRQAPGKCLEWVAVIWYDGSDKYYADSVRGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARDGYDILTGNPRDFDYWGQGTLVTVSS
>Etevritamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|light
DTVMTQTPLSSHVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYRISRRFSGVPDRFSGS
GAGTDFTLEISRVEAEDVGVYYCMQSTHVPRTFGCGTKVEIK
>Etigilimab|WholemAb|G1|Kappa|Phase-I|Active|heavy
QVQLQESGPGLVKPSETLSLTCAVSGYSITSDYAWNWIRQPPGKGLEWIGYISYSGSTSYNPSLRSRVTI
SRDTSKNQFFLKLSSVTAADTAVYYCARRQVGLGFAYWGQGTLVTVSS
>Etigilimab|WholemAb|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQDVSTAVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTD
FTFTISSLQPEDIATYYCQQHYSTPWTFGQGTKVEIK
>Etokimab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLMQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWMGTIYPRNSNTDYNQKFKARVTM
TRDTSTSTVYMELSSLRSEDTAVYYCARPLYYYLTSPPTLFWGQGTLVTVSS
>Etokimab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQLTQSPSFLSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTE
FTLTISSLQPEDFATYYCQQAKTYPFTFGSGTKLEIK
>Etrolizumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFFITNNYWGWVRQAPGKGLEWVGYISYSGSTSYNPSLKSRFTIS
RDTSKNTFYLQMNSLRAEDTAVYYCARTGSSGYFDFWGQGTLVTVSS
>Etrolizumab|WholemAb|G1|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASVGDRVTITCRASESVDDLLHWYQQKPGKAPKLLIKYASQSISGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQGNSLPNTFGQGTKVEIK
>Evinacumab|WholemAb|G4|Kappa|Phase-III|Active|heavy
EVQLVESGGGVIQPGGSLRLSCAASGFTFDDYAMNWVRQGPGKGLEWVSAISGDGGSTYYADSVKGRFTI
SRDNSKNSLYLQMNSLRAEDTAFFYCAKDLRNTIFGVVIPDAFDIWGQGTMVTVSS
>Evinacumab|WholemAb|G4|Kappa|Phase-III|Active|light
DIQMTQSPSTLSASVGDRVTITCRASQSIRSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTE
FTLTISSLQPDDFATYYCQQYNSYSYTFGQGTKLEIK
>Evolocumab|WholemAb|G2|Lambda|Approved|Active|heavy
EVQLVQSGAEVKKPGASVKVSCKASGYTLTSYGISWVRQAPGQGLEWMGWVSFYNGNTNYAQKLQGRGTM
TTDPSTSTAYMELRSLRSDDTAVYYCARGYGMDVWGQGTTVTVSS
>Evolocumab|WholemAb|G2|Lambda|Approved|Active|light
ESALTQPASVSGSPGQSITISCTGTSSDVGGYNSVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSG
NTASLTISGLQAEDEADYYCNSYTSTSMVFGGGTKLTVL
>Ezabenlimab|WholemAb|G4|Kappa|Phase-I|Active|heavy
EVMLVESGGGLVQPGGSLRLSCTASGFTFSKSAMSWVRQAPGKGLEWVAYISGGGGDTYYSSSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARHSNYNYYAMDYWGQGTLVTVSS
>Ezabenlimab|WholemAb|G4|Kappa|Phase-I|Active|light
EIVLTQSPATLSLSPGERATMSCRASENIDVSGISFMNWYQQKPGQAPKLLIYVASNQGSGIPARFSGSG
SGTDFTLTISRLEPEDFAVYYCQQSKEVPQTFGQGTKLEIK
>Faricimab|BispecificmAb|G1|Kappa;Lambda|Phase-III|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYDFTHYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTF
SLDTSKSTAYLQMNSLRAEDTAVYYCAKYPYYYGTSHWYFDVWGQGTLVTVSS
>Faricimab|BispecificmAb|G1|Kappa;Lambda|Phase-III|Active|light
DIQLTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK
>Farletuzumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
EVQLVESGGGVVQPGRSLRLSCSASGFTFSGYGLSWVRQAPGKGLEWVAMISSGGSYTYYADSVKGRFAI
SRDNAKNTLFLQMDSLRPEDTGVYFCARHGDDPAWFAYWGQGTPVTVSS
>Farletuzumab|WholemAb|G1|Kappa|Phase-III|Active|light
DIQLTQSPSSLSASVGDRVTITCSVSSSISSNNLHWYQQKPGKAPKPWIYGTSNLASGVPSRFSGSGSGT
DYTFTISSLQPEDIATYYCQQWSSYPYMYTFGQGTKVEIK
>Fasinumab|WholemAb|G4|Kappa|Phase-III|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKVSGFTLTELSIHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTM
TEDTSTDTAYMELTSLRSEDTAVYYCSTIFGVVTNFDNWGQGTLVTVSS
>Fasinumab|WholemAb|G4|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASAGDRVTITCRASQAIRNDLGWYQQKPGKAPKRLIYAAFNLQSGVPSRFSGSGSGTE
FTLTISSLQPEDLASYYCQQYNRYPWTFGQGTKVEIK
>Feladilimab|WholemAb|G4|Kappa|Phase-I/II|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYAMHWVRQAPGQGLEWMGLISIYSDHTNYNQKFQGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCGRNNYGNYGWYFDVWGQGTTVTVSS
>Feladilimab|WholemAb|G4|Kappa|Phase-I/II|Active|light
EIVLTQSPATLSLSPGERATLSCSASSSVSYMHWYQQKPGQAPRLLIYDTSKLASGIPARFSGSGSGTDY
TLTISSLEPEDFAVYYCFQGSGYPYTFGQGTKLEIK
>Felzartamab|WholemAb|G1|Lambda|Phase-I/II|Active|heavy
QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYYMNWVRQAPGKGLEWVSGISGDPSNTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARDLPLVYTGFAYWGQGTLVTVSS
>Felzartamab|WholemAb|G1|Lambda|Phase-I/II|Active|light
DIELTQPPSVSVAPGQTARISCSGDNLRHYYVYWYQQKPGQAPVLVIYGDSKRPSGIPERFSGSNSGNTA
TLTISGTQAEDEADYYCQTYTGGASLVFGGGTKLTVL
>Fezakinumab|WholemAb|G1|Lambda|Phase-I|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYMHWVRQAPGQGLEWVGWINPYTGSAFYAQKFRGRVTM
TRDTSISTAYMELSRLRSDDTAVYYCAREPEKFDSDDSDVWGRGTLVTVSS
>Fezakinumab|WholemAb|G1|Lambda|Phase-I|Discontinued|light
QAVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYGVHWYQQLPGTAPKLLIYGDSNRPSGVPDRFSGSKSG
TSASLAITGLQAEDEADYYCQSYDNSLSGYVFGGGTQLTVL
>Fianlimab|WholemAb|G4|Kappa|Phase-I|Active|heavy
QVQLVESGGGVVQPGRSLRLSCVASGFTFSSYGMHWVRQAPGKGLEWVAIIWYDGSNKYYADSVKGRFTI
SRDNSKNTQYLQMNSLRAEDTAVYYCASVATSGDFDYYGMDVWGQGTTVTVSS
>Fianlimab|WholemAb|G4|Kappa|Phase-I|Active|light
EIVLTQSPATLSLSPGERTTLSCRASQRISTYLAWYQQKPGQAPRLLIYDASKRATGIPARFSGSGSGTG
FTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK
>Fibatuzumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYWMNWVRQAPGQGLEWMGDIYPGSGNTNYDEKFQGRVTM
TRDTSISTAYMELSRLRSDDTAVYYCARGGYYEDFDSWGQGTTVTVSS
>Fibatuzumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSFLSASVGDRVTITCRASQGIISYLAWYQQKPEKAPKRLIYAASSLQSGVPSRFSGSGSGTE
FTLTISSLQPEDFATYYCGQYANYPYTFGQGTKLEIK
>Ficlatuzumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVQPGAEVKKPGTSVKLSCKASGYTFTTYWMHWVRQAPGQGLEWIGEINPTNGHTNYNQKFQGRATL
TVDKSTSTAYMELSSLRSEDTAVYYCARNYVGSIFDYWGQGTLLTVSS
>Ficlatuzumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIVMTQSPDSLAMSLGERVTLNCKASENVVSYVSWYQQKPGQSPKLLIYGASNRESGVPDRFSGSGSATD
FTLTISSVQAEDVADYHCGQSYNYPYTFGQGTKLEIK
>Figitumumab|WholemAb|G2|Kappa|Phase-I|Discontinued|heavy
EVQLLESGGGLVQPGGSLRLSCTASGFTFSSYAMNWVRQAPGKGLEWVSAISGSGGTTFYADSVKGRFTI
SRDNSRTTLYLQMNSLRAEDTAVYYCAKDLGWSDSYYYYYGMDVWGQGTTVTVSS
>Figitumumab|WholemAb|G2|Kappa|Phase-I|Discontinued|light
DIQMTQFPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASRLHRGVPSRFSGSGSGTE
FTLTISSLQPEDFATYYCLQHNSYPCSFGQGTKLEIK
>Firivumab|WholemAb|G1|Kappa|Preclinical|Discontinued|heavy
QVQLVQSGAEVKMPGSSVKVSCKTSGVFFSSHAISWVRQAPGQGLEWMGGISPMFGTTHYAQKFQGRVTI
TADQSTTTAYMELTSLTSEDTAVYYCARDGAGSYYPLNWFDPWGQGTLVTVSS
>Firivumab|WholemAb|G1|Kappa|Preclinical|Discontinued|light
EIVLTQSPATLSLSPGERATLSCRASENIWNNLAWYQQKPGQAPRLLISGASTGATGVPSRFRGSGSRTE
FTLTISSLQSEDFAIYFCQQYNSWPRTFGPGTKVEIK
>Flanvotumab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
QVQLVQSGSELKKPGASVKISCKASGYTFTSYAMNWVRQAPGQGLESMGWINTNTGNPTYAQGFTGRFVF
SMDTSVSTAYLQISSLKAEDTAIYYCAPRYSSSWYLDYWGQGTLVTVSS
>Flanvotumab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWLMYTFGQGTKLEIK
>Fletikumab|WholemAb|G4|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKRPGASVKVSCKASGYTFTNDIIHWVRQAPGQRLEWMGWINAGYGNTQYSQNFQDRVSI
TRDTSASTAYMELISLRSEDTAVYYCAREPLWFGESSPHDYYGMDVWGQGTTVTVSS
>Fletikumab|WholemAb|G4|Kappa|Phase-II|Discontinued|light
AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK
>Flotetuzumab|BispecificscFvwithCrossover|na|Kappa;Lambda|Phase-I/II|Active|heavy
EVQLVQSGAELKKPGASVKVSCKASGYTFTDYYMKWVRQAPGQGLEWIGDIIPSNGATFYNQKFKGRVTI
TVDKSTSTAYMELSSLRSEDTAVYYCARSHLLRASWFAYWGQGTLVTVSS
>Flotetuzumab|BispecificscFvwithCrossover|na|Kappa;Lambda|Phase-I/II|Active|light
DFVMTQSPDSLAVSLGERVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYYCQNDYSYPYTFGQGTKLEIK
>Fontolizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAELKKPGSSVKVSCKASGYIFTSSWINWVKQAPGQGLEWIGRIDPSDGEVHYNQDFKDKATL
TVDKSTNTAYMELSSLRSEDTAVYYCARGFLPWFADWGQGTLVTVSS
>Fontolizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSTLSASVGDRVTITCKASENVDTYVSWYQQKPGKAPKLLIYGASNRYTGVPSRFSGSGSGTD
FTLTISSLQPDDFATYYCGQSYNYPFTFGQGTKVEVK
>Foralumab|WholemAb|G1|Kappa|Phase-I/II|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFKFSGYGMHWVRQAPGKGLEWVAVIWYDGSKKYYVDSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARQMGYWHFDLWGRGTLVTVSS
>Foralumab|WholemAb|G1|Kappa|Phase-I/II|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWPPLTFGGGTKVEIK
>Foravirumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVESGGGAVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVILYDGSDKFYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKVAVAGTHFDYWGQGTLVTVSS
>Foravirumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQLNSYPPTFGGGTKVEIK
>Fremanezumab|WholemAb|G2|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWISWVRQAPGKGLEWVAEIRSESDASATHYAEAVKGRF
TISRDNAKNSLYLQMNSLRAEDTAVYYCLAYFDYGLAIQNYWGQGTLVTVSS
>Fremanezumab|WholemAb|G2|Kappa|Approved|Active|light
EIVLTQSPATLSLSPGERATLSCKASKRVTTYVSWYQQKPGQAPRLLIYGASNRYLGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCSQSYNYPYTFGQGTKLEIK
>Fresolimumab|WholemAb|G4|Kappa|Phase-I|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYTFSSNVISWVRQAPGQGLEWMGGVIPIVDIANYAQRFKGRVTI
TADESTSTTYMELSSLRSEDTAVYYCASTLGLVLDAMDYWGQGTLVTVSS
>Fresolimumab|WholemAb|G4|Kappa|Phase-I|Active|light
ETVLTQSPGTLSLSPGERATLSCRASQSLGSSYLAWYQQKPGQAPRLLIYGASSRAPGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYADSPITFGQGTRLEIK
>Frovocimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVKPGGSLRLSCAASGFPFSKLGMVWVRQAPGKGLEWVSTISSGGGYTYYPDSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCAREGISFQGGTYTYVMDYWGQGTLVTVSS
>Frovocimab|WholemAb|G4|Kappa|Phase-II|Active|light
DIVMTQSPLSLPVTPGEPASISCRSSKSLLHRNGITYSYWYLQKPGQSPQLLIYQLSNLASGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCYQNLELPLTFGQGTKVEIK
>Frunevetmab|FelineWholemAb|G1|Kappa|Unknown|Active|heavy
QVQLVESGAELVQPGESLRLTCAASGFSLTNNNVNWVRQAPGKGLEWMGGVWAGGATDYNSALKSRLTIT
RDTSKNTVFLQMHSLQSEDTATYYCARDGGYSSSTLYAMDAWGQGTTVTVSA
>Frunevetmab|FelineWholemAb|G1|Kappa|Unknown|Active|light
DIEMTQSPLSLSVTPGESVSISCRASEDIYNALAWYLQKPGRSPRLLIYNTDTLHTGVPDRFSGSGSGTD
FTLKISRVQTEDVGVYFCQHYFHYPRTFGQGTKLELK
>Fulranumab|WholemAb|G2|Kappa|Phase-III|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTLRSYSMNWVRQAPGKGLEWVSYISRSSHTIFYADSVKGRFTI
SRDNAKNSLYLQMDSLRDEDTAMYYCARVYSSGWHVSDYFDYWGQGILVTVSS
>Fulranumab|WholemAb|G2|Kappa|Phase-III|Discontinued|light
AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK
>Futuximab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLQQPGSELVRPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNIYPGSRSTNYDEKFKSKATL
TVDTSSSTAYMQLSSLTSEDSAVYYCTRNGDYYVSSGDAMDYWGQGTSVTVSS
>Futuximab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQTTSSLSASLGDRVTISCRTSQDIGNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTD
FSLTINNVEQEDVATYFCQHYNTVPPTFGGGTKLEIK
>Galcanezumab|WholemAb|G4|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYTFGNYWMQWVRQAPGQGLEWMGAIYEGTGKTVYIQKFADRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARLSDYVSGFGYWGQGTTVTVSS
>Galcanezumab|WholemAb|G4|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCRASKDISKYLNWYQQKPGKAPKLLIYYTSGYHSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQGDALPPTFGGGTKVEIK
>Galiximab|WholemAb|G1|Lambda|Phase-II|Discontinued|heavy
QVQLQESGPGLVKPSETLSLTCAVSGGSISGGYGWGWIRQPPGKGLEWIGSFYSSSGNTYYNPSLKSQVT
ISTDTSKNQFSLKLNSMTAADTAVYYCVRDRLFSVVGMVYNNWFDVWGPGVLVTVSS
>Galiximab|WholemAb|G1|Lambda|Phase-II|Discontinued|light
ESALTQPPSVSGAPGQKVTISCTGSTSNIGGYDLHWYQQLPGTAPKLLIYDINKRPSGISDRFSGSKSGT
AASLAITGLQTEDEADYYCQSYDSSLNAQVFGGGTRLTVL
>Gancotamab|scFv|na|Lambda|Phase-II|Discontinued|heavy
QVQLVESGGGLVQPGGSLRLSCAASGFTFRSYAMSWVRQAPGKGLEWVSAISGRGDNTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKMTSNAFAFDYWGQGTLVTVSS
>Gancotamab|scFv|na|Lambda|Phase-II|Discontinued|light
QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYGVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGFKSG
TSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTKLTVL
>Ganitumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTI
SVDKSKNQFSLKLSSVTAADTAVYYCARWTGRTDAFDIWGQGTMVTVSS
>Ganitumab|WholemAb|G1|Kappa|Phase-III|Active|light
DVVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCMQGTHWPLTFGQGTKVEIK
>Gantenerumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
QVELVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAINASGTRTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARGKGNTHKPYGYVRYFDVWGQGTLVTVSS
>Gantenerumab|WholemAb|G1|Kappa|Phase-III|Active|light
DIVLTQSPATLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGT
DFTLTISSLEPEDFATYYCLQIYNMPITFGQGTKVEIK
>Garadacimab|WholemAb|G4|Lambda|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSKYIMQWVRQAPGKGLEWVSGIDIPTKGTVYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARALPRSGYLISPHYYYYALDVWGQGTTVTVSS
>Garadacimab|WholemAb|G4|Lambda|Phase-II|Active|light
QSVLTQPPSASGTPGQRVTISCSGSSSNIGRNYVYWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGT
SASLAISGLRSEDEADYYCAAWDASLRGVFGGGTKLTVL
>Garetosmab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLQESGPGLVKPSETLSLTCTVSGGSFSSHFWSWIRQPPGKGLEWIGYILYTGGTSFNPSLKSRVSMS
VGTSKNQFSLKLSSVTAADTAVYYCARARSGITFTGIIVPGSFDIWGQGTMVTVSS
>Garetosmab|WholemAb|G4|Kappa|Phase-II|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK
>Garivulimab|WholemAb|G1|Kappa|TBC|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAVSGFSLTSYGVHWVRQAPGKGLEWVAVIWAGGSTNYADSVKGRFTIS
KDTSKNTVYLQMNSLRAEDTAVYYCAKPYGTSAMDYWGQGTLVTVSS
>Garivulimab|WholemAb|G1|Kappa|TBC|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQDVGIVVAWYQQKPGKAPKLLIYWASIRHTGVPSRFSGSGSGTE
FTLTISSLQPDDFATYYCQQYSNYPLYTFGQGTKVEIK
>Gatipotuzumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSMRLSCVASGFPFSNYWMNWVRQAPGKGLEWVGEIRLKSNNYTTHYAESVKGRF
TISRDDSKNSLYLQMNSLKTEDTAVYYCTRHYYFDYWGQGTLVTVSS
>Gatipotuzumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIVMTQSPLSNPVTPGEPASISCRSSKSLLHSNGITYFFWYLQKPGQSPQLLIYQMSNLASGVPDRFSGS
GSGTDFTLRISRVEAEDVGVYYCAQNLELPPTFGQGTKVEIK
>Gatralimab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFPFSNYWMNWVRQAPGKGLEWVGQIRLKSNNYATHYAESVKGRF
TISRDDSKNSLYLQMNSLKTEDTAVYYCTPIDYWGQGTTVTVSS
>Gatralimab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
DIVMTQTPLSLSVTPGQPASISCKSSQSLLYSNGKTYLNWVLQKPGQSPQRLIYLVSKLDSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCVQGSHFHTFGQGTKLEIK
>Gedivumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGVVQPGKSLRLSCAASGLTFSSYAVHWVRQAPGKGLEWVTLISYDGANQYYADSVKGRFTI
SRDNSKNTVYLQMNSLRPEDTAVYYCAVPGPVFGIFPPWSYFDNWGQGILVTVSS
>Gedivumab|WholemAb|G1|Kappa|Phase-II|Active|light
EIVLTQSPATLSVSPGERATLSCRASQVISHNLAWYQQKPGQAPRLLIYGASTRASGIPARFSGSGSGTD
YTLTITSLQSEDFAVYYCQHYSNWPPRLTFGGGTKVEIK
>Gemtuzumab|WholemAbADC|G4|Kappa|Approved|NFD|heavy
EVQLVQSGAEVKKPGSSVKVSCKASGYTITDSNIHWVRQAPGQSLEWIGYIYPYNGGTDYNQKFKNRATL
TVDNPTNTAYMELSSLRSEDTAFYYCVNGNPWLAYWGQGTLVTVSS
>Gemtuzumab|WholemAbADC|G4|Kappa|Approved|NFD|light
DIQLTQSPSTLSASVGDRVTITCRASESLDNYGIRFLTWFQQKPGKAPKLLMYAASNQGSGVPSRFSGSG
SGTEFTLTISSLQPDDFATYYCQQTKEVPWSFGQGTKVEVK
>Geptanolimab|WholemAb|G4|Kappa|TBC|Active|heavy
QIQLVQSGSELKKPGASVKVSCKASGYTFTNFGMNWVRQAPGQGLKWMGWISGYTREPTYAADFKGRFVI
SLDTSVSTAYLQISSLKAEDTAVYYCARDVFDYWGQGTLVTVSS
>Geptanolimab|WholemAb|G4|Kappa|TBC|Active|light
DIVLTQSPASLAVSPGQRATITCRASESVDNYGYSFMNWFQQKPGQPPKLLIYRASNLESGVPARFSGSG
SRTDFTLTINPVEADDTANYYCQQSNADPTFGQGTKLEIK
>Gevokizumab|WholemAb|G2|Kappa|Phase-III|Active|heavy
QVQLQESGPGLVKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDGDESYNPSLKSRLT
ISKDTSKNQVSLKITSVTAADTAVYFCARNRYDPPWFVDWGQGTLVTVSS
>Gevokizumab|WholemAb|G2|Kappa|Phase-III|Active|light
DIQMTQSTSSLSASVGDRVTITCRASQDISNYLSWYQQKPGKAVKLLIYYTSKLHSGVPSRFSGSGSGTD
YTLTISSLQQEDFATYFCLQGKMLPWTFGQGTKLEIK
>Giloralimab|WholemAb|G1|Kappa|Phase-I|Active|heavy
EVQLQESGPGLVKPSETLSLTCTVSGYSITSNYYWNWIRQPPGKGLEWMGYIRYDGSNNYNPSLKNRVTI
SRDTSKNQFSLKLSSVTAADTAVYYCARLDYWGQGTTVTVSS
>Giloralimab|WholemAb|G1|Kappa|Phase-I|Active|light
DIVMTQTPLSLSVTPGQPASISCRSSQSLENTNGNTFLNWYLQKPGQSPQLLIYRVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCLQVTHVPFTFGQGTKLEIK
>Gilvetmab|CanineWholemAb|G2|Kappa|Unknown|Active|heavy
EVQLVQSGGDLVKPGGSVRLSCVASGFNIKNTYMHWVRQAPGKGLQWIGRIAPANVDTKYAPKFQGKATI
SADTAKNTAYMQLNSLRAEDTAVYYCVLIYYDYDGDIDVWGQGTLVTVSS
>Gilvetmab|CanineWholemAb|G2|Kappa|Unknown|Active|light
DIVMTQTPLSLSVSLGEPASISCHASQNINVWLSWYRQKPGQIPQLLIYKASHLHTGVPDRFSGSGSGTD
FTLRISRVEADDAGVYYCQQGQSWPLTFGQGTKVEIK
>Gimsilumab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSRHWMHWLRQVPGKGPVWVSRINGAGTSITYADSVRGRFTI
SRDNANNTLFLQMNSLRADDTALYFCARANSVWFRGLFDYWGQGTPVTVSS
>Gimsilumab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
EIVLTQSPVTLSVSPGERVTLSCRASQSVSTNLAWYQQKLGQGPRLLIYGASTRATDIPARFSGSGSETE
FTLTISSLQSEDFAVYYCQQYDKWPDTFGQGTKLEIK
>Girentuximab|WholemAbRadiolabelled|G1|Kappa|Phase-III|Discontinued|heavy
DVKLVESGGGLVKLGGSLKLSCAASGFTFSNYYMSWVRQTPEKRLELVAAINSDGGITYYLDTVKGRFTI
SRDNAKNTLYLQMSSLKSEDTALFYCARHRSGYFSMDYWGQGTSVTVSS
>Girentuximab|WholemAbRadiolabelled|G1|Kappa|Phase-III|Discontinued|light
DIVMTQSQRFMSTTVGDRVSITCKASQNVVSAVAWYQQKPGQSPKLLIYSASNRYTGVPDRFTGSGSGTD
FTLTISNMQSEDLADFFCQQYSNYPWTFGGGTKLEIK
>Glembatumumab|WholemAbADC|G2|Kappa|Phase-III|Discontinued|heavy
QVQLQESGPGLVKPSQTLSLTCTVSGGSISSFNYYWSWIRHHPGKGLEWIGYIYYSGSTYSNPSLKSRVT
ISVDTSKNQFSLTLSSVTAADTAVYYCARGYNWNYFDYWGQGTLVTVSS
>Glembatumumab|WholemAbADC|G2|Kappa|Phase-III|Discontinued|light
EIVMTQSPATLSVSPGERATLSCRASQSVDNNLVWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTE
FTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK
>Glenzocimab|Fab|G1|Kappa|Phase-I|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYNMHWVRQAPGQGLEWMGGIYPGNGDTSYNQKFQGRVTM
TRDTSTSTVYMELSSLRSEDTAVYYCARGTVVGDWYFDVWGQGTLVTVSS
>Glenzocimab|Fab|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCRSSQSLENSNGNTYLNWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGS
GSGRDFTFTISSLQPEDIATYYCLQLTHVPWTFGQGTKVEIT
>Glofitamab|BispecificmAbwithDomainCrossover|G1|Lambda;Kappa|Phase-I|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYAMNWVRQAPGKGLEWVSRIRSKYNNYATYYADSVKGRF
TISRDDSKNTLYLQMNSLRAEDTAVYYCVRHGNFGNSYVSWFAYWGQGTLVTVSS
>Glofitamab|BispecificmAbwithDomainCrossover|G1|Lambda;Kappa|Phase-I|Active|light
QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTTSNYANWVQEKPGQAFRGLIGGTNKRAPGTPARFSGSLLG
GKAALTLSGAQPEDEAEYYCALWYSNLWVFGGGTKLTVL
>Golimumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFIFSSYAMHWVRQAPGNGLEWVAFMSYDGSNKKYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARDRGIAAGGNYYYYGMDVWGQGTTVTVSS
>Golimumab|WholemAb|G1|Kappa|Approved|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSVYSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIK
>Gomiliximab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLAKPGGSLRLSCAASGFRFTFNNYYMDWVRQAPGQGLEWVSRISSSGDPTWYADSVKGRF
TISRENANNTLFLQMNSLRAEDTAVYYCASLTTGSDSWGQGVLVTVSS
>Gomiliximab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQDIRYYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTE
FTLTVSSLQPEDFATYYCLQVYSTPRTFGQGTKVEIK
>Gontivimab|BispecificSingleDomains(VH-VH'-VH’)|na|na|Phase-II|Discontinued|heavy
DVQLVESGGGLVQAGGSLSISCAASGGSLSNYVLGWFRQAPGKEREFVAAINWRGDITIGPPNVEGRFTI
SRDNAKNTGYLQMNSLAPDDTAVYYCGAGTPLNPGAYIYDWSYDYWGRGTQVTVSS
>Gosuranemab|WholemAb|G4|Kappa|Phase-II|Active|heavy
EVHLVESGGALVKPGGSLRLSCAASGFSFSKYGMSWVRQAPGKGLEWVATISSSGSRTYYPDSVKGRFTI
SRDNAKNTLYLQMNSLRAEDTAMYYCSISWDGAMDYWGQGTTVTVSS
>Gosuranemab|WholemAb|G4|Kappa|Phase-II|Active|light
DVVMTQSPLSLPVTLGQPASISCKSSQSIVHSNGNTYLEWYLQKPGQSPQLLVYKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGTYYCFQGSLVPWAFGGGTKVEIK
>Gremubamab|BispecificmAb|G1|Kappa;Kappa|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMNWVRQAPGKGLEWVSAITMSGITAYYTDDVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKEEFLPGTHYYYGMDVWGQGTTVTVSS
>Gremubamab|BispecificmAb|G1|Kappa;Kappa|Phase-II|Active|light
AIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKLLIYSASTLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYCLQDYNYPWTFGQGTKVEIK
>Grisnilimab|WholemAb|G2a|Lambda|TBC|Active|heavy
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLMWLGWINTYTGEPTYADDFKGRFAF
SLETSASTAYLQINNLKNEDTATYFCARWAYFYGSSPYFFDYWGQGTTLTVSS
>Grisnilimab|WholemAb|G2a|Lambda|TBC|Active|light
QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIG
DKAALTITGAQTEDEAIYFCALWCSNHLVFGGGTKLTVL
>Guselkumab|WholemAb|G1|Lambda|Approved|Active|heavy
EVQLVQSGAEVKKPGESLKISCKGSGYSFSNYWIGWVRQMPGKGLEWMGIIDPSNSYTRYSPSFQGQVTI
SADKSISTAYLQWSSLKASDTAMYYCARWYYKPFDVWGQGTLVTVSS
>Guselkumab|WholemAb|G1|Lambda|Approved|Active|light
QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGYDVHWYQQLPGTAPKLLIYGNSKRPSGVPDRFSGSKSG
TSASLAITGLQSEDEADYYCASWTDGLSLVVFGGGTKLTVL
>Ianalumab|WholemAb|G1|Kappa|Phase-II/III|Active|heavy
QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWGWIRQSPGRGLEWLGRIYYRSKWYNSYAVSVKSR
ITINPDTSKNQFSLQLNSVTPEDTAVYYCARYQWVPKIGVFDSWGQGTLVTVSS
>Ianalumab|WholemAb|G1|Kappa|Phase-II/III|Active|light
DIVLTQSPATLSLSPGERATLSCRASQFILPEYLSWYQQKPGQAPRLLIYGSSSRATGVPARFSGSGSGT
DFTLTISSLEPEDFAVYYCQQFYSSPLTFGQGTKVEIK
>Ibalizumab|WholemAb|G4|Kappa|Approved|NFD|heavy
QVQLQQSGPEVVKPGASVKMSCKASGYTFTSYVIHWVRQKPGQGLDWIGYINPYNDGTDYDEKFKGKATL
TSDTSTSTAYMELSSLRSEDTAVYYCAREKDNYATGAWFAYWGQGTLVTVSS
>Ibalizumab|WholemAb|G4|Kappa|Approved|NFD|light
DIVMTQSPDSLAVSLGERVTMNCKSSQSLLYSTNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFSG
SGSGTDFTLTISSVQAEDVAVYYCQQYYSYRTFGGGTKLEIK
>Icatolimab|WholemAb|G4|Kappa|Phase-I|Active|heavy
QVQLVQSGAEVKKPGASVKLSCKASGYNFKHTYAHWVRQAPGQGLEWIGRIDPANGNTKYDPKFQGRATM
TADTASNTAYLELSSLRSEDTAVYYCVADHYGSSLLDYWGQGTLVTVSS
>Icatolimab|WholemAb|G4|Kappa|Phase-I|Active|light
DVVMTQTPLSLSVTPGQPASISCKSSQSLLDSDGKTYLNWFQQRPGQSPRRLIYLVSKLDSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCWQGTYFPYTFGQGTKLEIK
>Icrucumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QAQVVESGGGVVQSGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVRGRFTI
SRDNSENTLYLQMNSLRAEDTAVYYCARDHYGSGVHHYFYYGLDVWGQGTTVTVSS
>Icrucumab|WholemAb|G1|Kappa|Phase-II|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK
>Idactamab|WholemAb|G1|Kappa|TBC|Active|heavy
QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEIHHSGGANYNPSLKSRVTIS
VDTSKNQFSLKLSSVTAADTAVYYCARGQGKNWHYDYFDYWGQGTLVTVSS
>Idactamab|WholemAb|G1|Kappa|TBC|Active|light
DIQMTQSPSTLSASVGDRVTITCRASQSIRSWLAWYQQKPGKAPKLLIYKASILKIGVPSRFSGSGSGTE
FTLTISSLQPDDFATYYCQQYYSYSRTFGQGTKVEIK
>Idarucizumab|Fab|G1|Kappa|Approved|NFD|heavy
QVQLQESGPGLVKPSETLSLTCTVSGFSLTSYIVDWIRQPPGKGLEWIGVIWAGGSTGYNSALRSRVSIT
KDTSKNQFSLKLSSVTAADTAVYYCASAAYYSYYNYDGFAYWGQGTLVTVSS
>Idarucizumab|Fab|G1|Kappa|Approved|NFD|light
DVVMTQSPLSLPVTLGQPASISCKSSQSLLYTDGKTYLYWFLQRPGQSPRRLIYLVSKLDSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCLQSTHFPHTFGGGTKVEIK
>Ieramilimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGFTLTNYGMNWVRQARGQRLEWIGWINTDTGEPTYADDFKGRFVF
SLDTSVSTAYLQISSLKAEDTAVYYCARNPPYYYGTNNAEAMDYWGQGTTVTVSS
>Ieramilimab|WholemAb|G4|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCSSSQDISNYLNWYLQKPGQSPQLLIYYTSTLHLGVPSRFSGSGSGTE
FTLTISSLQPDDFATYYCQQYYNLPWTFGQGTKVEIK
>Ifabotuzumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYWMNWVRQAPGQGLEWMGDIYPGSGNTNYDEKFQGRVTM
TRDTSISTAYMELSRLRSDDTAVYYCARGGYYEDFDSWGQGTTVTVSS
>Ifabotuzumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSFLSASVGDRVTITCRASQGIISYLAWYQQKPEKAPKRLIYAASSLQSGVPSRFSGSGSGTE
FTLTISSLQPEDFATYYCGQYANYPYTFGQGTKLEIK
>Iladatuzumab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYTFSSYWIEWVRQAPGKGLEWIGEILPGGGDTNYNEIFKGRATF
SADTSKNTAYLQMNSLRAEDTAVYYCTRRVPIRLDYWGQGTLVTVSS
>Iladatuzumab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|light
DIQLTQSPSSLSASVGDRVTITCKASQSVDYEGDSFLNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSG
SGTDFTLTISSLQPEDFATYYCQQSNEDPLTFGQGTKVEIK
>Imalumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSIYSMNWVRQAPGKGLEWVSSIGSSGGTTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAGSQWLYGMDVWGQGTTVTVSS
>Imalumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRSSQRIMTYLNWYQQKPGKAPKLLIFVASHSQSGVPSRFRGSGSETD
FTLTISGLQPEDSATYYCQQSFWTPLTFGGGTKVEIK
>Imaprelimab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
QVTLKESGPVLVKPTETLTLTCTVSGFSLTSNAVSWVRQPPGKALEWIAAISSGGTTYYNSAFKSRLTIS
RDTSKSQVVLTMTNMDPVDTATYYCARRYGYGWYFDFWGQGTLVTVSS
>Imaprelimab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
DIQMTQSPSSLSASVGDRVTINCKASQNIYNSLAWYQQKPGKAPKVLIFNANSLQTGIPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQFYSGYTFGQGTKLEIK
>Imgatuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGFTFTDYKIHWVRQAPGQGLEWMGYFNPNSGYSTYAQKFQGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARLSPGGYYVMDAWGQGTTVTVSS
>Imgatuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQGINNYLNWYQQKPGKAPKRLIYNTNNLQTGVPSRFSGSGSGTE
FTLTISSLQPEDFATYYCLQHNSFPTFGQGTKLEIK
>Inclacumab|WholemAb|G4|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVRPGGSLRLSCAASGFTFSNYDMHWVRQATGKGLEWVSAITAAGDIYYPGSVKGRFTIS
RENAKNSLYLQMNSLRAGDTAVYYCARGRYSGSGSYYNDWFDPWGQGTLVTVSS
>Inclacumab|WholemAb|G4|Kappa|Phase-II|Discontinued|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK
>Indatuximab|WholemAbADC|G4|Kappa|Phase-II|Active|heavy
QVQLQQSGSELMMPGASVKISCKATGYTFSNYWIEWVKQRPGHGLEWIGEILPGTGRTIYNEKFKGKATF
TADISSNTVQMQLSSLTSEDSAVYYCARRDYYGNFYYAMDYWGQGTSVTVSS
>Indatuximab|WholemAbADC|G4|Kappa|Phase-II|Active|light
DIQMTQSTSSLSASLGDRVTISCSASQGINNYLNWYQQKPDGTVELLIYYTSTLQSGVPSRFSGSGSGTD
YSLTISNLEPEDIGTYYCQQYSKLPRTFGGGTKLEIK
>Indusatumab|WholemAbADC|G1|Kappa|Phase-II|Discontinued|heavy
QVQLQQWGAGLLKPSETLSLTCAVFGGSFSGYYWSWIRQPPGKGLEWIGEINHRGNTNDNPSLKSRVTIS
VDTSKNQFALKLSSVTAADTAVYYCARERGYTYGNFDHWGQGTLVTVSS
>Indusatumab|WholemAbADC|G1|Kappa|Phase-II|Discontinued|light
EIVMTQSPATLSVSPGERATLSCRASQSVSRNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTE
FTLTIGSLQSEDFAVYYCQQYKTWPRTFGQGTNVEIK
>Inebilizumab|WholemAb|G1|Kappa|Preregistration|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSSWMNWVRQAPGKGLEWVGRIYPGDGDTNYNVKFKGRFTI
SRDDSKNSLYLQMNSLKTEDTAVYYCARSGFITTVRDFDYWGQGTLVTVSS
>Inebilizumab|WholemAb|G1|Kappa|Preregistration|Active|light
EIVLTQSPDFQSVTPKEKVTITCRASESVDTFGISFMNWFQQKPDQSPKLLIHEASNQGSGVPSRFSGSG
SGTDFTLTINSLEAEDAATYYCQQSKEVPFTFGGGTKVEIK
>Infliximab|WholemAb|G1|Kappa|Approved|NFD|heavy
EVKLEESGGGLVQPGGSMKLSCVASGFIFSNHWMNWVRQSPEKGLEWVAEIRSKSINSATHYAESVKGRF
TISRDDSKSAVYLQMTDLRTEDTGVYYCSRNYYGSTYDYWGQGTTLTVSS
>Infliximab|WholemAb|G1|Kappa|Approved|NFD|light
DILLTQSPAILSVSPGERVSFSCRASQFVGSSIHWYQQRTNGSPRLLIKYASESMSGIPSRFSGSGSGTD
FTLSINTVESEDIADYYCQQSHSWPFTFGSGTNLEVK
>Inotuzumab|WholemAbADC|G4|Kappa|Approved|Active|heavy
EVQLVQSGAEVKKPGASVKVSCKASGYRFTNYWIHWVRQAPGQGLEWIGGINPGNNYATYRRKFQGRVTM
TADTSTSTVYMELSSLRSEDTAVYYCTREGYGNYGAWFAYWGQGTLVTVSS
>Inotuzumab|WholemAbADC|G4|Kappa|Approved|Active|light
DVQVTQSPSSLSASVGDRVTITCRSSQSLANSYGNTFLSWYLHKPGKAPQLLIYGISNRFSGVPDRFSGS
GSGTDFTLTISSLQPEDFATYYCLQGTHQPYTFGQGTKVEIK
>Intetumumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVESGGGVVQPGRSRRLSCAASGFTFSRYTMHWVRQAPGKGLEWVAVISFDGSNKYYVDSVKGRFTI
SRDNSENTLYLQVNILRAEDTAVYYCAREARGSYAFDIWGQGTMVTVSS
>Intetumumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIK
>Ipilimumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVTFISYDGNNKYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAIYYCARTGWLGPFDYWGQGTLVTVSS
>Ipilimumab|WholemAb|G1|Kappa|Approved|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVGSSYLAWYQQKPGQAPRLLIYGAFSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK
>Iratumumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLQQWGAGLLKPSETLSLTCAVYGGSFSAYYWSWIRQPPGKGLEWIGDINHGGGTNYNPSLKSRVTIS
VDTSKNQFSLKLNSVTAADTAVYYCASLTAYWGQGSLVTVSS
>Iratumumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPTSLSASVGDRVTITCRASQGISSWLTWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYDSYPITFGQGTRLEIK
>Isatuximab|WholemAb|G1|Kappa|Preregistration|Active|heavy
QVQLVQSGAEVAKPGTSVKLSCKASGYTFTDYWMQWVKQRPGQGLEWIGTIYPGDGDTGYAQKFQGKATL
TADKSSKTVYMHLSSLASEDSAVYYCARGDYYGSNSLDYWGQGTSVTVSS
>Isatuximab|WholemAb|G1|Kappa|Preregistration|Active|light
DIVMTQSHLSMSTSLGDPVSITCKASQDVSTVVAWYQQKPGQSPRRLIYSASYRYIGVPDRFTGSGAGTD
FTFTISSVQAEDLAVYYCQQHYSPPYTFGGGTKLEIK
>Iscalimab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYEESNRYHADSVKGRFTI
SRDNSKITLYLQMNSLRTEDTAVYYCARDGGIAAPGPDYWGQGTLVTVSS
>Iscalimab|WholemAb|G1|Kappa|Phase-II|Active|light
DIVMTQSPLSLTVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQVLISLGSNRASGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCMQARQTPFTFGPGTKVDIR
>Isecarosmab|BispecificSingleDomains(VH-VH')|na;na|na;na|Phase-I|Active|heavy
DVQLVESGGGVVQPGGSLRLSCAASGRTVSSYAMGWFRQAPGKEREFVAGISRSAERTYYVDSLKGRFTI
SRDNSKNTVYLQMNSLRPEDTALYYCAADLDPNRIFSREEYAYWGQGTLVTVSS
>Istiratumab|BispecificMixedmAbandscFv|G1;na|Kappa;Lambda|Phase-II|Discontinued|heavy
EVQLLQSGGGLVQPGGSLRLSCAASGFMFSRYPMHWVRQAPGKGLEWVGSISGSGGATPYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKDFYQILTGNAFDYWGQGTTVTVSS
>Istiratumab|BispecificMixedmAbandscFv|G1;na|Kappa;Lambda|Phase-II|Discontinued|light
DIQMTQSPSSLSASLGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAKSTLQSGVPSRFSGSGSGTD
FTLTISSLQPEDSATYYCQQYWTFPLTFGGGTKVEIK
>Itepekimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
EVQLVESGGNLEQPGGSLRLSCTASGFTFSRSAMNWVRRAPGKGLEWVSGISGSGGRTYYADSVKGRFTI
SRDNSKNTLYLQMNSLSAEDTAAYYCAKDSYTTSWYGGMDVWGHGTTVTVSS
>Itepekimab|WholemAb|G4|Kappa|Phase-II|Active|light
DIQMTQSPSSVSASVGDRVTITCRASQGIFSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFAIYYCQQANSVPITFGQGTRLEIK
>Itolizumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVKPGGSLKLSCAASGFKFSRYAMSWVRQAPGKRLEWVATISSGGSYIYYPDSVKGRFTI
SRDNVKNTLYLQMSSLRSEDTAMYYCARRDYDLDYFDSWGQGTLVTVSS
>Itolizumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCKASRDIRSYLTWYQQKPGKAPKTLIYYATSLADGVPSRFSGSGSGQD
YSLTISSLESDDTATYYCLQHGESPFTLGSGTKLEIK
>Ivuxolimab|WholemAb|G2|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIDYADSVKGRFTI
SRDNAKNSLYLQMNSLRDEDTAVYYCARESGWYLFDYWGQGTLVTVSS
>Ivuxolimab|WholemAb|G2|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYNSYPPTFGGGTKVEIK
>Ixekizumab|WholemAb|G4|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYSFTDYHIHWVRQAPGQGLEWMGVINPMYGTTDYNQRFKGRVTI
TADESTSTAYMELSSLRSEDTAVYYCARYDYFTGTGVYWGQGTLVTVSS
>Ixekizumab|WholemAb|G4|Kappa|Approved|Active|light
DIVMTQTPLSLSVTPGQPASISCRSSRSLVHSRGNTYLHWYLQKPGQSPQLLIYKVSNRFIGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCSQSTHLPFTFGQGTKLEIK
>Izuralimab|BispecificMixedmAbandscFv|G1;na|Kappa;Kappa|TBC|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPHSGGTNYAQKFQGRVTM
TRDTSISTAYMELSRLRSDDTAVYYCARTYYYDSSGYYHDAFDIWGQGTMVTVSS
>Izuralimab|BispecificMixedmAbandscFv|G1;na|Kappa;Kappa|TBC|Active|light
DIQMTQSPSSVSASVGDRVTITCRASQGISRLLAWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQANSFPWTFGQGTKVEIK
>Labetuzumab|WholemAbADC|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGVVQPGRSLRLSCSASGFDFTTYWMSWVRQAPGKGLEWIGEIHPDSSTINYAPSLKDRFTI
SRDNAKNTLFLQMDSLRPEDTGVYFCASLYFGFPWFAYWGQGTPVTVSS
>Labetuzumab|WholemAbADC|G1|Kappa|Phase-II|Active|light
DIQLTQSPSSLSASVGDRVTITCKASQDVGTSVAWYQQKPGKAPKLLIYWTSTRHTGVPSRFSGSGSGTD
FTFTISSLQPEDIATYYCQQYSLYRSFGQGTKVEIK
>Lacnotuzumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLQESGPGLVKPSQTLSLTCTVSDYSITSDYAWNWIRQFPGKGLEWMGYISYSGSTSYNPSLKSRITI
SRDTSKNQFSLQLNSVTAADTAVYYCASFDYAHAMDYWGQGTTVTVSS
>Lacnotuzumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIVLTQSPAFLSVTPGEKVTFTCQASQSIGTSIHWYQQKTDQAPKLLIKYASESISGIPSRFSGSGSGTD
FTLTISSVEAEDAADYYCQQINSWPTTFGGGTKLEIK
>Lacutamab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QIQLVQSGSELKKPGASVKVSCKASGYTFTTAGMQWVRQAPGQGLEWIGWINSHSGVPKYAEDFKGRFVF
SLDTSVSTAYLQISSLKAEDTAVYFCARGGDEGVMDYWGQGTTVTVSS
>Lacutamab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSFLSASVGDRVTITCKASQDVSTAVAWYQQKPGQPPKLLIYWTSTRHTGVPDRFSGSGSGTD
YTLTISSLQAEDVAVYYCQQHYSTPWTFGGGTKVEIK
>Ladiratuzumab|WholemAbADC|G1|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGLTIEDYYMHWVRQAPGQGLEWMGWIDPENGDTEYGPKFQGRVTM
TRDTSINTAYMELSRLRSDDTAVYYCAVHNAHYGTWFAYWGQGTLVTVSS
>Ladiratuzumab|WholemAbADC|G1|Kappa|Phase-II|Active|light
DVVMTQSPLSLPVTLGQPASISCRSSQSLLHSSGNTYLEWYQQRPGQSPRPLIYKISTRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCFQGSHVPYTFGGGTKVEIK
>Lambrolizumab|WholemAb|G4|Kappa|Approved|Active|heavy
QVQLVQSGVEVKKPGASVKVSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFNEKFKNRVTL
TTDSSTTTAYMELKSLQFDDTAVYYCARRDYRFDMGFDYWGQGTTVTVSS
>Lambrolizumab|WholemAb|G4|Kappa|Approved|Active|light
EIVLTQSPATLSLSPGERATLSCRASKGVSTSGYSYLHWYQQKPGQAPRLLIYLASYLESGVPARFSGSG
SGTDFTLTISSLEPEDFAVYYCQHSRDLPLTFGGGTKVEIK
>Lampalizumab|Fab|G1|Kappa|Phase-III|Discontinued|heavy
EVQLVQSGPELKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGETTYADDFKGRFVF
SLDTSVSTAYLQISSLKAEDTAVYYCEREGGVNNWGQGTLVTVSS
>Lampalizumab|Fab|G1|Kappa|Phase-III|Discontinued|light
DIQVTQSPSSLSASVGDRVTITCITSTDIDDDMNWYQQKPGKVPKLLISGGNTLRPGVPSRFSGSGSGTD
FTLTISSLQPEDVATYYCLQSDSLPYTFGQGTKVEIK
>Lanadelumab|WholemAb|G1|Kappa|Approved|NFD|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSHYIMMWVRQAPGKGLEWVSGIYSSGGITVYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAYRRIGVPRRDEFDIWGQGTMVTVSS
>Lanadelumab|WholemAb|G1|Kappa|Approved|NFD|light
DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASTLESGVPSRFSGSGSGTE
FTLTISSLQPDDFATYYCQQYNTYWTFGQGTKVEIK
>Landogrozumab|WholemAb|G4|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGLTFSRYPMSWVRQAPGKGLVWVSAITSSGGSTYYSDTVKGRFTI
SRDNAKNTLYLQMNSLRAEDTAVYYCARLPDYWGQGTLVTVSS
>Landogrozumab|WholemAb|G4|Kappa|Phase-II|Active|light
EIVLTQSPGTLSLSPGERATLSCRASSSVSSSYLHWYQQKPGQAPRLLIYSTSNLVAGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQHHSGYHFTFGGGTKVEIK
>Laprituximab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|heavy
QVQLVQSGAEVAKPGASVKLSCKASGYTFTSYWMQWVKQRPGQGLECIGTIYPGDGDTTYTQKFQGKATL
TADKSSSTAYMQLSSLRSEDSAVYYCARYDAPGYAMDYWGQGTLVTVSS
>Laprituximab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQDINNYLAWYQHKPGKGPKLLIHYTSTLHPGIPSRFSGSGSGRD
YSFSISSLEPEDIATYYCLQYDNLLYTFGQGTKLEIK
>Larcaviximab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLQESGPELEMPGASVKISCKASGSSFTGFSMNWVKQSNGKSLEWIGNIDTYYGGTTYNQKFKGKATL
TVDKSSSTAYMQLKSLTSEDSAVYYCARSAYYGSTFAYWGQGTLVTVSA
>Larcaviximab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLVYNAKTLIEGVPSRFSGSGSGTQ
FSLKINSLQPEDFGSYFCQHHFGTPFTFGSGTELEIK
>Lebrikizumab|WholemAb|G4|Kappa|Phase-III|Active|heavy
QVTLRESGPALVKPTQTLTLTCTVSGFSLSAYSVNWIRQPPGKALEWLAMIWGDGKIVYNSALKSRLTIS
KDTSKNQVVLTMTNMDPVDTATYYCAGDGYYPYAMDNWGQGSLVTVSS
>Lebrikizumab|WholemAb|G4|Kappa|Phase-III|Active|light
DIVMTQSPDSLSVSLGERATINCRASKSVDSYGNSFMHWYQQKPGQPPKLLIYLASNLESGVPDRFSGSG
SGTDFTLTISSLQAEDVAVYYCQQNNEDPRTFGGGTKVEIK
>Lecanemab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCSASGFTFSSFGMHWVRQAPGKGLEWVAYISSGSSTIYYGDTVKGRFTI
SRDNAKNSLFLQMSSLRAEDTAVYYCAREGGYYYGRSYYTMDYWGQGTTVTVSS
>Lecanemab|WholemAb|G1|Kappa|Phase-II|Active|light
DVVMTQSPLSLPVTPGAPASISCRSSQSIVHSNGNTYLEWYLQKPGQSPKLLIYKVSNFRSGVPDRFSGS
GSGTDFTLRISRVEAEDVGIYYCFQGSHVPPTFGPGTKLEIK
>Lenvervimab|WholemAb|G1|Kappa|Phase-II/III|Active|heavy
EVQLVESGGGLVKPGGSLRLSCSASGFSLTKYKMTWVRQAPGKGLEWVSSISSTSRDIDYADSVKGRFTI
SRDNAKNSLFLQMSSLRVDDTAVYYCTRDGWLWGWDVRSNYYYNALDVWGQGTTVTVSS
>Lenvervimab|WholemAb|G1|Kappa|Phase-II/III|Active|light
DIVVTQSPSSLSASVGDRVTITCRASQGIYNSIAWYQQKPGKAPKLLLYSTSTLLSGVPSRFSGSGSGTD
YTLTITNLQPEDFATYYCQQYFVTPETFGQGTKLEIK
>Lenzilumab|WholemAb|G1|Kappa|Phase-I/II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYSFTNYYIHWVRQAPGQRLEWMGWINAGNGNTKYSQKFQGRVTI
TRDTSASTAYMELSSLRSEDTAVYYCVRRQRFPYYFDYWGQGTLVTVSS
>Lenzilumab|WholemAb|G1|Kappa|Phase-I/II|Active|light
EIVLTQSPATLSVSPGERATLSCRASQSVGTNVAWYQQKPGQAPRVLIYSTSSRATGITDRFSGSGSGTD
FTLTISRLEPEDFAVYYCQQFNKSPLTFGGGTKVEIK
>Leronlimab|WholemAb|G4|Kappa|Preregistration|Active|heavy
EVQLVESGGGLVKPGGSLRLSCAASGYTFSNYWIGWVRQAPGKGLEWIGDIYPGGNYIRNNEKFKDKTTL
SADTSKNTAYLQMNSLKTEDTAVYYCGSSFGSNYVFAWFTYWGQGTLVTVSS
>Leronlimab|WholemAb|G4|Kappa|Preregistration|Active|light
DIVMTQSPLSLPVTPGEPASISCRSSQRLLSSYGHTYLHWYLQKPGQSPQLLIYEVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCSQSTHVPLTFGQGTKVEIK
>Lesofavumab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
EVQLVQSGAEVKKPGESLKISCKVSGYSFTSQWIGWVRQMPGKGLEWIGMMYPGESETIYSPSFQGQVTI
SADNSISTAYLQWSSLKASDTAIYYCASGPGYSGYHYGWFDTWGQGTLVTVSS
>Lesofavumab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
DIVMTQSPLSLPVTPGEPASISCRSSQSLLRSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCMQALQTPYTFGQGTKLEIK
>Letaplimab|WholemAb|G4|Kappa|TBC|Active|heavy
QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYIYYSGSTNYNPSLKSRVTIS
VDTSKNQFSLKLSSVTAADTAVYYCARGKTGSAAWGQGTLVTVSS
>Letaplimab|WholemAb|G4|Kappa|TBC|Active|light
DIQMTQSPSSVSASVGDRVTITCRASQGISRWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQTVSFPITFGGGTKVEIK
>Letolizumab|SingleDomainVariableFragment;H|G1|na|Phase-I/II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFNWELMGWARQAPGKGLEWVSGIEGPGDVTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCVKVGKDAKSDYRGQGTLVTVSS
>Levilimab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVQSGGGLVQPGGSLRLSCAASGFTFSSYYMSWVRQAPGKGLEWVSGIYSDGTTHYGDSVKGRFTIS
RDNAKNTVYLQLNSLRAEDTAMYYCAKGAGPTWWYALDAWGQGTLVTVSS
>Levilimab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQLTQSPSSVSVSVGERVTIDCKSSQSVLSASNTYLNWYQQKPGQAPQLLIYYASTRESGVPDRFSGSG
SGTDFTLTISSLQAEDAAVYYCQQAYRAPVTFGQGTKLEIK
>Lexatumumab|WholemAb|G1|Lambda|Phase-I|Discontinued|heavy
EVQLVQSGGGVERPGGSLRLSCAASGFTFDDYGMSWVRQAPGKGLEWVSGINWNGGSTGYADSVKGRVTI
SRDNAKNSLYLQMNSLRAEDTAVYYCAKILGAGRGWYFDLWGKGTTVTVSS
>Lexatumumab|WholemAb|G1|Lambda|Phase-I|Discontinued|light
SSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTA
SLTITGAQAEDEADYYCNSRDSSGNHVVFGGGTKLTVL
>Lifastuzumab|WholemAbADC|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFSFSDFAMSWVRQAPGKGLEWVATIGRVAFHTYYPDSMKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARHRGFDVGHFDFWGQGTLVTVSS
>Lifastuzumab|WholemAbADC|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRSSETLVHSSGNTYLEWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGS
GSGTDFTLTISSLQPEDFATYYCFQGSFNPLTFGQGTKVEIK
>Ligelizumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
QVQLVQSGAEVMKPGSSVKVSCKASGYTFSWYWLEWVRQAPGHGLEWMGEIDPGTFTTNYNEKFKARVTF
TADTSTSTAYMELSSLRSEDTAVYYCARFSHFSGSNYDYFDYWGQGTLVTVSS
>Ligelizumab|WholemAb|G1|Kappa|Phase-III|Active|light
EIVMTQSPATLSVSPGERATLSCRASQSIGTNIHWYQQKPGQAPRLLIYYASESISGIPARFSGSGSGTE
FTLTISSLQSEDFAVYYCQQSWSWPTTFGGGTKVEIK
>Lilotomab|WholemAbADC|G1|Kappa|Phase-II|Active|heavy
EIQLQQSGPELVKPGASVKVSCKASGYSFTDYNMYWVKQSHGKSLEWIGYIDPYNGDTTYNQKFKGKATL
TVDKSSSTAFIHLNSLTSEDSAVYYCARSPYGHYAMDYWGQGTSVTVSS
>Lilotomab|WholemAbADC|G1|Kappa|Phase-II|Active|light
DIVMTQSHKLLSTSVGDRVSITCKASQDVSTAVDWYQQKPGQSPKLLINWASTRHTGVPDRFTGSGSGTD
YTLTISSMQAEDLALYYCRQHYSTPFTFGSGTKLEIK
>Lintuzumab|WholemAbRadiolabelled|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYNMHWVRQAPGQGLEWIGYIYPYNGGTGYNQKFKSKATI
TADESTNTAYMELSSLRSEDTAVYYCARGRPAMDYWGQGTLVTVSS
>Lintuzumab|WholemAbRadiolabelled|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASESVDNYGISFMNWFQQKPGKAPKLLIYAASNQGSGVPSRFSGSG
SGTDFTLTISSLQPDDFATYYCQQSKEVPWTFGQGTKVEIK
>Lirilumab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSFYAISWVRQAPGQGLEWMGGFIPIFGAANYAQKFQGRVTI
TADESTSTAYMELSSLRSDDTAVYYCARIPSGSYYYDYDMDVWGQGTTVTVSS
>Lirilumab|WholemAb|G4|Kappa|Phase-II|Active|light
EIVLTQSPVTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWMYTFGQGTKLEIK
>Lodapolimab|WholemAb|G1|Lambda|Phase-I|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARSPDYSPYYYYGMDVWGQGTTVTVSS
>Lodapolimab|WholemAb|G1|Lambda|Phase-I|Active|light
QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGT
SASLAISGLQSEDEADYYCQSYDSSLSGSVFGGGIKLTVL
>Lodelcizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFSTMYMSWVRQAPGQGLEWMGRIDPANEHTNYAQKFQGRVTM
TRDTSISTAYMELSRLTSDDTAVYYCARSYYYYNMDYWGQGTLVTVSS
>Lodelcizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
QIVLTQSPATLSVSPGERATLSCRASQSVSYMHWYQQKPGQAPRLLIYGVFRRATGIPDRFSGSGSGTDF
TLTIGRLEPEDFAVYYCLQWSSDPPTFGQGTKLEIK
>Lokivetmab|CanineWholemAb|G2|Kappa|Approved|NFD|heavy
EVQLVESGGDLVKPGGSLRLSCVASGFTFSNYGMSWVRQAPGKGLQWVATISYGGSYTYYPDNIKGRFTI
SRDNAKNTLYLQMNSLRAEDTAMYYCVRGYGYDTMDYWGQGTLVTVSS
>Lokivetmab|CanineWholemAb|G2|Kappa|Approved|NFD|light
EIVMTQSPASLSLSQEEKVTITCKASQSVSFAGTGLMHWYQQKPGQAPKLLIYRASNLEAGVPSRFSGSG
SGTDFSFTISSLEPEDVAVYYCQQSREYPWTFGQGTKLEIK
>Loncastuximab|WholemAbADC|G1|Kappa|Phase-II|Active|heavy
QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKL
TVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSS
>Loncastuximab|WholemAbADC|G1|Kappa|Phase-II|Active|light
EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTSY
SLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK
>Lorukafusp|WholemAbFusion|G1|Kappa|Phase-II|Active|heavy
EVQLVQSGAEVEKPGASVKISCKASGSSFTGYNMNWVRQNIGKSLEWIGAIDPYYGGTSYNQKFKGRATL
TVDKSTSTAYMHLKSLRSEDTAVYYCVSGMEYWGQGTSVTVSS
>Lorukafusp|WholemAbFusion|G1|Kappa|Phase-II|Active|light
DVVMTQTPLSLPVTPGEPASISCRSSQSLVHRNGNTYLHWYLQKPGQSPKLLIHKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDLGVYFCSQSTHVPPLTFGAGTKLELK
>Lorvotuzumab|WholemAbADC|G1|Kappa|Phase-II|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAYISSGSFTIYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARMRKGYAMDYWGQGTLVTVSS
>Lorvotuzumab|WholemAbADC|G1|Kappa|Phase-II|Active|light
DVVMTQSPLSLPVTLGQPASISCRSSQIIIHSDGNTYLEWFQQRPGQSPRRLIYKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCFQGSHVPHTFGQGTKVEIK
>Losatuxizumab|WholemAbADC|G1|Kappa|Phase-I|Active|heavy
EVQLQESGPGLVKPSQTLSLTCTVSGYSISRDFAWNWIRQPPGKGLEWMGYISYNGNTRYQPSLKSRITI
SRDTSKNQFFLKLNSVTAADTATYYCVTASRGFPYWGQGTLVTVSS
>Losatuxizumab|WholemAbADC|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSMSVSVGDRVTITCHSSQDINSNIGWLQQKPGKSFKGLIYHGTNLDDGVPSRFSGSGSGTD
YTLTISSLQPEDFATYYCVQYAQFPWTFGGGTKLEIK
>Lucatumumab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYEESNRYHADSVKGRFTI
SRDNSKITLYLQMNSLRTEDTAVYYCARDGGIAAPGPDYWGQGTLVTVSS
>Lucatumumab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
DIVMTQSPLSLTVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQVLISLGSNRASGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCMQARQTPFTFGPGTKVDIR
>Lulizumab|SingleDomainVariableFragment;L|na|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASRPIWPFLEWYQQKPGKAPKLLIYFTSRLRHGVPSRFSGSGSGTC
FTLTISSLQPEDFATYYCLQNVANPATFSQGTKVEIK
>Lumiliximab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLAKPGGSLRLSCAASGFRFTFNNYYMDWVRQAPGQGLEWVSRISSSGDPTWYADSVKGRF
TISRENANNTLFLQMNSLRAEDTAVYYCASLTTGSDSWGQGVLVTVSS
>Lumiliximab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQDIRYYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTE
FTLTVSSLQPEDFATYYCLQVYSTPRTFGQGTKVEIK
>Lumretuzumab|WholemAb|G1|Kappa|Phase-I/II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFRSSYISWVRQAPGQGLEWMGWIYAGTGSPSYNQKLQGRVTM
TTDTSTSTAYMELRSLRSDDTAVYYCARHRDYYSNSLTYWGQGTLVTVSS
>Lumretuzumab|WholemAb|G1|Kappa|Phase-I/II|Active|light
DIVMTQSPDSLAVSLGERATINCKSSQSVLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYYCQSDYSYPYTFGQGTKLEIK
>Lupartumab|WholemAbADC|G1|Lambda|Phase-I|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAREGLWAFDYWGQGTLVTVSS
>Lupartumab|WholemAbADC|G1|Lambda|Phase-I|Active|light
ESVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYVVHWYQQLPGTAPKLLIYDNNKRPSGVPDRFSGSKSG
TSASLAISGLRSEDEADYYCAAWDDRLNGPVFGGGTKLTVL
>Lutikizumab|BispecificDualVariableDomainIG|G1|Kappa;Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGVVQPGRSLRLSCSASGFIFSRYDMSWVRQAPGKGLEWVAYISHGGAGTYYPDSVKGRFTI
SRDNSKNTLFLQMDSLRPEDTGVYFCARGGVTKGYFDVWGQGTPVTVSS
>Lutikizumab|BispecificDualVariableDomainIG|G1|Kappa;Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASGNIHNYLTWYQQTPGKAPKLLIYNAKTLADGVPSRFSGSGSGTD
YTFTISSLQPEDIATYYCQHFWSIPYTFGQGTKLQIT
>Maftivimab|WholemAb|G1|Kappa|Preregistration|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTSSSYAMNWVRQAPGKGLEWVSTISGMGGSTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKRGYPHSFDIWGQGTMVTVSS
>Maftivimab|WholemAb|G1|Kappa|Preregistration|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQSISSFLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQSYSTLTFGQGTRLEIK
>Magrolimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYNMHWVRQAPGQRLEWMGTIYPGNDDTSYNQKFKDRVTI
TADTSASTAYMELSSLRSEDTAVYYCARGGYRAMDYWGQGTLVTVSS
>Magrolimab|WholemAb|G4|Kappa|Phase-II|Active|light
DIVMTQSPLSLPVTPGEPASISCRSSQSIVYSNGNTYLGWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCFQGSHVPYTFGQGTKLEIK
>Manelimab|WholemAb|G1|Lambda|Phase-I|Active|heavy
EVQLVESGGGVVRPGGSLRLSCAASGFTFDDYAMSWVRQAPGKGLEWVSDISWSGSNTNYADSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTALYHCARAPLLLAMTFGVGSWGQGTLVTVSS
>Manelimab|WholemAb|G1|Lambda|Phase-I|Active|light
QTVVTQEPSLSVSPGGTVTLTCGLSSGTVTAINYPGWYQQTPGQAPRTLIYNTNTRHSGVPDRFSGSISG
NKAALTITGAQAEDEADYYCALYMGNGGHMFGGGTKLTVL
>Margetuximab|WholemAb|G1|Kappa|Phase-III|Active|heavy
QVQLQQSGPELVKPGASLKLSCTASGFNIKDTYIHWVKQRPEQGLEWIGRIYPTNGYTRYDPKFQDKATI
TADTSSNTAYLQVSRLTSEDTAVYYCSRWGGDGFYAMDYWGQGASVTVSS
>Margetuximab|WholemAb|G1|Kappa|Phase-III|Active|light
DIVMTQSHKFMSTSVGDRVSITCKASQDVNTAVAWYQQKPGHSPKLLIYSASFRYTGVPDRFTGSRSGTD
FTFTISSVQAEDLAVYYCQQHYTTPPTFGGGTKVEIK
>Marstacimab|WholemAb|G1|Lambda|Phase-III|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAILGATSLSAFDIWGQGTMVTVSS
>Marstacimab|WholemAb|G1|Lambda|Phase-III|Active|light
QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSG
TSASLAITGLQAEDEADYYCQSYDSSLSGSGVFGGGTKLTVL
>Matuzumab|WholemAb|G1|nd|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSHWMHWVRQAPGQGLEWIGEFNPSNGRTNYNEKFKSKATM
TVDTSTNTAYMELSSLRSEDTAVYYCASRDYDYDGRYFDYWGQGTLVTVSS
>Matuzumab|WholemAb|G1|nd|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCSASSSVTYMYWYQQKPGKAPKLLIYDTSNLASGVPSRFSGSGSGTDY
TFTISSLQPEDIATYYCQQWSSHIFTFGQGTKVEIK
>Mavezelimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QMQLVQSGPEVKKPGTSVKVSCKASGYTFTDYNVDWVRQARGQRLEWIGDINPNDGGTIYAQKFQERVTI
TVDKSTSTAYMELSSLRSEDTAVYYCARNYRWFGAMDHWGQGTTVTVSS
>Mavezelimab|WholemAb|G4|Kappa|Phase-II|Active|light
DIVMTQTPLSLSVTPGQPASISCKASQSLDYEGDSDMNWYLQKPGQPPQLLIYGASNLESGVPDRFSGSG
SGTDFTLKISRVEAEDVGVYYCQQSTEDPRTFGGGTKVEIK
>Mavrilimumab|WholemAb|G4|Lambda|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSIHWVRQAPGKGLEWMGGFDPEENEIVYAQRFQGRVTM
TEDTSTDTAYMELSSLRSEDTAVYYCAIVGSFSPLTLGLWGQGTMVTVSS
>Mavrilimumab|WholemAb|G4|Lambda|Phase-II|Active|light
QSVLTQPPSVSGAPGQRVTISCTGSGSNIGAPYDVSWYQQLPGTAPKLLIYHNNKRPSGVPDRFSGSKSG
TSASLAITGLQAEDEADYYCATVEAGLSGSVFGGGTKLTVL
>Melrilimab|WholemAb|G2|Kappa|TBC|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSIYDMIWVRQAPGKGLEWVSSIRGEGGGTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARDPWSTEGSFFVLDYWGQGTLVTVSS
>Melrilimab|WholemAb|G2|Kappa|TBC|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSVDDDLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQYITAPLTFGQGTKVEIK
>Mepolizumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVTLRESGPALVKPTQTLTLTCTVSGFSLTSYSVHWVRQPPGKGLEWLGVIWASGGTDYNSALMSRLSIS
KDTSRNQVVLTMTNMDPVDTATYYCARDPPSSLLRLDYWGRGTPVTVSS
>Mepolizumab|WholemAb|G1|Kappa|Approved|Active|light
DIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYYCQNVHSFPFTFGGGTKLEIK
>Mezagitamab|WholemAb|G1|Lambda|Phase-I/II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFDDYGMSWVRQAPGKGLEWVSDISWNGGKTHYVDSVKGQFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARGSLFHDSSGFYFGHWGQGTLVTVSS
>Mezagitamab|WholemAb|G1|Lambda|Phase-I/II|Active|light
QSVLTQPPSASGTPGQRVTISCSGSSSNIGDNYVSWYQQLPGTAPKLLIYRDSQRPSGVPDRFSGSKSGT
SASLAISGLRSEDEADYYCQSYDSSLSGSVFGGGTKLTVL
>Milatuzumab|WholemAb|G1|Kappa|Phase-I/II|Active|heavy
QVQLQQSGSELKKPGASVKVSCKASGYTFTNYGVNWIKQAPGQGLQWMGWINPNTGEPTFDDDFKGRFAF
SLDTSVSTAYLQISSLKADDTAVYFCSRSRGKNEAWFAYWGQGTLVTVSS
>Milatuzumab|WholemAb|G1|Kappa|Phase-I/II|Active|light
DIQLTQSPLSLPVTLGQPASISCRSSQSLVHRNGNTYLHWFQQRPGQSPRLLIYTVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYFCSQSSHVPPTFGAGTRLEIK
>Mipasetamab|WholemAb|G1|Kappa|TBC|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMSWVRQAPGKGLEWVATISSGGSYTYYPDSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARHPIYYTYDDTMDYWGQGTTVTVSS
>Mipasetamab|WholemAb|G1|Kappa|TBC|Active|light
EIVLTQSPGTLSLSPGERATLSCSASSSVSSGNFHWYQQKPGLAPRLLIYRTSNLASGIPARFSGSGSGT
DFTLTISSLEPEDFAVYYCQQWSGYPWTFGGGTKLEIK
>Miptenalimab|WholemAb|G4|Kappa|Phase-I|Active|heavy
QVTLVESGGGVVQPGRSLRLSCAFSGFSLSTSDMGVGWIRQAPGKGLEWVAHIWWDDVKRYNPALKSRFT
ISRDNSKNTLYLQMNSLRAEDTAVYFCARIEDYGVSYYFDYWGQGTTVTVSS
>Miptenalimab|WholemAb|G4|Kappa|Phase-I|Active|light
DIQMTQSPSFLSASVGDRVSITCKASQDVSTAVAWYQQKPGKAPKLLIYSASYRYTGVPDRFSGSGSGTD
FTLTISSLQPEDFATYYCQQHYSIPLTFGQGTKLEIK
>Mirikizumab|WholemAb|G4|Kappa|Phase-III|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYKFTRYVMHWVRQAPGQGLEWMGYINPYNDGTNYNEKFKGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARNWDTGLWGQGTTVTVSS
>Mirikizumab|WholemAb|G4|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASVGDRVTITCKASDHILKFLTWYQQKPGKAPKLLIYGATSLETGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQMYWSTPFTFGGGTKVEIK
>Miromavimab|WholemAb(Mouse)|G1|Kappa|Unknown|Active|heavy
QVQLQQPGSVLVRPGASVKLSCKTSGYAFTSSWMHWAKQRPGQGLEWIGQTHPNSGYTNYNEKFKGKATL
TVDTSSSTAYVDLSSLTSEDSAVYYCARESGDGPHWYFDVWGAGTAVTVSS
>Miromavimab|WholemAb(Mouse)|G1|Kappa|Unknown|Active|light
DIVMTQSHKFMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLIYSASYRYTGVPDRFTGSGSGTD
FTFTISSVQAEDLAVYYCQQHYSSPHTFGGGTKLETK
>Mirvetuximab|WholemAbADC|G1|Kappa|Phase-III|Active|heavy
QVQLVQSGAEVVKPGASVKISCKASGYTFTGYFMNWVKQSPGQSLEWIGRIHPYDGDTFYNQKFQGKATL
TVDKSSNTAHMELLSLTSEDFAVYYCTRYDGSRAMDYWGQGTTVTVSS
>Mirvetuximab|WholemAbADC|G1|Kappa|Phase-III|Active|light
DIVLTQSPLSLAVSLGQPAIISCKASQSVSFAGTSLMHWYHQKPGQQPRLLIYRASNLEAGVPDRFSGSG
SKTDFTLTISPVEAEDAATYYCQQSREYPYTFGGGTKLEIK
>Mirzotamab|WholemAb|G1|Kappa|Phase-I|Active|heavy
EVQLQESGPGLVKPSETLSLTCAVTGYSITSGYSWHWIRQFPGNGLEWMGYIHSSGSTNYNPSLKSRISI
SRDTSKNQFFLKLSSVTAADTAVYYCAGYDDYFEYWGQGTTVTVSS
>Mirzotamab|WholemAb|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQNVGFNVAWYQQKPGKSPKALIYSASYRYSGVPSRFSGSGSGTD
FTLTISSLQPEDFAEYFCQQYNWYPFTFGQGTKLEIK
>Mitazalimab|WholemAb|G1|Lambda|Phase-I|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWLSYISGGSSYIFYADSVRGRFTI
SRDNSENALYLQMNSLRAEDTAVYYCARILRGGSGMDLWGQGTLVTVSS
>Mitazalimab|WholemAb|G1|Lambda|Phase-I|Active|light
QSVLTQPPSASGTPGQRVTISCTGSSSNIGAGYNVYWYQQLPGTAPKLLIYGNINRPSGVPDRFSGSKSG
TSASLAISGLRSEDEADYYCAAWDKSISGLVFGGGTKLTVL
>Modakafusp|WholemAbFusion|G4|Kappa|Phase-II|Active|heavy
EVQLVQSGAEVKKPGATVKISCKVSGYTFTDSVMNWVQQAPGKGLEWMGWIDPEYGRTDVAEKFQGRVTI
TADTSTDTAYMELSSLRSEDTAVYYCARTKYNSGYGFPYWGQGTTVTVSS
>Modakafusp|WholemAbFusion|G4|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQNVDSDVDWYQQKPGKAPKLLIYKASNDYTGVPSRFSGSGSGTD
FTFTISSLQPEDIATYYCMQSNTHPRTFGGGTKVEIK
>Modotuximab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLQQPGAELVEPGGSVKLSCKASGYTFTSHWMHWVKQRPGQGLEWIGEINPSSGRNNYNEKFKSKATL
TVDKSSSTAYMQFSSLTSEDSAVYYCVRYYGYDEAMDYWGQGTSVTVSS
>Modotuximab|WholemAb|G1|Kappa|Phase-II|Active|light
DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSS
GSGTDFTLRISRVEAEDVGVYYCAQNLELPYTFGGGTKLEIK
>Mogamulizumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVESGGDLVQPGRSLRLSCAASGFIFSNYGMSWVRQAPGKGLEWVATISSASTYSYYPDSVKGRFTI
SRDNAKNSLYLQMNSLRVEDTALYYCGRHSDGNFAFGYWGQGTLVTVSS
>Mogamulizumab|WholemAb|G1|Kappa|Approved|Active|light
DVLMTQSPLSLPVTPGEPASISCRSSRNIVHINGDTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCFQGSLLPWTFGQGTKVEIK
>Monalizumab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMNWVRQAPGQGLEWMGRIDPYDSETHYAQKLQGRVTM
TTDTSTSTAYMELRSLRSDDTAVYYCARGGYDFDVGTLYWFFDVWGQGTTVTVSS
>Monalizumab|WholemAb|G4|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQHHYGTPRTFGGGTKVEIK
>Mosunetuzumab|BispecificmAb|G1|Kappa;Kappa|Phase-I/II|Active|heavy
EVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYIHWVRQAPGQGLEWIGWIYPGDGNTKYNEKFKGRATL
TADTSTSTAYLELSSLRSEDTAVYYCARDSYSNYYFDYWGQGTLVTVSS
>Mosunetuzumab|BispecificmAb|G1|Kappa;Kappa|Phase-I/II|Active|light
DIVMTQSPDSLAVSLGERATINCKSSQSLLNSRTRKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYYCTQSFILRTFGQGTKVEIK
>Motavizumab|WholemAb|G1|Kappa|Phase-III|Discontinued|heavy
QVTLRESGPALVKPTQTLTLTCTFSGFSLSTAGMSVGWIRQPPGKALEWLADIWWDDKKHYNPSLKDRLT
ISKDTSKNQVVLKVTNMDPADTATYYCARDMIFNFYFDVWGQGTTVTVSS
>Motavizumab|WholemAb|G1|Kappa|Phase-III|Discontinued|light
DIQMTQSPSTLSASVGDRVTITCSASSRVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEF
TLTISSLQPDDFATYYCFQGSGYPFTFGGGTKVEIK
>Moxetumomab|FvFusion|na|Kappa|Approved|NFD|heavy
EVQLVESGGGLVKPGGSLKLSCAASGFAFSIYDMSWVRQTPEKCLEWVAYISSGGGTTYYPDTVKGRFTI
SRDNAKNTLYLQMSSLKSEDTAMYYCARHSGYGTHWGVLFAYWGQGTLVTVSA
>Moxetumomab|FvFusion|na|Kappa|Approved|NFD|light
DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSILHSGVPSRFSGSGSGTD
YSLTISNLEQEDFATYFCQQGNTLPWTFGCGTKLEI
>Murlentamab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVRLVQSGAEVKKPGASVKVSCKASGYTFTSYHIHWVRQAPGQRLEWMGWIYPGDDSTKYSQKFQGRVTI
TRDTSASTAYMELSSLRSEDTAVYYCTRGDRFAYWGQGTLVTVSS
>Murlentamab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSTLSASVGDRVTITCRASSSVRYIAWYQQKPGKAPKLLTYPTSSLKSGVPSRFSGSGSGTEF
TLTISSLQPDDFATYYCLQWSSYPWTFGGGTKVEIK
>Muromonab|WholemAb|G2a|Kappa|Approved|Discontinued|heavy
QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKFKDKATL
TTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTTLTVSS
>Muromonab|WholemAb|G2a|Kappa|Approved|Discontinued|light
QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAHFRGSGSGTSY
SLTISGMEAEDAATYYCQQWSSNPFTFGSGTKLEIN
>Namilumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKAFGYPFTDYLLHWVRQAPGQGLEWVGWLNPYSGDTNYAQKFQGRVTM
TRDTSISTAYMELSRLRSDDTAVYYCTRTTLISVYFDYWGQGTMVTVSS
>Namilumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSVSASVGDRVTIACRASQNIRNILNWYQQRPGKAPQLLIYAASNLQSGVPSRFSGSGSGTD
FTLTINSLQPEDFATYYCQQSYSMPRTFGGGTKLEIK
>Naptumomab|FabFusion|G1|Kappa|Phase-III|Discontinued|heavy
EVQLQQSGPDLVKPGASVKISCKASGYSFTGYYMHWVKQSPGKGLEWIGRINPNNGVTLYNQKFKDKATL
TVDKSSTTAYMELRSLTSEDSAVYYCARSTMITNYVMDYWGQGTSVTVSS
>Naptumomab|FabFusion|G1|Kappa|Phase-III|Discontinued|light
SIVMTQTPTSLLVSAGDRVTITCKASQSVSNDVAWYQQKPGQSPKLLISYTSSRYAGVPDRFSGSGYGTD
FTLTISSVQAEDAAVYFCQQDYNSPPTFGGGTKLEIK
>Naratuximab|WholemAbADC|G1|Kappa|Phase-II|Active|heavy
QVQVQESGPGLVAPSQTLSITCTVSGFSLTTSGVSWVRQPPGKGLEWLGVIWGDGSTNYHPSLKSRLSIK
KDHSKSQVFLKLNSLTAADTATYYCAKGGYSLAHWGQGTLVTVSS
>Naratuximab|WholemAbADC|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSVSVGERVTITCRASENIRSNLAWYQQKPGKSPKLLVNVATNLADGVPSRFSGSGSGTD
YSLKINSLQPEDFGTYYCQHYWGTTWTFGQGTKLEIK
>Narnatumab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYLMTWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTI
SRDNAKNSLNLQMNSLRAEDTAVYYCTRDGYSSGRHYGMDVWGQGTTVIVSS
>Narnatumab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWPRTFGQGTKVEIK
>Narsoplimab|WholemAb|G4|Lambda|Preregistration|Active|heavy
QVTLKESGPVLVKPTETLTLTCTVSGFSLSRGKMGVSWIRQPPGKALEWLAHIFSSDEKSYRTSLKSRLT
ISKDTSKNQVVLTMTNMDPVDTATYYCARIRRGGIDYWGQGTLVTVSS
>Narsoplimab|WholemAb|G4|Lambda|Preregistration|Active|light
QPVLTQPPSLSVSPGQTASITCSGEKLGDKYAYWYQQKPGQSPVLVMYQDKQRPSGIPERFSGSNSGNTA
TLTISGTQAMDEADYYCQAWDSSTAVFGGGTKLTVL
>Natalizumab|WholemAb|G4|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGFNIKDTYIHWVRQAPGQRLEWMGRIDPANGYTKYDPKFQGRVTI
TADTSASTAYMELSSLRSEDTAVYYCAREGYYGNYGVYAMDYWGQGTLVTVSS
>Natalizumab|WholemAb|G4|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCKTSQDINKYMAWYQQTPGKAPRLLIHYTSALQPGIPSRFSGSGSGRD
YTFTISSLQPEDIATYYCLQYDNLWTFGQGTKVEIK
>Navivumab|WholemAb|G1|Kappa|Preclinical|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKTSGYSFSTYGVSWVRQAPGQGPEWVGWISAYTGITDYAQKFQGRVTL
TTDATTATAFLDLRSLRPDDTATYFCARDKVQGRVEVGSGGRHDYWGQGTLVIVSS
>Navivumab|WholemAb|G1|Kappa|Preclinical|Discontinued|light
EVVLTQSPGTLALPPGERATLSCRASHRVGSTYIAWYQQKSGQAPRRLIYGASNRATDIPDRFSGSGSGT
DFTLTIRRLEPEDSAVYYCQQFSVSPWTFGQGTRVEIK
>Navicixizumab|BispecificmAb|G2|Kappa;Kappa|Phase-I|Active|heavy
QVQLVQSGAEVKKPGASVKISCKASGYSFTAYYIHWVKQAPGQGLEWIGYISNYNRATNYNQKFKGRVTF
TTDTSTSTAYMELRSLRSDDTAVYYCARDYDYDVGMDYWGQGTLVTVSS
>Navicixizumab|BispecificmAb|G2|Kappa;Kappa|Phase-I|Active|light
DIVMTQSPDSLAVSLGERATISCRASESVDNYGISFMKWFQQKPGQPPKLLIYAASNQGSGVPDRFSGSG
SGTDFTLTISSLQAEDVAVYYCQQSKEVPWTFGGGTKVEIK
>Naxitamab|WholemAb|G1|Kappa|Preregistration|Active|heavy
QVQLVESGPGVVQPGRSLRISCAVSGFSVTNYGVHWVRQPPGKGLEWLGVIWAGGITNYNSAFMSRLTIS
KDNSKNTVYLQMNSLRAEDTAMYYCASRGGHYGYALDYWGQGTLVTVSS
>Naxitamab|WholemAb|G1|Kappa|Preregistration|Active|light
EIVMTQTPATLSVSAGERVTITCKASQSVSNDVTWYQQKPGQAPRLLIYSASNRYSGVPARFSGSGYGTE
FTFTISSVQSEDFAVYFCQQDYSSFGQGTKLEIK
>Necitumumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTDYNPSLKSRVT
MSVDTSKNQFSLKVNSVTAADTAVYYCARVSIFGVGTFDYWGQGTLVTVSS
>Necitumumab|WholemAb|G1|Kappa|Approved|Active|light
EIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCHQYGSTPLTFGGGTKAEIK
>Nemolizumab|WholemAb|G2|Kappa|Phase-III|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYIMNWVRQAPGQGLEWMGLINPYNGGTDYNPQFQDRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARDGYDDGPYTLETWGQGTLVTVSS
>Nemolizumab|WholemAb|G2|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASVGDRVTITCQASEDIYSFVAWYQQKPGKAPKLLIYNAQTEAQGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQHHYDSPLTFGGGTKVEIK
>Nesvacumab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDIHWVRQATGKGLEWVSAIGPAGDTYYPGSVKGRFTIS
RENAKNSLYLQMNSLRAGDTAVYYCARGLITFGGLIAPFDYWGQGTLVTVSS
>Nesvacumab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQHYDNSQTFGQGTKVEIK
>Netakimab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLVQSGGGLVQAGGSLRLSCAASGGTFATSPMGWLRQAPGKGTEFVAAISPSGGDRIYADSVKGRFTI
SRDNAGYFIYLQMNSLKPEDTAVYYCAVRRRFDGTSYYTGDYDSWGQGTLVTVSS
>Netakimab|WholemAb|G1|Kappa|Approved|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYDASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYSYSPVTFGQGTKVEIK
>Nidanilimab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYAFTSSWMNWVRQAPGQGLEWMGRIYPGDGNTHYAQKFQGRVTL
TADKSTSTAYMELSSLRSEDTAVYYCGEGYLDPMDYWGQGTLVTVSS
>Nidanilimab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCQASQGINNYLNWYQQKPGKAPKLLIHYTSGLHAGVPSRFSGSGSGTD
YTLTISSLEPEDVATYYCQQYSILPWTFGGGTKVEIK
>Nimacimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYEFSYYWMNWVRQAPGQGLEWMGQIYPGDGETKYAQKFQGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARSHGNYLPYWGQGTLVTVSS
>Nimacimab|WholemAb|G4|Kappa|Phase-II|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSSYLHWYQQKPGQAPRLLIYSTSNLASGIPARFSGSGSGT
DFTLTISRLEPEDFAVYYCHQYHRSPPTFGQGTKVEIK
>Nimotuzumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLQQSGAEVKKPGSSVKVSCKASGYTFTNYYIYWVRQAPGQGLEWIGGINPTSGGSNFNEKFKTRVTI
TADESSTTAYMELSSLRSEDTAFYFCTRQGLWFDSDGRGFDFWGQGTTVTVSS
>Nimotuzumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCRSSQNIVHSNGNTYLDWYQQTPGKAPKLLIYKVSNRFSGVPSRFSGS
GSGTDFTFTISSLQPEDIATYYCFQYSHVPWTFGQGTKLQIT
>Nipocalimab|WholemAb|G1|Lambda|Phase-I|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYAMGWVRQAPGKGLEWVSSIGASGSQTRYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARLAIGDSYWGQGTMVTVSS
>Nipocalimab|WholemAb|G1|Lambda|Phase-I|Active|light
QSALTQPASVSGSPGQSITISCTGTGSDVGSYNLVSWYQQHPGKAPKLMIYGDSERPSGVSNRFSGSKSG
NTASLTISGLQAEDEADYYCSSYAGSGIYVFGTGTKVTVL
>Nirsevimab|WholemAb|G1|Kappa|Phase-III|Active|heavy
QVQLVQSGAEVKKPGSSVMVSCQASGGLLEDYIINWVRQAPGQGPEWMGGIIPVLGTVHYGPKFQGRVTI
TADESTDTAYMELSSLRSEDTAMYYCATETALVVSETYLPHYFDNWGQGTLVTVSS
>Nirsevimab|WholemAb|G1|Kappa|Phase-III|Active|light
DIQMTQSPSSLSAAVGDRVTITCQASQDIVNYLNWYQQKPGKAPKLLIYVASNLETGVPSRFSGSGSGTD
FSLTISSLQPEDVATYYCQQYDNLPLTFGGGTKVEIK
>Nivolumab|WholemAb|G4|Kappa|Approved|Active|heavy
QVQLVESGGGVVQPGRSLRLDCKASGITFSNSGMHWVRQAPGKGLEWVAVIWYDGSKRYYADSVKGRFTI
SRDNSKNTLFLQMNSLRAEDTAVYYCATNDDYWGQGTLVTVSS
>Nivolumab|WholemAb|G4|Kappa|Approved|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQSSNWPRTFGQGTKVEIK
>Nurulimab|WholemAb|G1|Kappa|Phase-I|Active|heavy
EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVTFISYDGNNKYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAIYYCARTGWLGPFDYWGQGTLVTVSS
>Nurulimab|WholemAb|G1|Kappa|Phase-I|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVGSSYLAWYQQKPGQAPRLLIYGAFSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK
>Obexelimab|WholemAb|G1|Kappa|Phase-III|Active|heavy
EVQLVESGGGLVKPGGSLKLSCAASGYTFTSYVMHWVRQAPGKGLEWIGYINPYNDGTKYNEKFQGRVTI
SSDKSISTAYMELSSLRSEDTAMYYCARGTYYYGTRVFDYWGQGTLVTVSS
>Obexelimab|WholemAb|G1|Kappa|Phase-III|Active|light
DIVMTQSPATLSLSPGERATLSCRSSKSLQNVNGNTYLYWFQQKPGQSPQLLIYRMSNLNSGVPDRFSGS
GSGTEFTLTISSLEPEDFAVYYCMQHLEYPITFGAGTKLEIK
>Obiltoxaximab|WholemAb|G1|Kappa|Approved|NFD|heavy
QVQLQQSGPELKKPGASVKVSCKDSGYAFSSSWMNWVRQAPGQGLEWIGRIYPGDGDTNYNGKFQGRVTI
TADKSSSTAYMELSSLRSEDTAVYFCARSGLLRYAMDYWGQGTLVTVSS
>Obiltoxaximab|WholemAb|G1|Kappa|Approved|NFD|light
DIQMTQSPSSLSASVGDRVTITCRASQDIRNYLNWYQQKPGKAVKLLIYYTSRLLPGVPSRFSGSGSGTD
YSLTISSQEQEDIGTYFCQQGNTLPWTFGQGTKVEIR
>Obinutuzumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYAFSYSWINWVRQAPGQGLEWMGRIFPGDGDTDYNGKFKGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCARNVFDGYWLVYWGQGTLVTVSS
>Obinutuzumab|WholemAb|G1|Kappa|Approved|Active|light
DIVMTQTPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGGGTKVEIK
>Obrindatamab|BispecificscFvwithDomainCrossover||Kappa;Lambda|TBC|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAYISSDSSAIYYADTVKGRFTI
SRDNAKNSLYLQMNSLRDEDTAVYYCGRGRENIYYGSRLDYWGQGTTVTVSS
>Obrindatamab|BispecificscFvwithDomainCrossover||Kappa;Lambda|TBC|Active|light
DIQLTQSPSFLSASVGDRVTITCKASQNVDTNVAWYQQKPGKAPKALIYSASYRYSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYNNYPFTFGQGTKLEIK
>Ocaratuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVQSGAEVKKPGESLKISCKGSGRTFTSYNMHWVRQMPGKGLEWMGAIYPLTGDTSYNQKSKLQVTI
SADKSISTAYLQWSSLKASDTAMYYCARSTYVGGDWQFDVWGKGTTVTVSS
>Ocaratuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
EIVLTQSPGTLSLSPGERATLSCRASSSVPYIHWYQQKPGQAPRLLIYATSALASGIPDRFSGSGSGTDF
TLTISRLEPEDFAVYYCQQWLSNPPTFGQGTKLEIK
>Ociperlimab|WholemAb|G1|Kappa|TBC|Active|heavy
EVQLVESGGGLVQPGGSLRLSCASSGFTFSDYYMYWVRQAPGKGLEWVAYITKGGGSTYYPDSVKGRFTI
SRDNAKNTLYLQMNSLRAEDTAVYYCARQTNYDFTMDYWGQGTLVTVSS
>Ociperlimab|WholemAb|G1|Kappa|TBC|Active|light
EIVMTQSPATLSVSPGERATLSCKASQDVGTSVAWYQQKPGQAPRLLIYWASARHTGIPARFSGSGSGTE
FTLTISSLQSEDFAVYYCQQYSSYPLTFGGGTKVEIK
>Ocrelizumab|WholemAb|G1|Kappa|Approved|NFD|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYNMHWVRQAPGKGLEWVGAIYPGNGDTSYNQKFKGRFTI
SVDKSKNTLYLQMNSLRAEDTAVYYCARVVYYSNSYWYFDVWGQGTLVTVSS
>Ocrelizumab|WholemAb|G1|Kappa|Approved|NFD|light
DIQMTQSPSSLSASVGDRVTITCRASSSVSYMHWYQQKPGKAPKPLIYAPSNLASGVPSRFSGSGSGTDF
TLTISSLQPEDFATYYCQQWSFNPPTFGQGTKVEIK
>Odesivimab|WholemAb|G1|Kappa|Preregistration|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQATGKGLEWVSAIGTAGDTYYPGSVKGRFTIS
RENAKNSLYLQMNSLRAGDTAVYYCARTWFGELYFDYWGQGTLVTVSS
>Odesivimab|WholemAb|G1|Kappa|Preregistration|Active|light
DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSG
SGSGTEFTLTITSLQAEDVAVYYCQQYYSSPLTFGGGTKVEIK
>Odronextamab|BispecificmAb|G4|Kappa;Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGRSLRLSCVASGFTFNDYAMHWVRQAPGKGLEWVSVISWNSDSIGYADSVKGRFTI
SRDNAKNSLYLQMHSLRAEDTALYYCAKDNHYGSGSYYYYQYGMDVWGQGTTVTVSS
>Odronextamab|BispecificmAb|G4|Kappa;Kappa|Phase-II|Active|light
EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTE
FTLTISSLQSEDFAVYYCQHYINWPLTFGGGTKVEIK
>Ofatumumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGRSLRLSCAASGFTFNDYAMHWVRQAPGKGLEWVSTISWNSGSIGYADSVKGRFTI
SRDNAKKSLYLQMNSLRAEDTALYYCAKDIQYGNYYYGMDVWGQGTTVTVSS
>Ofatumumab|WholemAb|G1|Kappa|Approved|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWPITFGQGTRLEIK
>Olaratumab|WholemAb|G1|Kappa|Approved|Active|heavy
QLQLQESGPGLVKPSETLSLTCTVSGGSINSSSYYWGWLRQSPGKGLEWIGSFFYTGSTYYNPSLRSRLT
ISVDTSKNQFSLMLSSVTAADTAVYYCARQSTYYYGSGNYYGWFDRWDQGTLVTVSS
>Olaratumab|WholemAb|G1|Kappa|Approved|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWPPAFGQGTKVEIK
>Oleclumab|WholemAb|G1|Lambda|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAYSWVRQAPGKGLEWVSAISGSGGRTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARLGYGRVDEWGRGTLVTVSS
>Oleclumab|WholemAb|G1|Lambda|Phase-II|Active|light
QSVLTQPPSASGTPGQRVTISCSGSLSNIGRNPVNWYQQLPGTAPKLLIYLDNLRLSGVPDRFSGSKSGT
SASLAISGLQSEDEADYYCATWDDSHPGWTFGGGTKLTVL
>Olendalizumab|WholemAb|G2|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYSMDWVRQAPGQGLEWMGAIHLNTGYTNYNQKFKGRVTM
TRDTSTSTVYMELSSLRSEDTAVYYCARGFYDGYSPMDYWGQGTTVTVSS
>Olendalizumab|WholemAb|G2|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASESVDSYGNSFMHWYQQKPGKAPKLLIYRASNLESGVPSRFSGSG
SGTDFTLTISSLQPEDFATYYCQQSNEDPYTFGGGTKVEIK
>Olinvacimab|WholemAb|G1|Lambda|Phase-II|Active|heavy
QMQLVQSGAEVKKPGASVKLSCKASGYTFSSYWMHWVRQAPGQRLEWMGEINPGNGHTNYNEKFKSRVTI
TVDKSASTAYMELSSLRSEDTAVYYCAKIWGPSLTSPFDYWGQGTLVTVSS
>Olinvacimab|WholemAb|G1|Lambda|Phase-II|Active|light
NFMLTQPPSVSVSPGKTARITCRGDNLGDVNVHWYQQRPGQAPVLVMYYDADRPSGIPERFSGSNSGNTA
TLTISGVEAGDEADYYCQVWDRTSEYVFGTGTKVTVL
>Olokizumab|WholemAb|G4|Kappa|Phase-III|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFNFNDYFMNWVRQAPGKGLEWVAQMRNKNYQYGTYYAESLEGRF
TISRDDSKNSLYLQMNSLKTEDTAVYYCARESYYGFTSYWGQGTLVTVSS
>Olokizumab|WholemAb|G4|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASVGDRVTITCQASQDIGISLSWYQQKPGKAPKLLIYNANNLADGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCLQHNSAPYTFGQGTKLEIK
>Omalizumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSVKGRITI
SRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSS
>Omalizumab|WholemAb|G1|Kappa|Approved|Active|light
DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSG
SGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIK
>Omburtamab|WholemAbRadiolabelled|G1|Kappa|Phase-II/III|Active|heavy
QVQLQQSGAELVKPGASVKLSCKASGYTFTNYDINWVRQRPEQGLEWIGWIFPGDGSTQYNEKFKGKATL
TTDTSSSTAYMQLSRLTSEDSAVYFCARQTTATWFAYWGQGTLVTVSA
>Omburtamab|WholemAbRadiolabelled|G1|Kappa|Phase-II/III|Active|light
DIVMTQSPATLSVTPGDRVSLSCRASQSISDYLHWYQQKSHESPRLLIKYASQSISGIPSRFSGSGSGSD
FTLSINSVEPEDVGVYYCQNGHSFPLTFGAGTKLELK
>Omodenbamab|WholemAb|G3|Kappa|TBC|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYGMSWVRQAPGKGLEWVSSITGSGRSTFYADSVKGRFTI
SRDNSTNTLSLQMNSLRAEDTAVYYCARSPADIVTGYYPWWFDLWGQGTLVTVSS
>Omodenbamab|WholemAb|G3|Kappa|TBC|Active|light
DIQMTQSPSSLSASIGDRVTITCRASQSINTYLNWYQQKPGKAPRLLIAGASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQANSFPLTFGQGTRLEIK
>Onartuzumab|Fab+di-Fc|G1|Kappa|Phase-III|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYWLHWVRQAPGKGLEWVGMIDPSNSDTRFNPNFKDRFTI
SADTSKNTAYLQMNSLRAEDTAVYYCATYRSYVTPLDYWGQGTLVTVSS
>Onartuzumab|Fab+di-Fc|G1|Kappa|Phase-III|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCKSSQSLLYTSSQKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSG
SGSGTDFTLTISSLQPEDFATYYCQQYYAYPWTFGQGTKVEIK
>Onfekafusp|WholemAbFusion|na|Kappa|Phase-III|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSFSMSWVRQAPGKGLEWVSSISGSSGTTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKPFPYFDYWGQGTLVTVSS
>Onfekafusp|WholemAbFusion|na|Kappa|Phase-III|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFLAWYQQKPGQAPRLLIYYASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQTGRIPPTFGQGTKVEIK
>Ongericimab|WholemAb|G4|Kappa|Phase-I|Active|heavy
QVQLQESGPGLVKPSQTLSLTCTVSGFSISSYGIHWIRQSPGKGLEWIGVIWRGGITDYNAPFMSRVTIS
KDNSKNQVSFKLSSVTAADTAVYYCANHRDWGQGTLVTVSS
>Ongericimab|WholemAb|G4|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCQASQDINKYIDWYQHKPGKAPKLLIHYASTLQPGVPSRFSGSGSGRD
YTFTISSLQPEDIATYYCLQYDDLWTFGQGTKVEIK
>Ontamalimab|WholemAb|G2|Kappa|Phase-III|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGINWVRQAPGQGLEWMGWISVYSGNTNYAQKVQGRVTM
TADTSTSTAYMDLRSLRSDDTAVYYCAREGSSSSGDYYYGMDVWGQGTTVTVSS
>Ontamalimab|WholemAb|G2|Kappa|Phase-III|Active|light
DIVMTQTPLSLSVTPGQPASISCKSSQSLLHTDGTTYLYWYLQKPGQPPQLLIYEVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGIYYCMQNIQLPWTFGQGTKVEIK
>Ontuxizumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLQESGPGLVRPSQTLSLTCTASGYTFTDYVIHWVKQPPGRGLEWIGYINPYDDDTTYNQKFKGRVTM
LVDTSSNTAYLRLSSVTAEDTAVYYCARRGNSYDGYFDYSMDYWGSGTPVTVSS
>Ontuxizumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQNVGTAVAWLQQTPGKAPKLLIYSASNRYTGVPSRFSGSGSGTD
YTFTISSLQPEDIATYYCQQYTNYPMYTFGQGTKVQIK
>Onvatilimab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTI
TADESTSTAYMELSSLRSEDTAVYYCARSSYGWSYEFDYWGQGTLVTVSS
>Onvatilimab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQSIDTRLNWYQQKPGKAPKLLIYSASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQSAYNPITFGQGTKVEIK
>Opicinumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSAYEMKWVRQAPGKGLEWVSVIGPSGGFTFYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCATEGDNDAFDIWGQGTTVTVSS
>Opicinumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWPMYTFGQGTKLEIK
>Oportuzumab|scFv|na|Kappa|Preregistration|Active|heavy
EVQLVQSGPGLVQPGGSVRISCAASGYTFTNYGMNWVKQAPGKGLEWMGWINTYTGESTYADSFKGRFTF
SLDTSASAAYLQINSLRAEDTAVYYCARFAIKGDYWGQGTLLTVSS
>Oportuzumab|scFv|na|Kappa|Preregistration|Active|light
DIQMTQSPSSLSASVGDRVTITCRSTKSLLHSNGITYLYWYQQKPGKAPKLLIYQMSNLASGVPSRFSSS
GSGTDFTLTISSLQPEDFATYYCAQNLEIPRTFGQGTKVELK
>Opucolimab|WholemAb|G1|Lambda|Phase-I|Active|heavy
EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSYTMNWVRQAPGKGLEWVSSISSGSDYLYYADSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARNELRWYPQAGAFDRWGQGTMVTVSS
>Opucolimab|WholemAb|G1|Lambda|Phase-I|Active|light
QSVVTQPPSMSAAPGQRVTISCSGSSSYIESSYVGWYQQLPGTAPRLLIYDDDMRPSGIPDRFSGSKSGT
SATLAITGLQTGDEADYYCEIWRSGLGGVFGGGTKLTVLSQPKAAPSVTL
>Orilanolimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVQSGAELKKPGASVKLSCKASGYTFTSYGISWVKQATGQGLEWIGEIYPRSGNTYYNEKFKGRATL
TADKSTSTAYMELRSLRSEDSAVYFCARSTTVRPPGIWGTGTTVTVSS
>Orilanolimab|WholemAb|G4|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCKASDHINNWLAWYQQKPGQAPRLLISGATSLETGVPSRFSGSGTGKD
YTLTISSLQPEDFATYYCQQYWSTPYTFGGGTKVEIK
>Orticumab|WholemAb|G1|Lambda|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVSSISVGGHRTYYADSVKGRSTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARIRVGPSGGAFDYWGQGTLVTVSS
>Orticumab|WholemAb|G1|Lambda|Phase-II|Active|light
QSVLTQPPSASGTPGQRVTISCSGSNTNIGKNYVSWYQQLPGTAPKLLIYANSNRPSGVPDRFSGSKSGT
SASLAISGLRSEDEADYYCASWDASLNGWVFGGGTKLTVL
>Osocimab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSQYGMDWVRQAPGKGLEWVSGIGPSGGSTVYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCTRGGPYYYYGMDVWGQGTTVTVSS
>Osocimab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTD
FTFTISSLQPEDIATYYCQQADSFPVTFGGGTKVEIK
>Otelixizumab|WholemAb|G1|Lambda|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSFPMAWVRQAPGKGLEWVSTISTSGGRTYYRDSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKFRQYSGGFDYWGQGTLVTVSS
>Otelixizumab|WholemAb|G1|Lambda|Phase-II|Active|light
DIQLTQPNSVSTSLGSTVKLSCTLSSGNIENNYVHWYQLYEGRSPTTMIYDDDKRPDGVPDRFSGSIDRS
SNSAFLTIHNVAIEDEAIYFCHSYVSSFNVFGGGTKLTVL
>Otilimab|WholemAb|G1|Lambda|Phase-III|Active|heavy
QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMNWVRQAPGKGLEWVSGIENKYAGGATYYAASVKGRF
TISRDNSKNTLYLQMNSLRAEDTAVYYCARGFGTDFWGQGTLVTVSS
>Otilimab|WholemAb|G1|Lambda|Phase-III|Active|light
DIELTQPPSVSVAPGQTARISCSGDSIGKKYAYWYQQKPGQAPVLVIYKKRPSGIPERFSGSNSGNTATL
TISGTQAEDEADYYCSAWGDKGMVFGGGTKLTVL
>Otlertuzumab|di-scFv+Fc|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVQSGAEVKKPGESLKISCKGSGYSFTGYNMNWVRQMPGKGLEWMGNIDPYYGGTTYNRKFKGQVTI
SADKSISTAYLQWSSLKASDTAMYYCARSVGPFDSWGQGTLVTVSS
>Otlertuzumab|di-scFv+Fc|G1|Kappa|Phase-II|Discontinued|light
EIVLTQSPATLSLSPGERATLSCRASENVYSYLAWYQQKPGQAPRLLIYFAKTLAEGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQHHSDNPWTFGQGTKVEIK
>Oxelumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFNSYAMSWVRQAPGKGLEWVSIISGSGGFTYYADSVKGRFTI
SRDNSRTTLYLQMNSLRAEDTAVYYCAKDRLVAPGTFDYWGQGALVTVSS
>Oxelumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYNSYPYTFGQGTKLEIK
>Ozanezumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWIGNINPSNGGTNYNEKFKSKATM
TRDTSTSTAYMELSSLRSEDTAVYYCELMQGYWGQGTLVTVSS
>Ozanezumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIVMTQSPLSNPVTLGQPVSISCRSSKSLLYKDGKTYLNWFLQRPGQSPQLLIYLMSTRASGVPDRFSGG
GSGTDFTLKISRVEAEDVGVYYCQQLVEYPLTFGQGTKLEIK
>Ozoralizumab|BispecificSingleDomains(VH-VH'-VH)|na|na|Phase-III|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYWMYWVRQAPGKGLEWVSEINTNGLITKYPDSVKGRFTI
SRDNAKNTLYLQMNSLRPEDTAVYYCARSPSGFNRGQGTLVTVSS
>Pabinafusp|WholemAbFusion|G1|Kappa|Phase-III|Active|heavy
EVQLVQSGAEVKKPGESLKISCKGSGYSFTNYWLGWVRQMPGKGLEWMGDIYPGGDYPTYSEKFKVQVTI
SADKSISTAYLQWSSLKASDTAMYYCARSGNYDEVAYWGQGTLVTVSS
>Pabinafusp|WholemAbFusion|G1|Kappa|Phase-III|Active|light
DIVMTQTPLSLSVTPGQPASISCRSSQSLVHSNGNTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK
>Pacanalotamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTNHIIHWVRQAPGQGLEWMGYINPYPGYHAYNEKFQGRATM
TSDTSTSTVYMELSSLRSEDTAVYYCARDGYYRDTDVLDYWGQGTLVTVSS
>Pacanalotamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|light
DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYYTSRLHTGVPSRFSGSGSGTD
FTFTISSLEPEDIATYYCQQGNTLPWTFGQGTKVEIK
>Pacmilimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSSIWRNGIVTVYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKWSAAFDYWGQGTLVTVSS
>Pacmilimab|WholemAb|G4|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQDNGYPSTFGGGTKVEIK
>Palivizumab|WholemAb|G1|Kappa|Approved|NFD|heavy
QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMSVGWIRQPPGKALEWLADIWWDDKKDYNPSLKSRLT
ISKDTSKNQVVLKVTNMDPADTATYYCARSMITNWYFDVWGAGTTVTVSS
>Palivizumab|WholemAb|G1|Kappa|Approved|NFD|light
DIQMTQSPSTLSASVGDRVTITCKCQLSVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEF
TLTISSLQPDDFATYYCFQGSGYPFTFGGGTKLEIK
>Pamrevlumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
EGQLVQSGGGLVHPGGSLRLSCAGSGFTFSSYGMHWVRQAPGKGLEWVSGIGTGGGTYSTDSVKGRFTIS
RDNAKNSLYLQMNSLRAEDMAVYYCARGDYYGSGSFFDCWGQGTLVTVSS
>Pamrevlumab|WholemAb|G1|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYNSYPPTFGQGTKLEIK
>Panitumumab|WholemAb|G2|Kappa|Approved|Active|heavy
QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGDYYWTWIRQSPGKGLEWIGHIYYSGNTNYNPSLKSRLT
ISIDTSKTQFSLKLSSVTAADTAIYYCVRDRVTGAFDIWGQGTMVTVSS
>Panitumumab|WholemAb|G2|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTD
FTFTISSLQPEDIATYFCQHFDHLPLAFGGGTKVEIK
>PankoMab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSMRLSCVASGFPFSNYWMNWVRQAPGKGLEWVGEIRLKSNNYTTHYAESVKGRF
TISRDDSKNSLYLQMNSLKTEDTAVYYCTRHYYFDYWGQGTLVTVSS
>PankoMab|WholemAb|G1|Kappa|Phase-II|Active|light
DIVMTQSPLSNPVTPGEPASISCRSSKSLLHSNGITYFFWYLQKPGQSPQLLIYQMSNLASGVPDRFSGS
GSGTDFTLRISRVEAEDVGVYYCAQNLELPPTFGQGTKVEIK
>Panobacumab|WholemAb|M|Kappa|Phase-II|Active|heavy
EEQVVESGGGFVQPGGSLRLSCAASGFTFSPYWMHWVRQAPGKGLVWVSRINSDGSTYYADSVKGRFTIS
RDNARNTLYLQMNSLRAEDTAVYYCARDRYYGPEMWGQGTMVTVSS
>Panobacumab|WholemAb|M|Kappa|Phase-II|Active|light
DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCMQGTHWPLTFGGGTKVEIK
>Parsatuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYTFIDYYMNWVRQAPGKGLEWVGDINLDNSGTHYNQKFKGRFTI
SRDKSKNTAYLQMNSLRAEDTAVYYCAREGVYHDYDDYAMDYWGQGTLVTVSS
>Parsatuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRTSQSLVHINAITYLHWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGS
GSGTDFTLTISSLQPEDFATYYCGQSTHVPLTFGQGTKVEIK
>Pasotuxizumab|BispecificscFv|na|Kappa;Lambda|Phase-I|Discontinued|heavy
QVQLVESGGGLVKPGESLRLSCAASGFTFSDYYMYWVRQAPGKGLEWVAIISDGGYYTYYSDIIKGRFTI
SRDNAKNSLYLQMNSLKAEDTAVYYCARGFPLLRHGAMDYWGQGTLVTVSS
>Pasotuxizumab|BispecificscFv|na|Kappa;Lambda|Phase-I|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCKASQNVDTNVAWYQQKPGQAPKSLIYSASYRYSDVPSRFSGSASGTD
FTLTISSVQSEDFATYYCQQYDSYPYTFGGGTKLEIK
>Pateclizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYVIHWVRQAPGKGLEWVGYNNPYNAGTNYNEKFKGRFTI
SSDKSKNTAYLQMNSLRAEDTAVYYCSRPTMLPWFAYWGQGTLVTVSS
>Pateclizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQAVSSAVAWYQQKPGKAPKLLIYSASHRYTGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQESYSTPWTFGQGTKVEIK
>Patritumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTIS
VETSKNQFSLKLSSVTAADTAVYYCARDKWTWYFDLWGRGTLVTVSS
>Patritumab|WholemAb|G1|Kappa|Phase-III|Active|light
DIEMTQSPDSLAVSLGERATINCRSSQSVLYSSSNRNYLAWYQQNPGQPPKLLIYWASTRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYYCQQYYSTPRTFGQGTKVEIK
>Pavunalimab|BispecificMixedmAbandscFv|G1|Kappa|TBC|Active|heavy
EVQLVESGGGLVQPGGSLRLSCASSGFTFDDAWMSWVRQAPGKGLEWVAEISTKANNHATYYAESVKGRF
TISRDDSKSSVYLQMNSLRAEDTAVYYCTRLATWDWYFDVWGQGTTVTVSS
>Pavunalimab|BispecificMixedmAbandscFv|G1|Kappa|TBC|Active|light
DIVLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKPPKLLIYAASELESGIPARFSGSG
SGTDFTLTISSLQPEDFATYYCQQSNEDPFTFGSGTKLEIK
>Pavurutamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTNHIIHWVRQAPGQCLEWMGYINPYPGYHAYNEKFQGRATM
TSDTSTSTVYMELSSLRSEDTAVYYCARDGYYRDTDVLDYWGQGTLVTVSS
>Pavurutamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|light
DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYYTSRLHTGVPSRFSGSGSGTD
FTFTISSLEPEDIATYYCQQGNTLPWTFGCGTKVEIK
>Pembrolizumab|WholemAb|G4|Kappa|Approved|Active|heavy
QVQLVQSGVEVKKPGASVKVSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFNEKFKNRVTL
TTDSSTTTAYMELKSLQFDDTAVYYCARRDYRFDMGFDYWGQGTTVTVSS
>Pembrolizumab|WholemAb|G4|Kappa|Approved|Active|light
EIVLTQSPATLSLSPGERATLSCRASKGVSTSGYSYLHWYQQKPGQAPRLLIYLASYLESGVPARFSGSG
SGTDFTLTISSLEPEDFAVYYCQHSRDLPLTFGGGTKVEIK
>Penpulimab|WholemAb|G1|Kappa|Phase-III|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFAFSSYDMSWVRQAPGKGLDWVATISGGGRYTYYPDSVKGRFTI
SRDNSKNNLYLQMNSLRAEDTALYYCANRYGEAWFAYWGQGTLVTVSS
>Penpulimab|WholemAb|G1|Kappa|Phase-III|Active|light
DIQMTQSPSSMSASVGDRVTFTCRASQDINTYLSWFQQKPGKSPKTLIYRANRLVSGVPSRFSGSGSGQD
YTLTISSLQPEDMATYYCLQYDEFPLTFGAGTKLELK
>Pepinemab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYSFSDYYMHWVRQAPGQGLEWMGQINPTTGGASYNQKFKGKATI
TVDKSTSTAYMELSSLRSEDTAVYYCARYYYGRHFDVWGQGTTVTVSS
>Pepinemab|WholemAb|G4|Kappa|Phase-II|Active|light
DIVMTQSPDSLAVSLGERATINCKASQSVDYDGDSYMNWYQQKPGQPPKLLIYAASNLESGVPDRFSGSG
SGTDFTLTISSLQAEDVAVYYCQQSNEDPYTFGQGTKLEIK
>Perakizumab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYTMLWVRQAPGKGLEWVAIIKSGGSYSYYPDSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARDGDYGSSYGAMDYWGQGTLVTVSS
>Perakizumab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQDINSYLSWFQQKPGKAPKSLIVRANRLVDGVPSRFSGSGSGQD
YSLTISSLQPEDFATYYCLQYDAFPPYTFGQGTKLEIK
>Pertuzumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRQAPGKGLEWVADVNPNSGGSIYNQRFKGRFTL
SVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSS
>Pertuzumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIK
>Petosemtamab|BispecificmAb|G1|Kappa;Kappa|Phase-I|Active|heavy
QVQLVQSGSELKKPGASVKISCKASGYDFTNYAMNWVRQAPGHGLEWMGWINANTGDPTYAQGFTGRFVF
SLDTSVSTAYLQISSLKAEDSAVYYCTRERFLEWLHFDYWGQGTLVTVSS
>Petosemtamab|BispecificmAb|G1|Kappa;Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQSYSTPPTFGQGTKVEIK
>Pidilizumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVQSGSELKKPGASVKISCKASGYTFTNYGMNWVRQAPGQGLQWMGWINTDSGESTYAEEFKGRFVF
SLDTSVNTAYLQITSLTAEDTGMYFCVRVGYDALDYWGQGTLVTVSS
>Pidilizumab|WholemAb|G1|Kappa|Phase-II|Active|light
EIVLTQSPSSLSASVGDRVTITCSARSSVSYMHWFQQKPGKAPKLWIYRTSNLASGVPSRFSGSGSGTSY
CLTINSLQPEDFATYYCQQRSSFPLTFGGGTKLEIK
>Pimivalimab|WholemAb|G4|Kappa|TBC|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFPSYYMHWVRQAPGQGLEWMGIINPEGGSTAYAQKFQGRVTM
TRDTSTSTVYMELSSLRSEDTAVYYCARGGTYYDYTYWGQGTLVTVSS
>Pimivalimab|WholemAb|G4|Kappa|TBC|Active|light
DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYEASSLESGVPSRFSGSGSGTE
FTLTISSLQPDDFATYYCQQYNSFPPTFGGGTKVEIK
>Pimurutamab|WholemAb|G1|Kappa|Phase-I|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFSLTNYGVHWVRQAPGKGLESWLGVIWSGGNTDYGNEFTSRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARALDYYDYEFAYWGQGTMVTVSS
>Pimurutamab|WholemAb|G1|Kappa|Phase-I|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSIGTNIHWYQQKPGQAPRLLIKYASESISGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQNNNWPTSFGGGTKVEIK
>Pinatuzumab|WholemAbADC|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYEFSRSWMNWVRQAPGKGLEWVGRIYPGDGDTNYSGKFKGRFTI
SADTSKNTAYLQMNSLRAEDTAVYYCARDGSSWDWYFDVWGQGTLVTVSS
>Pinatuzumab|WholemAbADC|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRSSQSIVHSVGNTFLEWYQQKPGKAPKLLIYKVSNRFSGVPSRFSGS
GSGTDFTLTISSLQPEDFATYYCFQGSQFPYTFGQGTKVEIK
>Placulumab|SingleDomainVariableFragment+Fc|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQAIDSYLHWYQQKPGKAPKLLIYSASNLETGVPSRFSGSGSGTD
FTLTISSLLPEDFATYYCQQVVWRPFTFGQGTKVEIK
>Plamotamab|BispecificMixedmAbandscFv|G1|Kappa;Kappa|Phase-I|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYNMHWVRQAPGQGLEWMGAIYPGNGDTSYNQKFQGRVTI
TADKSISTAYMELSSLRSEDTAVYYCARSTYYGGDWYFNVWGAGTLVTVSS
>Plamotamab|BispecificMixedmAbandscFv|G1|Kappa;Kappa|Phase-I|Active|light
QIVLTQSPSSLSASVGDRVTITCRASSSVSYIHWFQQKPGKSPKPLIYATSNLASGVPVRFSGSGSGTDY
TLTISSLQPEDFATYYCQQWTSNPPTFGGGTKVEIK
>Plozalizumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVKPGGSLRLSCAASGFTFSAYAMNWVRQAPGKGLEWVGRIRTKNNNYATYYADSVKDRF
TISRDDSKNTLYLQMNSLKTEDTAVYYCTTFYGNGVWGQGTLVTVSS
>Plozalizumab|WholemAb|G1|Kappa|Phase-II|Active|light
DVVMTQSPLSLPVTLGQPASISCKSSQSLLDSDGKTFLNWFQQRPGQSPRRLIYLVSKLDSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCWQGTHFPYTFGQGTRLEIK
>Pogalizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVQSGAEVKKPGASVKVSCKASGYTFTDSYMSWVRQAPGQGLEWIGDMYPDNGDSSYNQKFRERVTI
TRDTSTSTAYLELSSLRSEDTAVYYCVLAPRWYFSVWGQGTLVTVSS
>Pogalizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLRSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQGHTLPPTFGQGTKVEIK
>Polatuzumab|WholemAbADC|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYTFSSYWIEWVRQAPGKGLEWIGEILPGGGDTNYNEIFKGRATF
SADTSKNTAYLQMNSLRAEDTAVYYCTRRVPIRLDYWGQGTLVTVSS
>Polatuzumab|WholemAbADC|G1|Kappa|Approved|Active|light
DIQLTQSPSSLSASVGDRVTITCKASQSVDYEGDSFLNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSG
SGTDFTLTISSLQPEDFATYYCQQSNEDPLTFGQGTKVEIK
>Ponezumab|WholemAb|G2|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYYTEAYYIHWVRQAPGQGLEWMGRIDPATGNTKYAPRLQDRVTM
TRDTSTSTVYMELSSLRSEDTAVYYCASLYSLPVYWGQGTTVTVSS
>Ponezumab|WholemAb|G2|Kappa|Phase-II|Discontinued|light
DVVMTQSPLSLPVTLGQPASISCKSSQSLLYSDAKTYLNWFQQRPGQSPRRLIYQISRLDPGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCLQGTHYPVLFGQGTRLEIK
>Porgaviximab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLQESGGGLMQPGGSMKLSCVASGFTFSNYWMNWVRQSPEKGLEWVAEIRLKSNNYATHYAESVKGRF
TISRDDSKRSVYLQMNTLRAEDTGIYYCTRGNGNYRAMDYWGQGTSVTVSS
>Porgaviximab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPASLSVSVGETVSITCRASENIYSSLAWYQQKQGKSPQLLVYSATILADGVPSRFSGSGSGTQ
YSLKINSLQSEDFGTYYCQHFWGTPYTFGGGTKLEIK
>Praluzatamab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QITLKESGPTLVKPTQTLTLTCTFSGFSLSTYGMGVGWIRQPPGKALEWLANIWWSEDKHYSPSLKSRLT
ITKDTSKNQVVLTITNVDPVDTATYYCVQIDYGNDYAFTYWGQGTLVTVSS
>Praluzatamab|WholemAb|G1|Kappa|Phase-II|Active|light
DIVMTQSPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGQGTKLEIK
>Prasinezumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYGMSWVRQAPGKGLEWVASISSGGGSTYYPDNVKGRFTI
SRDDAKNSLYLQMNSLRAEDTAVYYCARGGAGIDYWGQGTLVTVSS
>Prasinezumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCKSIQTLLYSSNQKNYLAWFQQKPGKAPKLLIYWASIRKSGVPSRFSG
SGSGTDFTLTISSLQPEDLATYYCQQYYSYPLTFGGGTKLEIK
>Prezalumab|WholemAb|G2|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAYIKQDGNEKYYVDSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCAREGILWFGDLPTFWGQGTLVTVSS
>Prezalumab|WholemAb|G2|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQGISNWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYDSYPRTFGQGTKVEIK
>Pritoxaximab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLQESGAELVRSGASVRMSCKASGYTFTSYNMHWVKQTPGQGLEWIGYIYPGNGGTNYIQKFKGKAIL
TADTSSSTAYMQISSLTSEDSAVYFCTRSPSHYSSDPYFDYWGQGTTLTVSS
>Pritoxaximab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIVMSQSHKFMSTSVGDRVSITCKASQDVGTAVAWYQQNPGQSPKFLIYWASTRHTGVPDRFTGSGSGTD
FTLTITNVQSEDLADYFCQQYSSYPLTFGAGTSLELK
>Prolgolimab|WholemAb|G1|Lambda|Phase-II/III|Active|heavy
QVQLVQSGGGLVQPGGSLRLSCAASGFTFSSYWMYWVRQVPGKGLEWVSAIDTGGGRTYYADSVKGRFAI
SRVNAKNTMYLQMNSLRAEDTAVYYCARDEGGGTGWGVLKDWPYGLDAWGQGTLVTVSS
>Prolgolimab|WholemAb|G1|Lambda|Phase-II/III|Active|light
QPVLTQPLSVSVALGQTARITCGGNNIGSKNVHWYQQKPGQAPVLVIYRDSNRPSGIPERFSGSNSGNTA
TLTISRAQAGDEADYYCQVWDSSTAVFGTGTKLTVL
>Quavonlimab|WholemAb|G1|Kappa|Phase-I|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDNWMNWVRQAPGKGLEWLAQIRNKPYNYETYYSASVKGRF
TISRDDSKNSVYLQMNSLKTEDTGVYYCTAQFAYWGQGTLVTVSS
>Quavonlimab|WholemAb|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCRTSENIYGGLNWYQRKPGKSPKLLIYGATNLASGVSSRFSGSGSGTD
YTLTISSLQPEDVATYYCQNVLRSPFTFGSGTKLEIK
>Quetmolimab|WholemAb|G2|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYYIHWVKQAPGQGLEWIGWIYPGDGSPKFNERFKGRTTL
TADKSTNTAYMLLSSLRSEDTAVYFCATGPTDGDYFDYWGQGTTVTVSS
>Quetmolimab|WholemAb|G2|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASGNIHNFLAWYQQKPGKAPKLLIYNEKTLADGVPSRFSGSGSGTD
YTLTISSLQPEDFATYFCQQFWSTPYTFGGGTKVEIK
>Quilizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYGIAWVRQAPGKGLEWVAFISDLAYTIYYADTVTGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARDNWDAMDYWGQGTLVTVSS
>Quilizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRSSQSLVHNNANTYLHWYQQKPGKAPKLLIYKVSNRFSGVPSRFSGS
GSGTDFTLTISSLQPEDFATYYCSQNTLVPWTFGQGTKVEIK
>Racotumomab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLQQSGAELVKPGASVKLSCKASGYTFTSYDINWVRQRPEQGLEWIGWIFPGDGSTKYNEKFKGKATL
TTDKSSSTAYMQLSRLTSEDSAVYFCAREDYYDNSYYFDYWGQGTTLTVSS
>Racotumomab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTD
YSLTISNLEQEDIATYFCQQGNTLPWTFGGGTKLEIK
>Radretumab|di-scFv+CH4|E|Kappa|Phase-II|Discontinued|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSFSMSWVRQAPGKGLEWVSSISGSSGTTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKPFPYFDYWGQGTLVTVSS
>Radretumab|di-scFv+CH4|E|Kappa|Phase-II|Discontinued|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFLAWYQQKPGQAPRLLIYYASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQTGRIPPTFGQGTKVEIK
>Rafivirumab|WholemAb|G1|Lambda|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGGTFNRYTVNWVRQAPGQGLEWMGGIIPIFGTANYAQRFQGRLTI
TADESTSTAYMELSSLRSDDTAVYFCARENLDNSGTYYYFSGWFDPWGQGTLVTVSS
>Rafivirumab|WholemAb|G1|Lambda|Phase-II|Discontinued|light
QSALTQPRSVSGSPGQSVTISCTGTSSDIGGYNFVSWYQQHPGKAPKLMIYDATKRPSGVPDRFSGSKSG
NTASLTISGLQAEDEADYYCCSYAGDYTPGVVFGGGTKLTVL
>Ragifilimab|WholemAb|G1|Kappa|Phase-I/II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKGSGYTFTDYAMYWVRQAPGQGLEWIGVIRTYSGDVTYNQKFKDRATM
TVDKSISTAYMELSRLRSDDTAVYYCAKSGTVRGFAYWGQGTLVTVSS
>Ragifilimab|WholemAb|G1|Kappa|Phase-I/II|Active|light
DIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYHCQNDYSYPYTFGQGTKLEIK
>Ralpancizumab|WholemAb|G2|Kappa|Phase-I|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGEIHPSGGRTNYNEKFKSRVTM
TRDTSTSTVYMELSSLRSEDTAVYYCARERPLYASDLWGQGTTVTVSS
>Ralpancizumab|WholemAb|G2|Kappa|Phase-I|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCKASQDVHTAVAWYQQKPGKAPKLLIYHASYRYTGVPSRFSGSGSGTD
FTFTISSLQPEDIATYYCQQRYSLWRTFGQGTKLEIK
>Ramucirumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARVTDAFDIWGQGTMVTVSS
>Ramucirumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSVSASIGDRVTITCRASQGIDNWLGWYQQKPGKAPKLLIYDASNLDTGVPSRFSGSGSGTY
FTLTISSLQAEDFAVYFCQQAKAFPPTFGGGTKVDIK
>Ranevetmab|CanineWholemAb|G1|Kappa|Unknown|Active|heavy
EVQLVESGGGLVQPGGSLRLSCVASGFSLTNNNVNWVRQAPGKGLEWVGGVWAGGATDYNSALKSRFTIS
RDNAKNTVFLQMHSLRSEDTAVYYCARDGGYSSSTLYAMDAWGQGTSVTVSS
>Ranevetmab|CanineWholemAb|G1|Kappa|Unknown|Active|light
DIVMTQSPASLSLSQGETVTITCRASEDIYNALAWYQQKPGQAPKLLIYNTDTLHTGVPSRFSGSGSGTD
FSLTISSLEPEDVAVYYCQHYFHYPRTFGQGTKVELK
>Ranibizumab|Fab|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYDFTHYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTF
SLDTSKSTAYLQMNSLRAEDTAVYYCAKYPYYYGTSHWYFDVWGQGTLVTVSS
>Ranibizumab|Fab|G1|Kappa|Approved|Active|light
DIQLTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK
>Ravagalimab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVKPGGSLRLSCAASGFTFSDYGMNWVRQAPGKGLEWIAYISSGRGNIYYADTVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARSWGYFDVWGQGTTVTVSS
>Ravagalimab|WholemAb|G1|Kappa|Phase-II|Active|light
DIVMTQSPDSLAVSLGERATINCKSSQSLLNRGNQKNYLTWFQQKPGQPPKLLIYWASTRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYYCQNDYTYPLTFGQGTKLEIK
>Ravulizumab|WholemAb|G2|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGHIFSNYWIQWVRQAPGQGLEWMGEILPGSGHTEYTENFKDRVTM
TRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSSPNWYFDVWGQGTLVTVSS
>Ravulizumab|WholemAb|G2|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK
>Recaticimab|WholemAb|G1|Kappa|TBC|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYWMHWVRQAPGQGLEWMGYINPSSGFTKYHQNFKDRVTM
TRDTSISTAYMELSRLRSDDTAVYYCARQYDYDEDWYFDVWGQGTTVTVSS
>Recaticimab|WholemAb|G1|Kappa|TBC|Active|light
DIVMSQSPSSLSASVGDRVTITCKSSQSLLNSRTRKNFLAWYQQKPGKSPKLLIYWASTRESGVPDRFSG
SGSGTDFTLTISSLQPEDFATYYCKQSFNLFTFGQGTKLEIK
>Refanezumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGSELKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGEPTYADDFTGRFVF
SLDTSVSTAYLQISSLKAEDTAVYYCARNPINYYGINYEGYVMDYWGQGTLVTVSS
>Refanezumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIVMTQSPDSLAVSLGERATINCKSSHSVLYSSNQKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYYCHQYLSSLTFGQGTKLEIK
>Relatlimab|WholemAb|G4|Kappa|Phase-II/III|Active|heavy
QVQLQQWGAGLLKPSETLSLTCAVYGGSFSDYYWNWIRQPPGKGLEWIGEINHRGSTNSNPSLKSRVTLS
LDTSKNQFSLKLRSVTAADTAVYYCAFGYSDYEYNWFDPWGQGTLVTVSS
>Relatlimab|WholemAb|G4|Kappa|Phase-II/III|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSISSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWPLTFGQGTNLEIK
>Relfovetmab|FelineWholemAb|G1|Kappa|Unknown|Active|heavy
DVQLVESGGDLVKPGGSLRLTCVASGFTYSNYWMHWVRQAPGKGLQWVARIDPYGGGTKHNEKFKRRFTI
SRDNAKNTLYLQMNSLKTEDTATYYCVRSGYDYYFDVWGQGTLVTVSS
>Relfovetmab|FelineWholemAb|G1|Kappa|Unknown|Active|light
EIQMTQSPSSLSASPGDRVTITCRASENIYSFLAWYQQKPGKVPKLLIYNANTLAEGVPSRFSGSGSGTD
FTLTISSLEPEDAATYYCQHHFGTPFTFGSGTKLEIK
>Remtolumab|BispecificDualVariableDomainIG|G1|Kappa;Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSS
>Remtolumab|BispecificDualVariableDomainIG|G1|Kappa;Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTD
FTLTISSLQPEDVATYYCQRYNRAPYTFGQGTKVEIK
>Reslizumab|WholemAb|G4|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAVSGLSLTSNSVNWIRQAPGKGLEWVGLIWSNGDTDYNSAIKSRFTIS
RDTSKSTVYLQMNSLRAEDTAVYYCAREYYGYFDYWGQGTLVTVSS
>Reslizumab|WholemAb|G4|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCLASEGISSYLAWYQQKPGKAPKLLIYGANSLQTGVPSRFSGSGSATD
YTLTISSLQPEDFATYYCQQSYKFPNTFGQGTKVEVK
>Retifanlimab|WholemAb|G4|Kappa|Phase-II/III|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYSFTSYWMNWVRQAPGQGLEWIGVIHPSDSETWLDQKFKDRVTI
TVDKSTSTAYMELSSLRSEDTAVYYCAREHYGTSPFAYWGQGTLVTVSS
>Retifanlimab|WholemAb|G4|Kappa|Phase-II/III|Active|light
EIVLTQSPATLSLSPGERATLSCRASESVDNYGMSFMNWFQQKPGQPPKLLIHAASNQGSGVPSRFSGSG
SGTDFTLTISSLEPEDFAVYFCQQSKEVPYTFGGGTKVEIK
>Revdofilimab|WholemAb|G1|Kappa|Phase-I|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYGMSWVRQAPGKGLELVATINSNGGRTYYPDSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCAREGITTAYAMDYWGQGTTVTVSS
>Revdofilimab|WholemAb|G1|Kappa|Phase-I|Active|light
DIVMTQSPDSLAVSLGERATINCKASQSVDYDGDSYMHWYQQKPGQPPKLLIYAASILESGVPDRFSGSG
SGTDFTLTISSLQAEDVAVYYCQQSNEDPRTFGGGTKVEIK
>Rilotumumab|WholemAb|G2|Kappa|Phase-II|Discontinued|heavy
QVQLQESGPGLVKPSETLSLTCTVSGGSISIYYWSWIRQPPGKGLEWIGYVYYSGSTNYNPSLKSRVTIS
VDTSKNQFSLKLNSVTAADTAVYYCARGGYDFWSGYFDYWGQGTLVTVSS
>Rilotumumab|WholemAb|G2|Kappa|Phase-II|Discontinued|light
EIVMTQSPATLSVSPGERATLSCRASQSVDSNLAWYRQKPGQAPRLLIYGASTRATGIPARFSGSGSGTE
FTLTISSLQSEDFAVYYCQQYINWPPITFGQGTRLEIK
>Rinucumab|WholemAb|G4|Kappa|Phase-II|Discontinued|heavy
QLQLQESGPGLVKPSETLSLTCTVSGGSITSSSYYWGWIRQPPGKGLEWIGSIYYRGSTNYNPSLKSRVT
ISVDSSKNQFYLKVSSVTAVDTAVYYCARQNGAARPSWFDPWGQGTLVTVSS
>Rinucumab|WholemAb|G4|Kappa|Phase-II|Discontinued|light
EIVLTQSPDTISLSPGERATLSCRASQSISSIYLAWYQQKPGQAPRLLIYGASSRVTGIPDRFSVSGSGT
DFTLTISRLEPEDFAVYYCQHYGISPFTFGPGTKVDIR
>Ripertamab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGRGLEWIGAIYPGNGDTSYNQKFKGKATL
TADKSSSTAYMQLSSLTSEDSAVYYCARSTYYGGDWYFNVWGAGTTVTVSA
>Ripertamab|WholemAb|G1|Kappa|Phase-II|Active|light
QIVLSQSPAILSASPGEKVTMTCRASSSVSYIHWFQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSY
SLTISRVEAEDAATYYCQQWTSNPPTFGGGTKLEIK
>Risankizumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDQTIHWMRQAPGQGLEWIGYIYPRDDSPKYNENFKGKVTI
TADKSTSTAYMELSSLRSEDTAVYYCAIPDRSGYAWFIYWGQGTLVTVSS
>Risankizumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCKASRDVAIAVAWYQQKPGKVPKLLIYWASTRHTGVPSRFSGSGSRTD
FTLTISSLQPEDVADYFCHQYSSYPFTFGSGTKLEIK
>Rituximab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGRGLEWIGAIYPGNGDTSYNQKFKGKATL
TADKSSSTAYMQLSSLTSEDSAVYYCARSTYYGGDWYFNVWGAGTTVTVSA
>Rituximab|WholemAb|G1|Kappa|Approved|Active|light
QIVLSQSPAILSASPGEKVTMTCRASSSVSYIHWFQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSY
SLTISRVEAEDAATYYCQQWTSNPPTFGGGTKLEIK
>Rivabazumab|Fab|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGVVQPGRSLRLSCAASGFTFSNYPMHWVRQAPGKGLEWVAVISYDGSEKWYADSVKGRFTI
SRDNSKNTLYLEMNSLRPEDTAVYYCARNRGDIYYDFTYAMDIWGQGTTVTVSS
>Rivabazumab|Fab|G1|Kappa|Phase-II|Discontinued|light
DIQLTQSPSTLSASVGDSVTITCRASEGVDRWLAWYQQKPGRAPKLLIYDASTLQSGVPSRFSGSGSGTE
FSLTISSLQPDDVATYYCQHFWGTPYTFGQGTKLEIK
>Robatumumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWISVIDTRGATYYADSVKGRFTIS
RDNAKNSLYLQMNSLRAEDTAVYYCARLGNFYYGMDVWGQGTTVTVSS
>Robatumumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
EIVLTQSPGTLSVSPGERATLSCRASQSIGSSLHWYQQKPGQAPRLLIKYASQSLSGIPDRFSGSGSGTD
FTLTISRLEPEDFAVYYCHQSSRLPHTFGQGTKVEIK
>Roledumab|WholemAb|G1|Kappa|Phase-II/III|Active|heavy
QVQLVESGGGVVQPGRSLRLSCTASGFTFKNYAMHWVRQAPAKGLEWVATISYDGRNIQYADSVKGRFTF
SRDNSQDTLYLQLNSLRPEDTAVYYCARPVRSRWLQLGLEDAFHIWGQGTMVTVSS
>Roledumab|WholemAb|G1|Kappa|Phase-II/III|Active|light
AIRMTQSPSSFSASTGDRVTITCRASQDIRNYVAWYQQKSGKAPKFLIYAASTLQSGVPSRFSGSGSGTD
FTLTINSLQSEDFATYYCQQYYNSPPTFGQGTRVEIT
>Rolinsatamab|WholemAbADC|G1|Kappa|Phase-I|Active|heavy
EVQLVQSGAEVKKPGSSVKVSCKASGYTFTTYWMHWVRQAPGQGLEWIGEIDPSDSYSNYNQKFKDRATL
TVDKSTSTAYMELSSLRSEDTAVYYCARNGGLGPAWFSYWGQGTLVTVSS
>Rolinsatamab|WholemAbADC|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSVSASVGDRVTITCKASQYVGTAVAWYQQKPGKSPKLLIYSASNRYTGVPSRFSDSGSGTD
FTLTISSLQPEDFATYFCQQYSSYPWTFGGGTKVEIK
>Romilkimab|BispecificDualVariableDomainIG|G1|Kappa;Kappa|Phase-II|Active|heavy
EVQLKESGPGLVAPGGSLSITCTVSGFSLTDSSINWVRQPPGKGLEWLGMIWGDGRIDYADALKSRLSIS
KDSSKSQVFLEMTSLRTDDTATYYCARDGYFPYAMDFWGQGTSVTVSS
>Romilkimab|BispecificDualVariableDomainIG|G1|Kappa;Kappa|Phase-II|Active|light
DIVLTQSPASLAVSLGQRATISCRASESVDSYGQSYMHWYQQKAGQPPKLLIYLASNLESGVPARFSGSG
SRTDFTLTIDPVQAEDAATYYCQQNAEDSRTFGGGTKLEIK
>Romosozumab|WholemAb|G2|Kappa|Approved|NFD|heavy
EVQLVQSGAEVKKPGASVKVSCKASGYTFTDYNMHWVRQAPGQGLEWMGEINPNSGGAGYNQKFKGRVTM
TTDTSTSTAYMELRSLRSDDTAVYYCARLGYDDIYDDWYFDVWGQGTTVTVSS
>Romosozumab|WholemAb|G2|Kappa|Approved|NFD|light
DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLLSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQGDTLPYTFGGGTKVEIK
>Rontalizumab|WholemAb|G2|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCATSGYTFTEYIIHWVRQAPGKGLEWVASINPDYDITNYNQRFKGRFTI
SLDKSKRTAYLQMNSLRAEDTAVYYCASWISDFFDYWGQGTLVTVSS
>Rontalizumab|WholemAb|G2|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQSVSTSSYSYMHWYQQKPGKAPKVLISYASNLESGVPSRFSGSG
SGTDFTLTISSLQPEDFATYYCQHSWGIPRTFGQGTKVEIK
>Rosmantuzumab|WholemAb|G1|Kappa|Phase-I|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYSIHWVRQAPGQGLEWIGYIYPSNGDSGYNQKFKNRVTM
TRDTSTSTAYMELSRLRSEDTAVYYCATYFANNFDYWGQGTTLTVSS
>Rosmantuzumab|WholemAb|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSG
SGTDFTLTISPVQAEDFATYYCQQSNEDPLTFGAGTKLELK
>Rosopatamab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLVQSGPEVKKPGATVKISCKTSGYTFTEYTIHWVKQAPGKGLEWIGNINPNNGGTTYNQKFEDKATL
TVDKSTDTAYMELSSLRSEDTAVYYCAAGWNFDYWGQGTLLTVSS
>Rosopatamab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSTSVGDRVTLTCKASQDVGTAVDWYQQKPGPSPKLLIYWASTRHTGIPSRFSGSGSGTD
FTLTISSLQPEDFADYYCQQYNSYPLTFGPGTKVDIK
>Rovalpituzumab|WholemAbADC|G1|Kappa|Phase-III|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGEPTYADDFKGRVTM
TTDTSTSTAYMELRSLRSDDTAVYYCARIGDSSPSDYWGQGTLVTVSS
>Rovalpituzumab|WholemAbADC|G1|Kappa|Phase-III|Discontinued|light
EIVMTQSPATLSVSPGERATLSCKASQSVSNDVVWYQQKPGQAPRLLIYYASNRYTGIPARFSGSGSGTE
FTLTISSLQSEDFAVYYCQQDYTSPWTFGQGTKLEIK
>Rozanolixizumab|WholemAb|G4|Kappa|Phase-III|Active|heavy
EVPLVESGGGLVQPGGSLRLSCAVSGFTFSNYGMVWVRQAPGKGLEWVAYIDSDGDNTYYRDSVKGRFTI
SRDNAKSSLYLQMNSLRAEDTAVYYCTTGIVRPFLYWGQGTLVTVSS
>Rozanolixizumab|WholemAb|G4|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASVGDRVTITCKSSQSLVGASGKTYLYWLFQKPGKAPKRLIYLVSTLDSGIPSRFSGS
GSGTEFTLTISSLQPEDFATYYCLQGTHFPHTFGQGTKLEIK
>Rozipafusp|WholemAbFusion|G2|Kappa|Phase-I|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAYIKQDGNEKYYVDSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCAREGILWFGDLPTFWGQGTLVTVSS
>Rozipafusp|WholemAbFusion|G2|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQGISNWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYDSYPRTFGQGTKVEIK
>Ruplizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVVKPGASVKLSCKASGYIFTSYYMYWVKQAPGQGLEWIGEINPSNGDTNFNEKFKSKATL
TVDKSASTAYMELSSLRSEDTAVYYCTRSDGRNDMDSWGQGTLVTVSS
>Ruplizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIVLTQSPATLSVSPGERATISCRASQRVSSSTYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSG
SGTDFTLTISSVEPEDFATYYCQHSWEIPPTFGGGTKLEIK
>Sabatolimab|WholemAb|G4|Kappa|Phase-I/II|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVRQAPGQGLEWMGDIYPGNGDTSYNQKFKGRVTI
TADKSTSTVYMELSSLRSEDTAVYYCARVGGAFPMDYWGQGTTVTVSS
>Sabatolimab|WholemAb|G4|Kappa|Phase-I/II|Active|light
AIQLTQSPSSLSASVGDRVTITCRASESVEYYGTSLMQWYQQKPGKAPKLLIYAASNVESGVPSRFSGSG
SGTDFTLTISSLQPEDFATYFCQQSRKDPSTFGGGTKVEIK
>Sacituzumab|WholemAbADC|G1|Kappa|Preregistration|Active|heavy
QVQLQQSGSELKKPGASVKVSCKASGYTFTNYGMNWVKQAPGQGLKWMGWINTYTGEPTYTDDFKGRFAF
SLDTSVSTAYLQISSLKADDTAVYFCARGGFGSSYWYFDVWGQGSLVTVSS
>Sacituzumab|WholemAbADC|G1|Kappa|Preregistration|Active|light
DIQLTQSPSSLSASVGDRVSITCKASQDVSIAVAWYQQKPGKAPKLLIYSASYRYTGVPDRFSGSGSGTD
FTLTISSLQPEDFAVYYCQQHYITPLTFGAGTKVEIK
>Samalizumab|WholemAb|G2|Kappa|Phase-I|Discontinued|heavy
QVQLQQSGSELKKPGASVKISCKASGYSFTDYIILWVRQNPGKGLEWIGHIDPYYGSSNYNLKFKGRVTI
TADQSTTTAYMELSSLRSEDTAVYYCGRSKRDYFDYWGQGTTLTVSS
>Samalizumab|WholemAb|G2|Kappa|Phase-I|Discontinued|light
DIQMTQSPSSLSASIGDRVTITCKASQDINSYLSWFQQKPGKAPKLLIYRANRLVDGVPSRFSGSGSGTD
YTLTISSLQPEDFAVYYCLQYDEFPYTFGGGTKLEIK
>Samrotamab|WholemAbADC|G1|Kappa|Phase-I|Active|heavy
EVQLVQSGAEVKKPGASVKVSCKASGYKFSSYWIEWVKQAPGQGLEWIGEILPGSDTTNYNEKFKDRATF
TSDTSINTAYMELSRLRSDDTAVYYCARDRGNYRAWFGYWGQGTLVTVSS
>Samrotamab|WholemAbADC|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGGAVKFLIYYTSRLHSGVPSRFSGSGSGTD
YTLTISSLQPEDFATYFCQQGEALPWTFGGGTKVEIK
>Sapelizumab|WholemAb|G2|Kappa|Preregistration|Active|heavy
QVQLQESGPGLVKPSETLSLTCAVSGHSISHDHAWSWVRQPPGEGLEWIGFISYSGITNYNPSLQGRVTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARSLARTTAMDYWGEGTLVTVSS
>Sapelizumab|WholemAb|G2|Kappa|Preregistration|Active|light
DIQMTQSPSSLSASVGDSVTITCQASTDISSHLNWYQQKPGKAPELLIYYGSHLLSGVPSRFSGSGSGTD
FTFTISSLEAEDAATYYCGQGNRLPYTFGQGTKVEIE
>Sarilumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGRSLRLSCAASRFTFDDYAMHWVRQAPGKGLEWVSGISWNSGRIGYADSVKGRFTI
SRDNAENSLFLQMNGLRAEDTALYYCAKGRDSFDIWGQGTMVTVSS
>Sarilumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASSLESGVPSRFSGSGSGTD
FTLTISSLQPEDFASYYCQQANSFPYTFGQGTKLEIK
>Sasanlimab|WholemAb|G4|Kappa|Phase-I|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWINWVRQAPGQGLEWMGNIYPGSSLTNYNEKFKNRVTM
TRDTSTSTVYMELSSLRSEDTAVYYCARLSTGTFAYWGQGTLVTVSS
>Sasanlimab|WholemAb|G4|Kappa|Phase-I|Active|light
DIVMTQSPDSLAVSLGERATINCKSSQSLWDSGNQKNFLTWYQQKPGQPPKLLIYWTSYRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYYCQNDYFYPHTFGGGTKVEIK
>Satralizumab|WholemAb|G2|Kappa|Preregistration|Active|heavy
QVQLQESGPGLVKPSETLSLTCAVSGHSISHDHAWSWVRQPPGEGLEWIGFISYSGITNYNPSLQGRVTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARSLARTTAMDYWGEGTLVTVSS
>Satralizumab|WholemAb|G2|Kappa|Preregistration|Active|light
DIQMTQSPSSLSASVGDSVTITCQASTDISSHLNWYQQKPGKAPELLIYYGSHLLSGVPSRFSGSGSGTD
FTFTISSLEAEDAATYYCGQGNRLPYTFGQGTKVEIE
>Secukinumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWMNWVRQAPGKGLEWVAAINQDGSEKYYVGSVKGRFTI
SRDNAKNSLYLQMNSLRVEDTAVYYCVRDYYDILTDYYIHYWYFDLWGRGTLVTVSS
>Secukinumab|WholemAb|G1|Kappa|Approved|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSSPCTFGQGTRLEIK
>Selicrelumab|WholemAb|G2|Kappa|Phase-I|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPDSGGTNYAQKFQGRVTM
TRDTSISTAYMELNRLRSDDTAVYYCARDQPLGYCTNGVCSYFDYWGQGTLVTVSS
>Selicrelumab|WholemAb|G2|Kappa|Phase-I|Active|light
DIQMTQSPSSVSASVGDRVTITCRASQGIYSWLAWYQQKPGKAPNLLIYTASTLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQANIFPLTFGGGTKVEIK
>Semorinemab|WholemAb|G4|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGLIFRSYGMSWVRQAPGKGLEWVATINSGGTYTYYPDSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCANSYSGAMDYWGQGTLVTVSS
>Semorinemab|WholemAb|G4|Kappa|Phase-II|Active|light
DDVLTQTPLSLPVTPGQPASISCRSSQSIVHSNGNTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCFQGSLVPWTFGQGTKVEIK
>Serclutamab|WholemAbADC|G1|Kappa|Phase-I|Active|heavy
EVQLQESGPGLVKPSQTLSLTCTVSGYSISRDFAWNWIRQPPGKGLEWMGYISYNGNTRYQPSLKSRITI
SRDTSKNQFFLKLNSVTAADTATYYCVTASRGFPYWGQGTLVTVSS
>Serclutamab|WholemAbADC|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSMSVSVGDRVTITCHSSQDINSNIGWLQQKPGKSFKGLIYHGTNLDDGVPSRFSGSGSGTD
YTLTISSLQPEDFATYYCVQYAQFPWTFGGGTKLEIK
>Seribantumab|WholemAb|G2|Lambda|Phase-II|Discontinued|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSHYVMAWVRQAPGKGLEWVSSISSSGGWTLYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCTRGLKMATIFDYWGQGTLVTVSS
>Seribantumab|WholemAb|G2|Lambda|Phase-II|Discontinued|light
QSALTQPASVSGSPGQSITISCTGTSSDVGSYNVVSWYQQHPGKAPKLIIYEVSQRPSGVSNRFSGSKSG
NTASLTISGLQTEDEADYYCCSYAGSSIFVIFGGGTKVTVL
>Serplulimab|WholemAb|G4|Kappa|Phase-III|Active|heavy
QVQLVESGGGLVKPGGSLRLSCAASGFTFSNYGMSWIRQAPGKGLEWVSTISGGGSNIYYADSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCVSYYYGIDFWGQGTSVTVSS
>Serplulimab|WholemAb|G4|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQDVTTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQHYTIPWTFGGGTKLEIK
>Setoxaximab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLQQPGPELEKPGASVKLSCKASGYSFTDYNMNWVKQNNGESLEWIGKIDPYYGGPSYNQKFKDKATL
TVDKSSSTAYMQLKSLTSEDSAVYYCTRGGNRDWYFDVWGAGTTLTVSA
>Setoxaximab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIVLSQSPSSLVVSVGEKVTMSCKSSQSLLYSRNQKNYLAWYQQKPGQSPKVLIYWASTRESGVPDRLTG
SGSGTDFTLTISSVKAEDLAVYYCQQYYSYPLTFGAGTKLELK
>Setrusumab|WholemAb|G2|Lambda|Phase-II|Active|heavy
QVQLVESGGGLVQPGGSLRLSCAASGFTFRSHWLSWVRQAPGKGLEWVSNINYDGSSTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARDTYLHFDYWGQGTLVTVSS
>Setrusumab|WholemAb|G2|Lambda|Phase-II|Active|light
DIALTQPASVSGSPGQSITISCTGTSSDVGDINDVSWYQQHPGKAPKLMIYDVNNRPSGVSNRFSGSKSG
NTASLTISGLQAEDEADYYCQSYAGSYLSEVFGGGTKLTVL
>Sifalimumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYSISWVRQAPGQGLEWMGWISVYNGNTNYAQKFQGRVTM
TTDTSTSTAYLELRSLRSDDTAVYYCARDPIAAGYWGQGTLVTVSS
>Sifalimumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK
>Siltuximab|WholemAb|G1|Kappa|Approved|CentocorInc;JanssenBiotech;MemorialSloan-KetteringCancerCenter|heavy
EVQLVESGGKLLKPGGSLKLSCAASGFTFSSFAMSWFRQSPEKRLEWVAEISSGGSYTYYPDTVTGRFTI
SRDNAKNTLYLEMSSLRSEDTAMYYCARGLWGYYALDYWGQGTSVTVSS
>Siltuximab|WholemAb|G1|Kappa|Approved|CentocorInc;JanssenBiotech;MemorialSloan-KetteringCancerCenter|light
QIVLIQSPAIMSASPGEKVTMTCSASSSVSYMYWYQQKPGSSPRLLIYDTSNLASGVPVRFSGSGSGTSY
SLTISRMEAEDAATYYCQQWSGYPYTFGGGTKLEIK
>Simlukafusp|WholemAbFusion|G1|Kappa|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAIIGSGASTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKGWFGGFNYWGQGTLVTVSS
>Simlukafusp|WholemAbFusion|G1|Kappa|Phase-II|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVTSSYLAWYQQKPGQAPRLLINVGSRRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQGIMLPPTFGQGTKVEIK
>Simtuzumab|WholemAb|G4|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYAFTYYLIEWVRQAPGQGLEWIGVINPGSGGTNYNEKFKGRATI
TADKSTSTAYMELSSLRSEDTAVYFCARNWMNFDYWGQGTTVTVSS
>Simtuzumab|WholemAb|G4|Kappa|Phase-II|Discontinued|light
DIVMTQTPLSLSVTPGQPASISCRSSKSLLHSNGNTYLYWFLQKPGQSPQFLIYRMSNLASGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCMQHLEYPYTFGGGTKVEIK
>Sintilimab|WholemAb|G4|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGLIIPMFDTAGYAQKFQGRVAI
TVDESTSTAYMELSSLRSEDTAVYYCARAEHSSTGTFDYWGQGTLVTVSS
>Sintilimab|WholemAb|G4|Kappa|Approved|Active|light
DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLISAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQANHLPFTFGGGTKVEIK
>Sirtratumab|WholemAbADC|G2|Kappa|Phase-I|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNQYYADSVKGRFTI
SRDNSKNTLFLQMHSLRAEDTAVYYCARGLTSGRYGMDVWGQGTTVTVSS
>Sirtratumab|WholemAbADC|G2|Kappa|Phase-I|Active|light
DIVMTQSPLSLPVTPGEPASISCRSSQSLLLSHGFNYLDWYLQKPGQSPQLLIYLGSSRASGVPDRFSGS
GSGTDFTLKISRVEAEDVGLYYCMQPLQIPWTFGQGTKVEIK
>Sirukumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSPFAMSWVRQAPGKGLEWVAKISPGGSWTYYSDTVTGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARQLWGYYALDIWGQGTTVTVSS
>Sirukumab|WholemAb|G1|Kappa|Phase-III|Active|light
EIVLTQSPATLSLSPGERATLSCSASISVSYMYWYQQKPGQAPRLLIYDMSNLASGIPARFSGSGSGTDF
TLTISSLEPEDFAVYYCMQWSGYPYTFGGGTKVEIK
>Sofituzumab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYSITNDYAWNWVRQAPGKGLEWVGYISYSGYTTYNPSLKSRFTI
SRDTSKNTLYLQMNSLRAEDTAVYYCARWTSGLDYWGQGTLVTVSS
>Sofituzumab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCKASDLIHNWLAWYQQKPGKAPKLLIYGATSLETGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYWTTPFTFGQGTKVEIK
>Solanezumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYSMSWVRQAPGKGLELVAQINSVGNSTYYPDTVKGRFTI
SRDNAKNTLYLQMNSLRAEDTAVYYCASGDYWGQGTLVTVSS
>Solanezumab|WholemAb|G1|Kappa|Phase-III|Active|light
DVVMTQSPLSLPVTLGQPASISCRSSQSLIYSDGNAYLHWFLQKPGQSPRLLIYKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK
>Solitomab|BispecificscFv|na|Kappa;Kappa|Phase-I|Discontinued|heavy
EVQLLEQSGAELVRPGTSVKISCKASGYAFTNYWLGWVKQRPGHGLEWIGDIFPGSGNIHYNEKFKGKAT
LTADKSSSTAYMQLSSLTFEDSAVYFCARLRNWDEPMDYWGQGTTVTVSS
>Solitomab|BispecificscFv|na|Kappa;Kappa|Phase-I|Discontinued|light
ELVMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTG
SGSGTDFTLTISSVQAEDLAVYYCQNDYSYPLTFGAGTKLEIK
>Sotigalimab|WholemAb|G1|Kappa|TBC|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFSFSSTYVCWVRQAPGKGLEWIACIYTGDGTNYSASWAKGRFTI
SKDSSKNTVYLQMNSLRAEDTAVYFCARPDITYGFAINFWGPGTLVTVSS
>Sotigalimab|WholemAb|G1|Kappa|TBC|Active|light
DIQMTQSPSSLSASVGDRVTIKCQASQSISSRLAWYQQKPGKPPKLLIYRASTLASGVPSRFSGSGSGTD
FTLTISSLQPEDVATYYCQCTGYGISWPIGGGTKVEIK
>Spartalizumab|WholemAb|G4|Kappa|Phase-III|Active|heavy
EVQLVQSGAEVKKPGESLRISCKGSGYTFTTYWMHWVRQATGQGLEWMGNIYPGTGGSNFDEKFKNRVTI
TADKSTSTAYMELSSLRSEDTAVYYCTRWTTGTGAYWGQGTTVTVSS
>Spartalizumab|WholemAb|G4|Kappa|Phase-III|Active|light
EIVLTQSPATLSLSPGERATLSCKSSQSLLDSGNQKNFLTWYQQKPGQAPRLLIYWASTRESGVPSRFSG
SGSGTDFTFTISSLEAEDAATYYCQNDYSYPYTFGQGTKVEIK
>Spesolimab|WholemAb|G1|Kappa|Phase-III|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYSFTSSWIHWVKQAPGQGLEWMGEINPGNVRTNYNENFRNKVTM
TVDTSISTAYMELSRLRSDDTAVYYCTVVFYGEPYFPYWGQGTLVTVSS
>Spesolimab|WholemAb|G1|Kappa|Phase-III|Active|light
QIVLTQSPGTLSLSPGERATMTCTASSSVSSSYFHWYQQKPGQAPRLWIYRTSRLASGVPDRFSGSGSGT
DFTLTISRLEPEDAATYYCHQFHRSPLTFGAGTKLEIK
>Sugemalimab|WholemAb|G4|Lambda|Phase-III|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGISGSGGFTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCAKPPRGYNYGPFDYWGQGTLVTVSS
>Sugemalimab|WholemAb|G4|Lambda|Phase-III|Active|light
SYVLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTA
TLTISRVEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL
>Suptavumab|WholemAb|G1|Kappa|Phase-III|Discontinued|heavy
EVQLVESGGDLVQPGRSLRLSCVASGFTFDDYAMHWVRQAPGKGLEWVSGVSWSGSTVGYADSVKGRFTV
SRDNAQKSLYLQMNSLRAEDTALYYCVKDAYKFNYYYYGLDVWGQGTTVTVSS
>Suptavumab|WholemAb|G1|Kappa|Phase-III|Discontinued|light
EIVMTQSPATLSVSPGERATLSCRASQTILSNLAWYLQKPGQAPRLLIYGASTRATGLPARFSGSGSGTE
FTLTISSLQSEDFAVYYCQQYNNWPLTFGGGTKVEIK
>Sutimlimab|WholemAb|G4|Kappa|Phase-III|Active|heavy
EVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVATISSGGSHTYYLDSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTALYYCARLFTGYAMDYWGQGTLVTVSS
>Sutimlimab|WholemAb|G4|Kappa|Phase-III|Active|light
QIVLTQSPATLSLSPGERATMSCTASSSVSSSYLHWYQQKPGKAPKLWIYSTSNLASGVPSRFSGSGSGT
DYTLTISSLQPEDFATYYCHQYYRLPPITFGQGTKLEIK
>Suvizumab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTNSWIGWFRQAPGQGLEWIGDIYPGGGYTNYNEIFKGKATM
TADTSTNTAYMELSSLRSEDTAVYYCSRGIPGYAMDYWGQGTLVTVSS
>Suvizumab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
DIQMTQRPDSLSASVGDRVTMSCKSSQSLLNSGDQKNYLTWYQQKPGQPPKLLIYWASTGESGVPDRFSG
SGSGTDFTFTISSLQPEDIATYYCQNDYSYPWTFGQGTKVEIK
>Suvratoxumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSHDMHWVRQATGKGLEWVSGIGTAGDTYYPDSVKGRFTIS
RENAKNSLYLQMNSLRAGDTAVYYCARDRYSPTGHYYGMDVWGQGTTVTVSS
>Suvratoxumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTE
FTLTISSLQPDDFATYYCKQYADYWTFGQGTKVEIK
>Tabalumab|WholemAb|G4|Kappa|Phase-III|Discontinued|heavy
QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTIS
VDTSKNQFSLKLSSVTAADTAVYYCARGYYDILTGYYYYFDYWGQGTLVTVSS
>Tabalumab|WholemAb|G4|Kappa|Phase-III|Discontinued|light
EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
STLTISSLEPEDFAVYYCQQRSNWPRTFGQGTKVEIK
>Tabituximab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|heavy
EVQLQQSGAELVKPGASVKLSCTASGFNINDTYMHWVKQRPEQGLEWIGRIDPANGNTKYDPKFQGKATI
TADTSSNTAYLQLSSLTSEDTAVYYCARGARGSRFAYWGQGTLVTVSA
>Tabituximab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|light
DIQMTQSPASLSVSVGETVTITCRASENIYSNLAWYQQKQGKSPQLLVYVATNLADGVPSRFSGSGSGTQ
YSLKINSLQSEDFGSYYCQHFWGTPYTFGGGTKLEIK
>Tadocizumab|Fab|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYAFTNYLIEWVRQAPGQGLEWIGVIYPGSGGTNYNEKFKGRVTL
TVDESTNTAYMELSSLRSEDTAVYFCARRDGNYGWFAYWGQGTLVTVSS
>Tadocizumab|Fab|G1|Kappa|Phase-II|Discontinued|light
DIQMTQTPSTLSASVGDRVTISCRASQDINNYLNWYQQKPGKAPKLLIYYTSTLHSGVPSRFSGSGSGTD
YTLTISSLQPDDFATYFCQQGNTLPWTFGQGTKVEVK
>Tafasitamab|WholemAb|G1|Kappa|Phase-III|Active|heavy
EVQLVESGGGLVKPGGSLKLSCAASGYTFTSYVMHWVRQAPGKGLEWIGYINPYNDGTKYNEKFQGRVTI
SSDKSISTAYMELSSLRSEDTAMYYCARGTYYYGTRVFDYWGQGTLVTVSS
>Tafasitamab|WholemAb|G1|Kappa|Phase-III|Active|light
DIVMTQSPATLSLSPGERATLSCRSSKSLQNVNGNTYLYWFQQKPGQSPQLLIYRMSNLNSGVPDRFSGS
GSGTEFTLTISSLEPEDFAVYYCMQHLEYPITFGAGTKLEIK
>Tafolecimab|WholemAb|G2|Kappa|Phase-III|Active|heavy
QLQLQESGPGLVKPSETLSLTCTVSGGSISSASYYWSWIRQPPGKGLEWIGSINYRGSTYYNPSLKSRVT
ISVDTSKNQFSLKLSSVTAADTAVYYCARENSGVVPAAGPNWFGPWGQGTLVTVSS
>Tafolecimab|WholemAb|G2|Kappa|Phase-III|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRRNWFTFGGGTKVEIK
>Talacotuzumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
EVQLVQSGAEVKKPGESLKISCKGSGYSFTDYYMKWARQMPGKGLEWMGDIIPSNGATFYNQKFKGQVTI
SADKSISTTYLQWSSLKASDTAMYYCARSHLLRASWFAYWGQGTMVTVSS
>Talacotuzumab|WholemAb|G1|Kappa|Phase-III|Active|light
DIVMTQSPDSLAVSLGERATINCESSQSLLNSGNQKNYLTWYQQKPGQPPKPLIYWASTRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYYCQNDYSYPYTFGQGTKLEIK
>Talquetamab|BispecificmAb|G4|Kappa;Lambda|Phase-I|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYSFTGYTMNWVRQAPGQGLEWMGLINPYNSDTNYAQKLQGRVTM
TTDTSTSTAYMELRSLRSDDTAVYYCARVALRVALDYWGQGTLVTVSS
>Talquetamab|BispecificmAb|G4|Kappa;Lambda|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQNVATHVGWYQQKPGKAPKRLIYSASYRYSGVPSRFSGSGSGTE
FTLTISNLQPEDFATYYCQQYNRYPYTFGQGTKLEIK
>Tamrintamab|WholemAbADC|G1|Kappa|Phase-I|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYWIEWVRQAPGQGLEWMGEILPGSGNTYYNERFKDRVTI
TADESTSTAYMELSSLRSEDTAVYYCARRAAAYYSNPEWFAYWGQGTLVTVSS
>Tamrintamab|WholemAbADC|G1|Kappa|Phase-I|Active|light
EIVLTQSPATLSLSPGERATLSCTASSSVNSFYLHWYQQKPGLAPRLLIYSTSNLASGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCHQYHRSPYTFGQGTKLEIK
>Tamtuvetmab|CanineWholemAb|G2|Kappa|Unknown|Active|heavy
EVKLLESGGGLVQPGGSMRLSCAGSGFTFTDFYMNWIRQPAGKAPEWLGFIRDKAKGYTTEYNPSVKGRF
TISRDNTQNMLYLQMNTLRAEDTATYYCAREGHTAAPFDYWGQGTLVTVSS
>Tamtuvetmab|CanineWholemAb|G2|Kappa|Unknown|Active|light
DIKMTQSPSFLSASVGDRVTLNCKASQNIDKYLNWYQQKLGESPKLLIYNTNNLQTGIPSRFSGSGSGTD
FTLTISSLQPEDVATYFCLQHISRPRTFGGGTHLTVL
>Tanezumab|WholemAb|G2|Kappa|Phase-III|Active|heavy
QVQLQESGPGLVKPSETLSLTCTVSGFSLIGYDLNWIRQPPGKGLEWIGIIWGDGTTDYNSAVKSRVTIS
KDTSKNQFSLKLSSVTAADTAVYYCARGGYWYATSYYFDYWGQGTLVTVSS
>Tanezumab|WholemAb|G2|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQSISNNLNWYQQKPGKAPKLLIYYTSRFHSGVPSRFSGSGSGTD
FTFTISSLQPEDIATYYCQQEHTLPYTFGQGTKLEIK
>Tanibirumab|WholemAb|G1|Lambda|Phase-II|Active|heavy
QMQLVQSGAEVKKPGASVKLSCKASGYTFSSYWMHWVRQAPGQRLEWMGEINPGNGHTNYNEKFKSRVTI
TVDKSASTAYMELSSLRSEDTAVYYCAKIWGPSLTSPFDYWGQGTLVTVSS
>Tanibirumab|WholemAb|G1|Lambda|Phase-II|Active|light
NFMLTQPPSVSVSPGKTARITCRGDNLGDVNVHWYQQRPGQAPVLVMYYDADRPSGIPERFSGSNSGNTA
TLTISGVEAGDEADYYCQVWDRTSEYVFGTGTKVTVL
>Tarextumab|WholemAb|G2|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSSGMSWVRQAPGKGLEWVSVIASSGSNTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARSIFYTTWGQGTLVTVSS
>Tarextumab|WholemAb|G2|Kappa|Phase-II|Active|light
DIVLTQSPATLSLSPGERATLSCRASQSVRSNYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGT
DFTLTISSLEPEDFAVYYCQQYSNFPITFGQGTKVEIK
>Tarlatamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|heavy
QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKCLEWIGYVYYSGTTNYNPSLKSRVTIS
VDTSKNQFSLKLSSVTAADTAVYYCASIAVTGFYFDYWGQGTLVTVSS
>Tarlatamab|BispecificscFv|na;na|Kappa;Lambda|TBC|Active|light
EIVLTQSPGTLSLSPGERVTLSCRASQRVNNNYLAWYQQRPGQAPRLLIYGASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYDRSPLTFGCGTKLEIK
>Tavolimab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLQESGPGLVKPSQTLSLTCAVYGGSFSSGYWNWIRKHPGKGLEYIGYISYNGITYHNPSLKSRITIN
RDTSKNQYSLQLNSVTPEDTAVYYCARYKYDYDGGHAMDYWGQGTLVTVSS
>Tavolimab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSKLHSGVPSRFSGSGSGTD
YTLTISSLQPEDFATYYCQQGSALPWTFGQGTKVEIK
>Tavolixizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLQESGPGLVKPSQTLSLTCAVYGGSFSSGYWNWIRKHPGKGLEYIGYISYNGITYHNPSLKSRITIN
RDTSKNQYSLQLNSVTPEDTAVYYCARYKYDYDGGHAMDYWGQGTLVTVSS
>Tavolixizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSKLHSGVPSRFSGSGSGTD
YTLTISSLQPEDFATYYCQQGSALPWTFGQGTKVEIK
>Tebentafusp|scFvFusion|na|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYSFTGYTMNWVRQAPGKGLEWVALINPYKGVSTYNQKFKDRFTI
SVDKSKNTAYLQMNSLRAEDTAVYYCARSGYYGDSDWYFDVWGQGTLVTVSS
>Tebentafusp|scFvFusion|na|Kappa|Phase-II|Active|light
AIQMTQSPSSLSASVGDRVTITCRASQDIRNYLNWYQQKPGKAPKLLIYYTSRLESGVPSRFSGSGSGTD
YTLTISSLQPEDFATYYCQQGNTLPWTFGQGTKVEIK
>Tebotelimab|BispecificscFvwithCrossover|G4|Kappa;Kappa|Phase-I|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYSFTSYWMNWVRQAPGQGLEWIGVIHPSDSETWLDQKFKDRVTI
TVDKSTSTAYMELSSLRSEDTAVYYCAREHYGTSPFAYWGQGTLVTVSS
>Tebotelimab|BispecificscFvwithCrossover|G4|Kappa;Kappa|Phase-I|Active|light
EIVLTQSPATLSLSPGERATLSCRASESVDNYGMSFMNWFQQKPGQPPKLLIHAASNQGSGVPSRFSGSG
SGTDFTLTISSLEPEDFAVYFCQQSKEVPYTFGGGTKVEIK
>Teclistamab|BispecificmAb|G4|Lambda;Lambda|Phase-I|Active|heavy
QLQLQESGPGLVKPSETLSLTCTVSGGSISSGSYFWGWIRQPPGKGLEWIGSIYYSGITYYNPSLKSRVT
ISVDTSKNQFSLKLSSVTAADTAVYYCARHDGAVAGLFDYWGQGTLVTVSS
>Teclistamab|BispecificmAb|G4|Lambda;Lambda|Phase-I|Active|light
SYVLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQPPGQAPVVVVYDDSDRPSGIPERFSGSNSGNTA
TLTISRVEAGDEAVYYCQVWDSSSDHVVFGGGTKLTVL
>Telazorlimab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVTLKESGPALVKPTQTLTLTCSFSGFSLSTSGMGVGWIRQPPGKALEWIAHIWWDDDKYYNTALKTRLT
ISKDTSKNQVVLTMTNMDPVDTATYYCARIDWDGFAYWGQGTLVTVSS
>Telazorlimab|WholemAb|G1|Kappa|Phase-II|Active|light
EIVLTQSPATLSLSPGERATLSCRASSSVSYMHWYQQKPGQAPRPWIYATSNRATGIPARFSGSGSGTDY
TLTISSLEPEDFAVYYCQQWSSNPWTFGQGTKVEIK
>Telisotuzumab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYIFTAYTMHWVRQAPGQGLEWMGWIKPNNGLANYAQKFQGRVTM
TRDTSISTAYMELSRLRSDDTAVYYCARSEITTEFDYWGQGTLVTVSS
>Telisotuzumab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|light
DIVMTQSPDSLAVSLGERATINCKSSESVDSYANSFLHWYQQKPGQPPKLLIYRASTRESGVPDRFSGSG
SGTDFTLTISSLQAEDVAVYYCQQSKEDPLTFGGGTKVEIK
>Temelimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYEMHWVRQAPGQGLEWIGAVAPETGGTAYNQKFKGRATI
TADKSTSTAYMELSSLRSEDTAVYYCTSTVVPFAYWGQGTLVTVSS
>Temelimab|WholemAb|G4|Kappa|Phase-II|Active|light
QIQLTQSPSSLSASVGDRVTITCSASSSVSYMYWYQQKPGKAPKAWIYRTSNLASGVPSRFSGSGSGTDY
TLTISSLQPEDFATYYCQQYQSLPLTFGGGTKVEIK
>Tenatumomab|WholemAbRadiolabelled|G2b|Kappa|Phase-I|Discontinued|heavy
EIQLQQSGPELVKPGASVKVSCKASGYAFTSYNMYWVKQSHGKSLEWIGYIDPYNGVTSYNQKFKGKATL
TVDKSSSTAYMHLNSLTSEDSAVYYCARGGGSIYYAMDYWGQGTSVTVSS
>Tenatumomab|WholemAbRadiolabelled|G2b|Kappa|Phase-I|Discontinued|light
DIVMTQAAPSVPVTPGESVSISCRSSKSLLHSNGNTYLYWFLQRPGQSPQLLIYRMSNLASGVPDRFSGS
GSGTAFTLRISRVEAEDVGVYYCMQHLEYPLTFGAGTKLELK
>Teplizumab|WholemAb|G1|Kappa|Phase-III|Active|heavy
QVQLVQSGGGVVQPGRSLRLSCKASGYTFTRYTMHWVRQAPGKGLEWIGYINPSRGYTNYNQKVKDRFTI
SRDNSKNTAFLQMDSLRPEDTGVYFCARYYDDHYCLDYWGQGTPVTVSS
>Teplizumab|WholemAb|G1|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQTPGKAPKRWIYDTSKLASGVPSRFSGSGSGTDY
TFTISSLQPEDIATYYCQQWSSNPFTFGQGTKLQIT
>Tepoditamab|BispecificmAb|G1|Kappa;Kappa|Phase-I|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKFQGRVTM
TRDTSTSTVYMELSSLRSEDTAVYYCAKGTTGDWFDYWGQGTLVTVSS
>Tepoditamab|BispecificmAb|G1|Kappa;Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQSYSTPPTFGQGTKVEIK
>Teprotumumab|WholemAb|G1|Kappa|Preregistration|Active|heavy
QVELVESGGGVVQPGRSQRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAIIWFDGSSTYYADSVRGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYFCARELGRRYFDLWGRGTLVSVSS
>Teprotumumab|WholemAb|G1|Kappa|Preregistration|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASKRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSKWPPWTFGQGTKVESK
>Tesidolumab|WholemAb|G1|Lambda|Phase-II|Active|heavy
EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIGPFFGTANYAQKFQGRVTI
TADESTSTAYMELSSLRSEDTAVYYCARDTPYFDYWGQGTLVTVSS
>Tesidolumab|WholemAb|G1|Lambda|Phase-II|Active|light
SYELTQPLSVSVALGQTARITCSGDSIPNYYVYWYQQKPGQAPVLVIYDDSNRPSGIPERFSGSNSGNTA
TLTISRAQAGDEADYYCQSFDSSLNAEVFGGGTKLTVL
>Tesnatilimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVHLQESGPGLVKPSETLSLTCTVSDDSISSYYWSWIRQPPGKGLEWIGHISYSGSANYNPSLKSRVTIS
VDTSKNQFSLKLSSVTAADTAVYYCANWDDAFNIWGQGTMVTVSS
>Tesnatilimab|WholemAb|G4|Kappa|Phase-II|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK
>Tezepelumab|WholemAb|G2|Lambda|Phase-III|Active|heavy
QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTI
TRDNSKNTLNLQMNSLRAEDTAVYYCARAPQWELVHEAFDIWGQGTMVTVSS
>Tezepelumab|WholemAb|G2|Lambda|Phase-III|Active|light
SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTA
TLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL
>Tibulizumab|BispecificMixedmAbandscFv|G4|Kappa;Kappa|Phase-I|Discontinued|heavy
QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTIS
VDTSKNQFSLKLSSVTAADTAVYYCARGYYDILTGYYYYFDYWGQGTLVTVSS
>Tibulizumab|BispecificMixedmAbandscFv|G4|Kappa;Kappa|Phase-I|Discontinued|light
EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
STLTISSLEPEDFAVYYCQQRSNWPRTFGQGTKVEIK
>Ticilimumab|WholemAb|G2|Kappa|Phase-III|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARDPRGATLYYYYYGMDVWGQGTTVTVSS
>Ticilimumab|WholemAb|G2|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQSINSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYYSTPFTFGPGTKVEIK
>Tidutamab|BispecificMixedmAbandscFv|G1|Kappa;Lambda|Phase-I|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYGMAWFRQAPGKGLEWVSFISNLGYSIYYADSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARAPYDYDSFDPMDYWGQGTLVTVSS
>Tidutamab|BispecificMixedmAbandscFv|G1|Kappa;Lambda|Phase-I|Active|light
DIVMTQSPDSLAVSLGERATINCKSSQSLLNSRNRKNYLAWYQQKPDQSPKLLIYWASTRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYYCKQSYYLWTFGGGTKVEIK
>Tigatuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYVMSWVRQAPGKGLEWVATISSGGSYTYYPDSVKGRFTI
SRDNAKNTLYLQMNSLRAEDTAVYYCARRGDSMITTDYWGQGTLVTVSS
>Tigatuzumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYSSYRTFGQGTKVEIK
>Tilavonemab|WholemAb|G4|Kappa|Phase-II|Active|heavy
EVKVVESGGGLVQPGGSMKLSCVVSGFTFSNYWVNWVRQAPGKGLEWVAQIRLKSDNYATHYEESVKGRF
TISRDDSKSSVYLQMNNLRAEDSGIYYCTNWEDYWGQGTTVTVSS
>Tilavonemab|WholemAb|G4|Kappa|Phase-II|Active|light
DIVLTQSPDSLAVSLGERATISCRASQSVSTSRYSYIHWYQQKPGQPPKLLIKYASNLESGVPSRFGSGS
GTDFTLNIHPLEPEDFATYYCHHSWEIPLTFGQGTKLEIK
>Tildrakizumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYIFITYWMTWVRQAPGQGLEWMGQIFPASGSADYNEKFEGRVTM
TTDTSTSTAYMELRSLRSDDTAVYYCARGGGGFAYWGQGTLVTVSS
>Tildrakizumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCRTSENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQHHYGIPFTFGQGTKVEIK
>Tilogotamab|WholemAb|G1|Kappa|Phase-I/II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGFNIKDTHMHWVRQAPGQRLEWIGRIDPANGNTEYDQKFQGRVTI
TVDTSASTAYMELSSLRSEDTAVYYCARWGTNVYFAYWGQGTLVTVSS
>Tilogotamab|WholemAb|G1|Kappa|Phase-I/II|Active|light
DIQLTQSPSSLSASVGDRVTITCSASSSVSYMYWYQQKPGKAPKPWIYRTSNLASGVPSRFSGSGSGTDF
TLTISSLQPEDFATYYCQQYHSYPPTFGGGTVEIK
>Tilvestamab|WholemAb|G1|Kappa|Phase-I|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGYSFTDFYINWWVRQAPGKGLEWVARIFPGGDNTYYNEKFKGRFT
LSADTSKSTAYLQMNSLRAEDTAVYYCARRGLYYAMDYWGQGTLVTVSS
>Tilvestamab|WholemAb|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCRSSQSLVHSNGIPYLHWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGS
GSGTDFTLTISSLQPEDFATYYCSQGTHVPPTFGQGTKVEIK
>Timigutuzumab|WholemAb|G1|Kappa|Phase-I|NFD|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTI
SADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS
>Timigutuzumab|WholemAb|G1|Kappa|Phase-I|NFD|light
DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTD
FTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK
>Timolumab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFFSYAMHWVRQTPGKGLEWVAVIWFDGSNENYVDSVKGRFTI
SRDNSKNTLYLQMNTLRAEDTAVYYCARDAWSYFDYWGQGTLVTVSS
>Timolumab|WholemAb|G4|Kappa|Phase-II|Active|light
VIQLTQSPSSLSASVGDRVTITCRASQGISRALAWYQQKPGKGPKLLIYDASSLESGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK
>Tinurilimab|WholemAb|G2|Kappa|Phase-I|Active|heavy
QVTLRESGPALVKPTQTLTLTCTFSGFSLSTYGIGVGWIRQPPGKALEWLAHIWWNDNKYYSTSLKTRLT
ISKDTSKNQVVLTMTNMDPVDTATYYCARISLPYFDYWGQGTTLTVSS
>Tinurilimab|WholemAb|G2|Kappa|Phase-I|Active|light
DIQLTQSPSFLSASVGDRVTITCKASQNVGTAVAWYQQKPGKAPKLLIYSASNRYTGVPSRFSGSGSGTE
FTLTISSLQPEDFATYYCQQYSSYPLTFGGGTKVEIK
>Tiragolumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWNWIRQSPSRGLEWLGKTYYRFKWYSDYAVSVKGR
ITINPDTSKNQFSLQLNSVTPEDTAVFYCTRESTTYDLLAGPFDYWGQGTLVTVSS
>Tiragolumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIVMTQSPDSLAVSLGERATINCKSSQTVLYSSNNKKYLAWYQQKPGQPPNLLIYWASTRESGVPDRFSG
SGSGTDFTLTISSLQAEDVAVYYCQQYYSTPFTFGPGTKVEIK
>Tislelizumab|WholemAb|G4|Kappa|Preregistration|Active|heavy
QVQLQESGPGLVKPSETLSLTCTVSGFSLTSYGVHWIRQPPGKGLEWIGVIYADGSTNYNPSLKSRVTIS
KDTSKNQVSLKLSSVTAADTAVYYCARAYGNYWYIDVWGQGTTVTVSS
>Tislelizumab|WholemAb|G4|Kappa|Preregistration|Active|light
DIVMTQSPDSLAVSLGERATINCKSSESVSNDVAWYQQKPGQPPKLLINYAFHRFTGVPDRFSGSGYGTD
FTLTISSLQAEDVAVYYCHQAYSSPYTFGQGTKLEIK
>Tisotumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVSSISGSGDYTYYTDSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARSPWGYYLDSWGQGTLVTVSS
>Tisotumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPPSLSASAGDRVTITCRASQGISSRLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYNSYPYTFGQGTKLEIK
>Tocilizumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLQESGPGLVRPSQTLSLTCTVSGYSITSDHAWSWVRQPPGRGLEWIGYISYSGITTYNPSLKSRVTM
LRDTSKNQFSLRLSSVTAADTAVYYCARSLARTTAMDYWGQGSLVTVSS
>Tocilizumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTD
FTFTISSLQPEDIATYYCQQGNTLPYTFGQGTKVEIK
>Tomaralimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
EVQLVQSGSELKKPGASVKLSCKASGFTFTTYGINWVRQAPGQGLEWIGWIYPRDGSTNFNENFKDRATI
TVDTSASTAYMELSSLRSEDTAVYFCARLTGGTFLDYWGQGTTVTVSS
>Tomaralimab|WholemAb|G4|Kappa|Phase-II|Active|light
DIVLTQSPATLSLSPGERATLSCRASESVEYYGTSLMQWYQQKPGQPPKLLIFGASNVESGVPDRFSGSG
SGTDFTLKISRVEAEDVGMYFCQQSRKLPWTFGGGTKVEIK
>Tomuzotuximab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSIN
KDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVST
>Tomuzotuximab|WholemAb|G1|Kappa|Phase-II|Active|light
DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTD
FTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELK
>Toripalimab|WholemAb|G4|Kappa|Approved|Active|heavy
QGQLVQSGAEVKKPGASVKVSCKASGYTFTDYEMHWVRQAPIHGLEWIGVIESETGGTAYNQKFKGRVTI
TADKSTSTAYMELSSLRSEDTAVYYCAREGITTVATTYYWYFDVWGQGTTVTVSS
>Toripalimab|WholemAb|G4|Kappa|Approved|Active|light
DVVMTQSPLSLPVTLGQPASISCRSSQSIVHSNGNTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCFQGSHVPLTFGQGTKLEIK
>Tosatoxumab|WholemAb|G1|Lambda|Phase-III|Active|heavy
EVQMVQSGAEVKKPGEPLKISCKGSGYKFGTHWIGWVRQRPGKGLEWMGIIHPADSETKYSPSFQGQVSF
SADKSSNTAYLHWSTLRASDTAMYYCARRSGSSSWYALDFWGQGTMVTVSS
>Tosatoxumab|WholemAb|G1|Lambda|Phase-III|Active|light
QSVLTQSPSASGTPGQRVTISCSGGSSNIGSNTVNWYQQFPGAAPKLLIYTNNQRPSGVPDRFSGSKSGT
SASLAISGLQSEDEADYYCATWDDSLNGLYVFGTGTKVTVL
>Tovetumab|WholemAb|G2|Kappa|Phase-II|Discontinued|heavy
QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMNWIRQAPGKGLEWVSYISSSGSIIYYADSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCAREGRIAARGMDVWGQGTTVTVSS
>Tovetumab|WholemAb|G2|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVSITCRPSQSFSRYINWYQQKPGKAPKLLIHAASSLVGGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQTYSNPPITFGQGTRLEMK
>Tralokinumab|WholemAb|G4|Lambda|Phase-III|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGLSWVRQAPGQGLEWMGWISANNGDTNYGQEFQGRVTM
TTDTSTSTAYMELRSLRSDDTAVYYCARDSSSSWARWFFDLWGRGTLVTVSS
>Tralokinumab|WholemAb|G4|Lambda|Phase-III|Active|light
SYVLTQPPSVSVAPGKTARITCGGNIIGSKLVHWYQQKPGQAPVLVIYDDGDRPSGIPERFSGSNSGNTA
TLTISRVEAGDEADYYCQVWDTGSDPVVFGGGTKLTVL
>Trastuzumab|WholemAb|G1|Kappa|Approved|NFD|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTI
SADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS
>Trastuzumab|WholemAb|G1|Kappa|Approved|NFD|light
DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTD
FTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK
>Tregalizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EEQLVESGGGLVKPGGSLRLSCAASGFSFSDCRMYWLRQAPGKGLEWIGVISVKSENYGANYAESVRGRF
TISRDDSKNTVYLQMNSLKTEDTAVYYCSASYYRYDVGAWFAYWGQGTLVTVSS
>Tregalizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIVMTQSPDSLAVSLGERATINCRASKSVSTSGYSYIYWYQQKPGQPPKLLIYLASILESGVPDRFSGSG
SGTDFTLTISSLQAEDVAVYYCQHSRELPWTFGQGTKVEIK
>Tremelimumab|WholemAb|G2|Kappa|Phase-III|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARDPRGATLYYYYYGMDVWGQGTTVTVSS
>Tremelimumab|WholemAb|G2|Kappa|Phase-III|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQSINSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYYSTPFTFGPGTKVEIK
>Trevogrumab|WholemAb|G4|Kappa|Phase-II|Active|heavy
EVQVLESGGDLVQPGGSLRLSCAASGFTFSAYAMTWVRQAPGKGLEWVSAISGSGGSAYYADSVKGRFTI
SRDNSKNTVYLQMNSLRAEDTAVYYCAKDGAWKMSGLDVWGQGTTVIVSS
>Trevogrumab|WholemAb|G4|Kappa|Phase-II|Active|light
DIQMTQSPASLSASVGDRVTITCRASQDISDYLAWYQQKPGKIPRLLIYTTSTLQSGVPSRFRGSGSGTD
FTLTISSLQPEDVATYYCQKYDSAPLTFGGGTKVEIK
>Tusamitamab|WholemAb|G1|Kappa|TBC|Active|heavy
EVQLQESGPGLVKPGGSLSLSCAASGFVFSSYDMSWVRQTPERGLEWVAYISSGGGITYAPSTVKGRFTV
SRDNAKNTLYLQMNSLTSEDTAVYYCAAHYFGSSGPFAYWGQGTLVTVSS
>Tusamitamab|WholemAb|G1|Kappa|TBC|Active|light
DIQMTQSPASLSASVGDRVTITCRASENIFSYLAWYQQKPGKSPKLLVYNTRTLAEGVPSRFSGSGSGTD
FSLTISSLQPEDFATYYCQHHYGTPFTFGSGTKLEIK
>Ublituximab|WholemAb|G1|Kappa|Phase-III|Active|heavy
QAYLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGGIYPGNGDTSYNQKFKGKATL
TVGKSSSTAYMQLSSLTSEDSAVYFCARYDYNYAMDYWGQGTSVTVSS
>Ublituximab|WholemAb|G1|Kappa|Phase-III|Active|light
QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYATSNLASGVPARFSGSGSGTSY
SFTISRVEAEDAATYYCQQWTFNPPTFGGGTRLEIK
>Ulocuplumab|WholemAb|G4|Kappa|Phase-I/II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAAAGFTFSSYSMNWVRQAPGKGLEWVSYISSRSRTIYYADSVKGRFTI
SRDNAKNSLYLQMNSLRDEDTAVYYCARDYGGQPPYYYYYGMDVWGQGTTVTVSS
>Ulocuplumab|WholemAb|G4|Kappa|Phase-I/II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFVTYYCQQYNSYPRTFGQGTKVEIK
>Upifitamab|WholemAb|G1|Kappa|Phase-I|Active|heavy
QVQLVQSGAEVVKPGASVKMSCKASGYTFTGYNIHWVKQAPGQGLEWIGAIYPGNGDTSYKQKFRGRATL
TADTSTSTVYMELSSLRSEDSAVYYCARGETARATFAYWGQGTLVTVSS
>Upifitamab|WholemAb|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCSASQDIGNFLNWYQQKPGKTVKVLIYYTSSLYSGVPSRFSGSGSGTD
YTLTISSLQPEDFATYYCQQYSKLPLTFGQGTKLELK
>Urabrelimab|WholemAb|G4|Kappa|Phase-I|Active|heavy
QVQLQESGPGLVKPSGTLSLTCAVSGVSIRSINWWNWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTI
SVDKSKNQFSLKLNSVTAADTAVYYCARDGGIAVTDYYYYGLDVWGQGTTVTVSS
>Urabrelimab|WholemAb|G4|Kappa|Phase-I|Active|light
EIVLTQSPATLSLSPGERATLSCRASESVSSNLAWYQQKPGQAPRLLIYGAFNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSDWFTFGGGTKVEIK
>Urelumab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQSPEKGLEWIGEINHGGYVTYNPSLESRVTIS
VDTSKNQFSLKLSSVTAADTAVYYCARDYGPGNYDWYFDLWGRGTLVTVSS
>Urelumab|WholemAb|G4|Kappa|Phase-II|Active|light
EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTD
FTLTISSLEPEDFAVYYCQQRSNWPPALTFGGGTKVEIK
>Ustekinumab|WholemAb|G1|Kappa|Approved|Active|heavy
EVQLVQSGAEVKKPGESLKISCKGSGYSFTTYWLGWVRQMPGKGLDWIGIMSPVDSDIRYSPSFQGQVTM
SVDKSITTAYLQWNSLKASDTAMYYCARRRPGQGYFDFWGQGTLVTVSS
>Ustekinumab|WholemAb|G1|Kappa|Approved|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYNIYPYTFGQGTKLEIK
>Utomilumab|WholemAb|G2|Lambda|Phase-II|Active|heavy
EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTI
SADKSISTAYLQWSSLKASDTAMYYCARGYGIFDYWGQGTLVTVSS
>Utomilumab|WholemAb|G2|Lambda|Phase-II|Active|light
SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTA
TLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL
>Vadastuximab|WholemAbADC|G1|Kappa|Phase-III|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYDINWVRQAPGQGLEWIGWIYPGDGSTKYNEKFKAKATL
TADTSTSTAYMELRSLRSDDTAVYYCASGYEDAMDYWGQGTTVTVSS
>Vadastuximab|WholemAbADC|G1|Kappa|Phase-III|Discontinued|light
DIQMTQSPSSLSASVGDRVTINCKASQDINSYLSWFQQKPGKAPKTLIYRANRLVDGVPSRFSGSGSGQD
YTLTISSLQPEDFATYYCLQYDEFPLTFGGGTKVEIK
>Valanafusp|WholemAbFusion|G1|Kappa|Phase-II|Active|heavy
QVQLQQSGPELVKPGALVKISCKASGYTFTNYDIHWVKQRPGQGLEWIGWIYPGDGSTKYNEKFKGKATL
TADKSSSTAYMHLSSLTSEKSAVYFCAREWAYWGQGTLVTVSA
>Valanafusp|WholemAbFusion|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASLGERVSLTCRASQDIGGNLYWLQQGPDGTIKRLIYATSSLDSGVPKRFSGSRSGSD
YSLTISSLESEDFVDYYCLQYSSSPWTFGGGTKMEIK
>Vanalimab|WholemAb|G1|Lambda|Phase-I|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWLSYISGGSSYIFYADSVRGRFTI
SRDNSENALYLQMNSLRAEDTAVYYCARILRGGSGMDLWGQGTLVTVSS
>Vanalimab|WholemAb|G1|Lambda|Phase-I|Active|light
QSVLTQPPSASGTPGQRVTISCTGSSSNIGAGYNVYWYQQLPGTAPKLLIYGNINRPSGVPDRFSGSKSG
TSASLAISGLRSEDEADYYCAAWDKSISGLVFGGGTKLTVL
>Vandortuzumab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAVSGYSITSDYAWNWVRQAPGKGLEWVGYISNSGSTSYNPSLKSRFTI
SRDTSKNTLYLQMNSLRAEDTAVYYCARERNYDYDDYYYAMDYWGQGTLVTVSS
>Vandortuzumab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCKSSQSLLYRSNQKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSG
SGSGTDFTLTISSLQPEDFATYYCQQYYNYPRTFGQGTKVEIK
>Vantictumab|WholemAb|G2|Lambda|Phase-I|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSHYTLSWVRQAPGKGLEWVSVISGDGSYTYYADSVKGRFTI
SSDNSKNTLYLQMNSLRAEDTAVYYCARNFIKYVFANWGQGTLVTVSS
>Vantictumab|WholemAb|G2|Lambda|Phase-I|Active|light
DIELTQPPSVSVAPGQTARISCSGDNIGSFYVHWYQQKPGQAPVLVIYDKSNRPSGIPERFSGSNSGNTA
TLTISGTQAEDEADYYCQSYANTLSLVFGGGTKLTVL
>Vanucizumab|BispecificmAb|G1|Lambda;Kappa|Phase-II|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTM
TRDTSISTAYMELSRLRSDDTAVYYCARSPNPYYYDSSGYYYPGAFDIWGQGTMVTVSS
>Vanucizumab|BispecificmAb|G1|Lambda;Kappa|Phase-II|Discontinued|light
QPGLTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTA
TLTISRVEAGDEADYYCQVWDSSSDHYVFGTGTKVTVL
>Varisacumab|WholemAb|G1|Kappa|Phase-II/III|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGFDPEDGETIYAQKFQGRVTM
TEDTSTDTAYMELSSLRSEDTAVYYCATGRSMVRGVIIPFNGMDVWGQGTTVTVSS
>Varisacumab|WholemAb|G1|Kappa|Phase-II/III|Active|light
DIRMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK
>Varlilumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARGSGNWGFFDYWGQGTLVTVSS
>Varlilumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQGISRWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYNTYPRTFGQGTKVEIK
>Vatelizumab|WholemAb|G4|Kappa|Phase-II/III|Discontinued|heavy
QVQLQESGPGLVKPSETLSLTCTVSGFSLTNYGIHWIRQPPGKGLEWLGVIWARGFTNYNSALMSRLTIS
KDNSKNQVSLKLSSVTAADTAVYYCARANDGVYYAMDYWGQGTLVTVSS
>Vatelizumab|WholemAb|G4|Kappa|Phase-II/III|Discontinued|light
DFVMTQSPAFLSVTPGEKVTITCSAQSSVNYIHWYQQKPDQAPKKLIYDTSKLASGVPSRFSGSGSGTDY
TFTISSLEAEDAATYYCQQWTTNPLTFGQGTKVEIK
>Vedolizumab|WholemAb|G1|Kappa|Approved|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKGSGYTFTSYWMHWVRQAPGQRLEWIGEIDPSESNTNYNQKFKGRVTL
TVDISASTAYMELSSLRSEDTAVYYCARGGYDGWDYAIDYWGQGTLVTVSS
>Vedolizumab|WholemAb|G1|Kappa|Approved|Active|light
DVVMTQSPLSLPVTPGEPASISCRSSQSLAKSYGNTYLSWYLQKPGQSPQLLIYGISNRFSGVPDRFSGS
GSGTDFTLKISRVEAEDVGVYYCLQGTHQPYTFGQGTKVEIK
>Veltuzumab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLQQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVKQAPGQGLEWIGAIYPGMGDTSYNQKFKGKATL
TADESTNTAYMELSSLRSEDTAFYYCARSTYYGGDWYFDVWGQGTTVTVSS
>Veltuzumab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQLTQSPSSLSASVGDRVTMTCRASSSVSYIHWFQQKPGKAPKPWIYATSNLASGVPVRFSGSGSGTDY
TFTISSLQPEDIATYYCQQWTSNPPTFGGGTKLEIK
>Vesencumab|WholemAb|G1|Kappa|Phase-I|Discontinued|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSQISPAGGYTNYADSVKGRFTI
SADTSKNTAYLQMNSLRAEDTAVYYCARGELPYYRMSKVMDVWGQGTLVTVSS
>Vesencumab|WholemAb|G1|Kappa|Phase-I|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQYFSSYLAWYQQKPGKAPKLLIYGASSRASGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYLGSPPTFGQGTKVEIK
>Vibecotamab|BispecificMixedmAbandscFv|G1|Kappa;Kappa|Phase-I|Active|heavy
QVQLQQSGAEVKKPGASVKVSCKASGYTFTDYYMKWVKQSHGKSLEWMGDIIPSNGATFYNQKFKGKATL
TVDRSTSTAYMELSSLRSEDTAVYYCARSHLLRASWFAYWGQGTLVTVSS
>Vibecotamab|BispecificMixedmAbandscFv|G1|Kappa;Kappa|Phase-I|Active|light
DFVMTQSPDSLAVSLGERATINCKSSQSLLNTGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTG
SGSGTDFTLTISSLQAEDVAVYYCQNDYSYPYTFGGGTKLEIK
>Vibostolimab|WholemAb|G1|Kappa|Phase-I|Active|heavy
EVQLVQSGAEVKKPGSSVKVSCKASGYTFSSYVMHWVRQAPGQGLEWIGYIDPYNDGAKYAQKFQGRVTL
TSDKSTSTAYMELSSLRSEDTAVYYCARGGPYGWYFDVWGQGTTVTVSS
>Vibostolimab|WholemAb|G1|Kappa|Phase-I|Active|light
DIQMTQSPSSLSASVGDRVTITCRASEHIYSYLSWYQQKPGKVPKLLIYNAKTLAEGVPSRFSGSGSGTD
FTLTISSLQPEDVATYYCQHHFGSPLTFGQGTRLEIK
>Vilobelimab|WholemAb|G4|Kappa|Phase-II|Active|heavy
QVQLQQSGPQLVRPGTSVKISCKASGYSFTTFWMDWVKQRPGQGLEWIGRIDPSDSESRLDQRFKDRATL
TVDKSSSTVYMQLSSPTSEDSAVYYCARGNDGYYGFAYWGQGTLVTVSS
>Vilobelimab|WholemAb|G4|Kappa|Phase-II|Active|light
DIVLTQSPASLAVSLGQRATISCKASQSVDYDGDSYMKWYQQKPGQPPKLLIYAASNLQSGIPARFSGSG
SGTDFTLNIHPVEEEDAATYYCQQSNEDPYTFGGGTKLEIK
>Visilizumab|WholemAb|G2|nd|Phase-III|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFISYTMHWVRQAPGQGLEWMGYINPRSGYTHYNQKLKDKATL
TADKSASTAYMELSSLRSEDTAVYYCARSAYYDYDGFAYWGQGTLVTVSS
>Visilizumab|WholemAb|G2|nd|Phase-III|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQKPGKAPKRLIYDTSKLASGVPSRFSGSGSGTDF
TLTISSLQPEDFATYYCQQWSSNPPTFGGGTKVEIK
>Vixarelimab|WholemAb|G4-G1|Lambda|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYEINWVRQATGQGLEWMGWMNPNSGYTGYAQKFQGRVTM
TRDTSISTAYMEMSSLRSEDTAVYYCARDIVAANTDYYFYYGMDVWGQGTTVTVSS
>Vixarelimab|WholemAb|G4-G1|Lambda|Phase-II|Active|light
QSVLTQPPSASGTPGQRVTISCSGSNSNIGSNTVNWYHQLPGTAPKLLIYNINKRPSGVPDRFSGSKSGS
SASLAISGLQSEDEADYYCSTWDDSLDGVVFGGGTKLTVL
>Vobarilizumab|BispecificSingleDomains(VH-VH')|na|na|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGSVFKINVMAWYRQAPGKGRELVAGIISGGSTSYADSVKGRFTIS
RDNAKNTLYLQMNSLRPEDTAVYYCAFITTESDYDLGRRYWGQGTLVTVSS
>Vofatamab|WholemAb|G1|Kappa|Phase-I/II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFTSTGISWVRQAPGKGLEWVGRIYPTSGSTNYADSVKGRFTI
SADTSKNTAYLQMNSLRAEDTAVYYCARTYGIYDLYVDYTEYVMDYWGQGTLVTVSS
>Vofatamab|WholemAb|G1|Kappa|Phase-I/II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQDVDTSLAWYKQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQSTGHPQTFGQGTKVEIK
>Volagidemab|WholemAb|G2|Kappa|Phase-II|Active|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVMWYDGSNKDYVDSVKGRFTI
SRDNSKNTLYLQMNRLRAEDTAVYYCAREKDHYDILTGYNYYYGLDVWGQGTTVTVSS
>Volagidemab|WholemAb|G2|Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASSLQSGVPSRFSGSGSGTE
FTLTISSVQPEDFVTYYCLQHNSNPLTFGGGTKVEIK
>Vonlerolizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
EVQLVQSGAEVKKPGASVKVSCKASGYTFTDSYMSWVRQAPGQGLEWIGDMYPDNGDSSYNQKFRERVTI
TRDTSTSTAYLELSSLRSEDTAVYYCVLAPRWYFSVWGQGTLVTVSS
>Vonlerolizumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLRSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQGHTLPPTFGQGTKVEIK
>Vopratelimab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYWMDWVRQAPGKGLVWVSNIDEDGSITEYSPFVKGRFTI
SRDNAKNTLYLQMNSLRAEDTAVYYCTRWGRFGFDSWGQGTLVTVSS
>Vopratelimab|WholemAb|G1|Kappa|Phase-II|Active|light
DIVMTQSPDSLAVSLGERATINCKSSQSLLSGSFNYLTWYQQKPGQPPKLLIFYASTRHTGVPDRFSGSG
SGTDFTLTISSLQAEDVAVYYCHHHYNAPPTFGPGTKVDIK
>Vorsetuzumab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLKWMGWINTYTGEPTYADAFKGRVTM
TRDTSISTAYMELSRLRSDDTAVYYCARDYGDYGMDYWGQGTTVTVSS
>Vorsetuzumab|WholemAbADC|G1|Kappa|Phase-I|Discontinued|light
DIVMTQSPDSLAVSLGERATINCRASKSVSTSGYSFMHWYQQKPGQPPKLLIYLASNLESGVPDRFSGSG
SGTDFTLTISSLQAEDVAVYYCQHSREVPWTFGQGTKVEIK
>Vudalimab|BispecificMixedmAbandscFv|G1|Kappa;Kappa|TBC|Active|heavy
EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVSFISYDGNNKYYADSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARTGWLGPFDYWGQGTLVTVSS
>Vudalimab|BispecificMixedmAbandscFv|G1|Kappa;Kappa|TBC|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGAFSRATGIPDRFSGSGSGT
DFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK
>Vulinacimab|WholemAb|G1|Kappa|Phase-I|Active|heavy
QVQLVQSGGGLVQPGGSLRLSCAASGFSFSTYAMSWVRQAPGKGLEWVSGISGSGGTTHYADSVKGRFTI
SRDNSKNTVNLQMNSLRAEDTAVYYCAKGLWFGEGLWGQGTLVTVSS
>Vulinacimab|WholemAb|G1|Kappa|Phase-I|Active|light
DVVMTQSPLSLPVTLGQPASISCRSSQSLYYRSGYTFLDWYVQKPGQSPQLLIYQSSKRDSGVPDRISGS
GSGTDFTLRISRVEAEDVGVYYCFQGTHWPYTFGQGTKLEIK
>Vunakizumab|WholemAb|G1|Kappa|Phase-I/II|Active|heavy
EVQLVQSGAEVKKPGASVKVSCKASGYTFTDYEVHWVRQAPGQGLEWMGVIDPGTGGVAYNQKFEGRVTM
TADTSTSTAYMELRSLRSDDTAVYYCTRYSLFYGSSPYAMDYWGQGTLVTVSS
>Vunakizumab|WholemAb|G1|Kappa|Phase-I/II|Active|light
EIVLTQSPDFQSVTPKEKVTITCSASSSVNYMHWFQQKPDQSPKLWIYRTSNLASGVPSRFSGSGSGTDY
TLTINSLEAEDAATYYCQQRSSYPWTFGQGTKLEIK
>Xentuzumab|WholemAb|G1|Lambda|Phase-II|Active|heavy
QVELVESGGGLVQPGGSLRLSCAASGFTFTSYWMSWVRQAPGKGLELVSSITSYGSFTYYADSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARNMYTHFDSWGQGTLVTVSS
>Xentuzumab|WholemAb|G1|Lambda|Phase-II|Active|light
DIVLTQPPSVSGAPGQRVTISCSGSSSNIGSNSVSWYQQLPGTAPKLLIYDNSKRPSGVPDRFSGSKSGT
SASLAITGLQSEDEADYYCQSRDTYGYYWVFGGGTKLTVL
>Zagotenemab|WholemAb|G4|Kappa|Phase-II|Active|heavy
EVQLVQSGAEVKKPGESLKISCKGSGYTFSNYWIEWVRQMPGKGLEWMGEILPGSDSIKYEKNFKGQVTI
SADKSISTAYLQWSSLKASDTAMYYCARRGNYVDDWGQGTLVTVSS
>Zagotenemab|WholemAb|G4|Kappa|Phase-II|Active|light
EIVLTQSPGTLSLSPGERATLSCRSSQSLVHSNQNTYLHWYQQKPGQAPRLLIYKVDNRFSGIPDRFSGS
GSGTDFTLTISRLEPEDFAVYYCSQSTLVPLTFGGGTKVEIK
>Zalifrelimab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTI
SRDNAKNSLYLQMNSLRAEDTAVYYCARVGLMGPFDIWGQGTMVTVSS
>Zalifrelimab|WholemAb|G1|Kappa|Phase-II|Active|light
EIVLTQSPGTLSLSPGERATLSCRASQSVSRYLGWYQQKPGQAPRLLIYGASTRATGIPDRFSGSGSGTD
FTLTITRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK
>Zalutumumab|WholemAb|G1|Kappa|Phase-II|Discontinued|heavy
QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVIWDDGSYKYYGDSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYYCARDGITMVRGVMKDYFDYWGQGTLVTVSS
>Zalutumumab|WholemAb|G1|Kappa|Phase-II|Discontinued|light
AIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSESGTD
FTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK
>Zampilimab|WholemAb|G4|Kappa|Phase-I/II|Active|heavy
EVQLLESGGGLVQPGGSLRLSCAASGFTLSTHAMSWVRQAPGKGLEWVATISSGGRSTYYPDSVKGRFTI
SRDNSKNTLYLQMNSLRAEDTAVYFCARLISTYWGQGTLVTVSS
>Zampilimab|WholemAb|G4|Kappa|Phase-I/II|Active|light
DITMTQSPSSLSASVGDRVTITCKASQDINSYLTWFQQKPGKAPKILIYLVNRLVDGVPSRFSGSGSGQD
YALTISSLQPEDFATYYCLQYDDFPYTFGQGTKVEIK
>Zanidatamab|BispecificmAb|G1|Kappa;Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTFADYTMDWVRQAPGKGLEWVGDVNPNSGGSIYNQRFKGRFTF
SVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSS
>Zanidatamab|BispecificmAb|G1|Kappa;Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQYYIYPATFGQGTKVEIK
>Zanolimumab|WholemAb|G1|Kappa|Phase-III|Discontinued|heavy
QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTIS
VDTSKNQFSLKLSSVTAADTAVYYCARVINWFDPWGQGTLVTVSS
>Zanolimumab|WholemAb|G1|Kappa|Phase-III|Discontinued|light
DIQMTQSPSSVSASVGDRVTITCRASQDISSWLAWYQHKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQANSFPYTFGQGTKLEIK
>Zatuximab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLQQPGSELVRPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNIYPGSRSTNYDEKFKSKATL
TVDTSSSTAYMQLSSLTSEDSAVYYCTRNGDYYVSSGDAMDYWGQGTSVTVSS
>Zatuximab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQTTSSLSASLGDRVTISCRTSQDIGNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTD
FSLTINNVEQEDVATYFCQHYNTVPPTFGGGTKLEIK
>Zelminemab|WholemAb|G1|Kappa|Phase-II|Active|heavy
QVQLVESGAEVVKPGASVKVSCKASGFTFSRFAMHWVRQAPGQGLEWMGVISYDGGNKYYAESVKGRVTM
TRDTSTSTLYMELSSLRSEDTAVYYCARGYDVLTGYPDYWGQGTLVTVSS
>Zelminemab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQLTQSPSFLSASVGDRVTITCRASQSIGRSLHWYQQKPGKAPKLLIKYASQSLSGVPSRFSGSGSGTE
FTLTISSLQPEDFATYYCHQSSRLPFTFGPGTKVDIK
>Zenocutuzumab|BispecificmAb|G1|Kappa;Kappa|Phase-II|Active|heavy
QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTM
TRDTSISTAYMELSRLRSDDTAVYYCARDHGSRHFWSYWGFDYWGQGTLVTVSS
>Zenocutuzumab|BispecificmAb|G1|Kappa;Kappa|Phase-II|Active|light
DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTD
FTLTISSLQPEDFATYYCQQSYSTPPTFGQGTKVEIK
>Ziltivekimab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLVESGGGLVQPGGSLRLSCAASGFTISSNYMIWVRQAPGKGLEWVSDLYYYAGDTYYADSVKGRFTM
SRDISKNTVYLQMNSLRAEDTAVYYCARWADDHPPWIDLWGRGTLVTVSS
>Ziltivekimab|WholemAb|G1|Kappa|Phase-II|Active|light
DIQMTQSPSTLSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKVLIYKASTLESGVPSRFSGSGSGTE
FTLTISSLQPDDFATYYCQQSWLGGSFGQGTKLEIK
>Zimberelimab|WholemAb|G4|Lambda|Phase-II|Active|heavy
QLQLQESGPGLVKPSETLTLTCTVSADSISSTTYYWVWIRQPPGKGLEWIGSISYSGSTYYNPSLKSRVT
VSVDTSKNQFSLKLNSVAATDTALYYCARHLGYNGRYLPFDYWGQGTLVTVSS
>Zimberelimab|WholemAb|G4|Lambda|Phase-II|Active|light
QSALTQPASVSGSPGQSITISCTGTSSDVGFYNYVSWYQQHPGKAPELMIYDVSNRPSGVSDRFSGSKSG
NTASLTISGLQAEDEADYYCSSYTSISTWVFGGGTKLTVL
>Zolbetuximab|WholemAb|G1|Kappa|Phase-III|Active|heavy
QVQLQQPGAELVRPGASVKLSCKASGYTFTSYWINWVKQRPGQGLEWIGNIYPSDSYTNYNQKFKDKATL
TVDKSSSTAYMQLSSPTSEDSAVYYCTRSWRGNSFDYWGQGTTLTVSS
>Zolbetuximab|WholemAb|G1|Kappa|Phase-III|Active|light
DIVMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTG
SGSGTDFTLTISSVQAEDLAVYYCQNDYSYPFTFGSGTKLEIK
>Zolimomab|WholemAb|G2a|Kappa|Approved|Discontinued|heavy
QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKFKDKATL
TTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTTLTVSS
>Zolimomab|WholemAb|G2a|Kappa|Approved|Discontinued|light
QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAHFRGSGSGTSY
SLTISGMEAEDAATYYCQQWSSNPFTFGSGTKLEIN
>Zuberitamab|WholemAb|G1|Kappa|Phase-II|Active|heavy
EVQLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGAIYPGNGDYSYNQKFKGKATL
TVDKSSSTAYMQLSSLTSEDSAVYFCARVVYYSNSYWYFDVWGTGTTVTVSS
>Zuberitamab|WholemAb|G1|Kappa|Phase-II|Active|light
DIELSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYAPSNLASGVPARFSGSGSGTSY
SLTISRVEAEDAATYYCQQWSFNPPTFGAGTKLEIK
